Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_000709.4(BCKDHA):c.1074C>A (p.Asp358Glu)	BCKDHA	D357E, D358E	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001195924	19	41928981	19	41423076	1195924	1185970		NC_000019.10:41423075:C:A
NM_000709.4(BCKDHA):c.691G>T (p.Val231Phe)	BCKDHA	V231F	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001195923	19	41928113	19	41422208	1195923	1185969		NC_000019.10:41422207:G:T
NM_000709.4(BCKDHA):c.586G>A (p.Gly196Ser)	BCKDHA	G196S	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001195904	19	41925141	19	41419236	1195904	1185968		NC_000019.10:41419235:G:A
NM_000709.4(BCKDHA):c.995+90C>T	BCKDHA		not provided|Maple syrup urine disease	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV001181397	19	41928765	19	41422860	1181397	1173258		NC_000019.10:41422859:C:T
NM_000709.4(BCKDHA):c.853+61T>C	BCKDHA		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV001172985	19	41928336	19	41422431	1172985	1162170		NC_000019.10:41422430:T:C
NM_000709.4(BCKDHA):c.289-7C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001161176	19	41916821	19	41410916	1161176	1148876		NC_000019.10:41410915:C:T
NM_000709.4(BCKDHA):c.192G>A (p.Lys64=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jan 21, 2020)	criteria provided, single submitter	VCV001159113	19	41916625	19	41410720	1159113	1148874		NC_000019.10:41410719:G:A
NM_000709.4(BCKDHA):c.1038C>T (p.Arg346=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001158633	19	41928945	19	41423040	1158633	1148884		NC_000019.10:41423039:C:T
NM_000709.4(BCKDHA):c.822C>T (p.Pro274=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Apr 11, 2020)	criteria provided, single submitter	VCV001157377	19	41928244	19	41422339	1157377	1148881		NC_000019.10:41422338:C:T
NM_000709.4(BCKDHA):c.258C>G (p.Gly86=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV001157291	19	41916691	19	41410786	1157291	1148875		NC_000019.10:41410785:C:G
NM_000709.4(BCKDHA):c.517C>T (p.Leu173=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV001154993	19	41925072	19	41419167	1154993	1148879		NC_000019.10:41419166:C:T
NM_000709.4(BCKDHA):c.705C>T (p.Tyr235=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV001153995	19	41928127	19	41422222	1153995	1148880		NC_000019.10:41422221:C:T
NM_000709.4(BCKDHA):c.27G>A (p.Arg9=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV001153739	19	41903759	19	41397854	1153739	1148871		NC_000019.10:41397853:G:A
NM_000709.4(BCKDHA):c.1168-4A>G	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jul 18, 2020)	criteria provided, single submitter	VCV001152253	19	41930339	19	41424434	1152253	1148886		NC_000019.10:41424433:A:G
NM_000709.4(BCKDHA):c.995+10G>A	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001150487	19	41928685	19	41422780	1150487	1148882		NC_000019.10:41422779:G:A
NM_000709.4(BCKDHA):c.1317A>C (p.Pro439=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001150313	19	41930492	19	41424587	1150313	1148888		NC_000019.10:41424586:A:C
NM_000709.4(BCKDHA):c.423C>T (p.His141=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Apr 26, 2020)	criteria provided, single submitter	VCV001147587	19	41920001	19	41414096	1147587	1148877		NC_000019.10:41414095:C:T
NM_000709.4(BCKDHA):c.504C>T (p.Asp168=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 19, 2020)	criteria provided, single submitter	VCV001147552	19	41925059	19	41419154	1147552	1148878		NC_000019.10:41419153:C:T
NM_000709.4(BCKDHA):c.1197G>C (p.Arg399=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001146677	19	41930372	19	41424467	1146677	1148887		NC_000019.10:41424466:G:C
NM_000709.4(BCKDHA):c.108+8C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 2, 2019)	criteria provided, single submitter	VCV001145188	19	41903848	19	41397943	1145188	1148872		NC_000019.10:41397942:C:T
NM_000709.4(BCKDHA):c.999C>T (p.Ile333=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001143235	19	41928906	19	41423001	1143235	1148883		NC_000019.10:41423000:C:T
NM_000709.4(BCKDHA):c.1101T>C (p.Tyr367=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV001143208	19	41929008	19	41423103	1143208	1148885		NC_000019.10:41423102:T:C
NM_000709.4(BCKDHA):c.129G>A (p.Gln43=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV001143042	19	41916562	19	41410657	1143042	1148873		NC_000019.10:41410656:G:A
NM_000709.4(BCKDHA):c.24G>A (p.Ala8=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV001138391	19	41903756	19	41397851	1138391	1127905		NC_000019.10:41397850:G:A
NM_000709.4(BCKDHA):c.126G>A (p.Gln42=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV001137145	19	41916559	19	41410654	1137145	1127907		NC_000019.10:41410653:G:A
NM_000709.4(BCKDHA):c.492G>C (p.Leu164=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV001136162	19	41925047	19	41419142	1136162	1127911		NC_000019.10:41419141:G:C
NM_000709.4(BCKDHA):c.867C>T (p.Pro289=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 14, 2019)	criteria provided, single submitter	VCV001135489	19	41928547	19	41422642	1135489	1127913		NC_000019.10:41422641:C:T
NM_000709.4(BCKDHA):c.438C>T (p.Ala146=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001133167	19	41920016	19	41414111	1133167	1127910		NC_000019.10:41414110:C:T
NM_000709.4(BCKDHA):c.438C>G (p.Ala146=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001130026	19	41920016	19	41414111	1130026	1127909		NC_000019.10:41414110:C:G
NM_000709.4(BCKDHA):c.888C>T (p.Ile296=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 27, 2020)	criteria provided, single submitter	VCV001127738	19	41928568	19	41422663	1127738	1127914		NC_000019.10:41422662:C:T
NM_000709.4(BCKDHA):c.660G>A (p.Ala220=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001124331	19	41928082	19	41422177	1124331	1127912		NC_000019.10:41422176:G:A
NM_000709.4(BCKDHA):c.1176G>A (p.Glu392=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 24, 2020)	criteria provided, single submitter	VCV001122508	19	41930351	19	41424446	1122508	1127918		NC_000019.10:41424445:G:A
NM_000709.4(BCKDHA):c.1168-6C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 7, 2020)	criteria provided, single submitter	VCV001121903	19	41930337	19	41424432	1121903	1127917		NC_000019.10:41424431:C:T
NM_000709.4(BCKDHA):c.915C>T (p.Ala305=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, single submitter	VCV001121756	19	41928595	19	41422690	1121756	1127915		NC_000019.10:41422689:C:T
NM_000709.4(BCKDHA):c.996-10C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 13, 2020)	criteria provided, single submitter	VCV001121386	19	41928893	19	41422988	1121386	1127916		NC_000019.10:41422987:C:T
NM_000709.4(BCKDHA):c.30C>T (p.Val10=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 7, 2019)	criteria provided, single submitter	VCV001120833	19	41903762	19	41397857	1120833	1127906		NC_000019.10:41397856:C:T
NM_000709.4(BCKDHA):c.1320G>A (p.Leu440=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001120728	19	41930495	19	41424590	1120728	1127919		NC_000019.10:41424589:G:A
NM_000709.4(BCKDHA):c.420G>T (p.Thr140=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 18, 2020)	criteria provided, single submitter	VCV001119616	19	41919998	19	41414093	1119616	1106542		NC_000019.10:41414092:G:T
NM_000709.4(BCKDHA):c.15C>A (p.Ile5=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV001118789	19	41903747	19	41397842	1118789	1106531		NC_000019.10:41397841:C:A
NM_000709.4(BCKDHA):c.633G>T (p.Thr211=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 30, 2019)	criteria provided, single submitter	VCV001118225	19	41925188	19	41419283	1118225	1106545		NC_000019.10:41419282:G:T
NM_000709.4(BCKDHA):c.426G>A (p.Val142=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001117719	19	41920004	19	41414099	1117719	1106543		NC_000019.10:41414098:G:A
NM_000709.4(BCKDHA):c.289-4G>A	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001115872	19	41916824	19	41410919	1115872	1106538		NC_000019.10:41410918:G:A
NM_000709.4(BCKDHA):c.186A>T (p.Ile62=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 26, 2019)	criteria provided, single submitter	VCV001114780	19	41916619	19	41410714	1114780	1106536		NC_000019.10:41410713:A:T
NM_000709.4(BCKDHA):c.1286G>A (p.Arg429His)	BCKDHA	R428H, R429H	Maple syrup urine disease	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV001114459	19	41930461	19	41424556	1114459	1106549		NC_000019.10:41424555:G:A
NM_000709.4(BCKDHA):c.138A>T (p.Ser46=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001112565	19	41916571	19	41410666	1112565	1106534		NC_000019.10:41410665:A:T
NM_000709.4(BCKDHA):c.1308G>A (p.Glu436=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001112239	19	41930483	19	41424578	1112239	1106550		NC_000019.10:41424577:G:A
NM_000709.4(BCKDHA):c.123G>A (p.Gln41=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Sep 27, 2020)	criteria provided, single submitter	VCV001111115	19	41916556	19	41410651	1111115	1106533		NC_000019.10:41410650:G:A
NM_000709.4(BCKDHA):c.282C>T (p.Asp94=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 30, 2019)	criteria provided, single submitter	VCV001110227	19	41916715	19	41410810	1110227	1106537		NC_000019.10:41410809:C:T
NM_000709.4(BCKDHA):c.376-9C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001108936	19	41919945	19	41414040	1108936	1106541		NC_000019.10:41414039:C:T
NM_000709.4(BCKDHA):c.489G>A (p.Val163=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 28, 2019)	criteria provided, single submitter	VCV001107022	19	41925044	19	41419139	1107022	1106544		NC_000019.10:41419138:G:A
NM_000709.4(BCKDHA):c.109-5C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: May 7, 2019)	criteria provided, single submitter	VCV001106715	19	41916537	19	41410632	1106715	1106532		NC_000019.10:41410631:C:T
NM_000709.4(BCKDHA):c.171C>T (p.Ala57=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, single submitter	VCV001106654	19	41916604	19	41410699	1106654	1106535		NC_000019.10:41410698:C:T
NM_000709.4(BCKDHA):c.339C>T (p.Asn113=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001104189	19	41916878	19	41410973	1104189	1106539		NC_000019.10:41410972:C:T
NM_000709.4(BCKDHA):c.351C>T (p.Arg117=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV001102695	19	41916890	19	41410985	1102695	1106540		NC_000019.10:41410984:C:T
NM_000709.4(BCKDHA):c.810C>T (p.Ala270=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001101621	19	41928232	19	41422327	1101621	1106546		NC_000019.10:41422326:C:T
NM_000709.4(BCKDHA):c.996-6G>C	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001100432	19	41928897	19	41422992	1100432	1106548		NC_000019.10:41422991:G:C
NM_000709.4(BCKDHA):c.963C>T (p.Asn321=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 1, 2020)	criteria provided, single submitter	VCV001099873	19	41928643	19	41422738	1099873	1106547		NC_000019.10:41422737:C:T
NM_000709.4(BCKDHA):c.376-10A>G	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV001094584	19	41919944	19	41414039	1094584	1084758		NC_000019.10:41414038:A:G
NM_000709.4(BCKDHA):c.35G>C (p.Arg12Pro)	BCKDHA	R12P	Maple syrup urine disease	Likely benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001093746	19	41903767	19	41397862	1093746	1084748		NC_000019.10:41397861:G:C
NM_000709.4(BCKDHA):c.681T>C (p.Asn227=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001093039	19	41928103	19	41422198	1093039	1084760		NC_000019.10:41422197:T:C
NM_000709.4(BCKDHA):c.684C>T (p.Ala228=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV001092191	19	41928106	19	41422201	1092191	1084761		NC_000019.10:41422200:C:T
NM_000709.4(BCKDHA):c.729G>A (p.Glu243=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV001091072	19	41928151	19	41422246	1091072	1084763		NC_000019.10:41422245:G:A
NM_000709.4(BCKDHA):c.176C>T (p.Ala59Val)	BCKDHA	A59V	Maple syrup urine disease	Likely benign(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001090704	19	41916609	19	41410704	1090704	1084755		NC_000019.10:41410703:C:T
NM_000709.4(BCKDHA):c.1070A>G (p.Gln357Arg)	BCKDHA	Q356R, Q357R	Maple syrup urine disease	Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, single submitter	VCV001090099	19	41928977	19	41423072	1090099	1084769		NC_000019.10:41423071:A:G
NM_000709.4(BCKDHA):c.69G>C (p.Leu23=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 24, 2020)	criteria provided, single submitter	VCV001089960	19	41903801	19	41397896	1089960	1084749		NC_000019.10:41397895:G:C
NM_000709.4(BCKDHA):c.1167+9G>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV001089909	19	41929083	19	41423178	1089909	1084770		NC_000019.10:41423177:G:T
NM_000709.4(BCKDHA):c.73C>T (p.Leu25=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001089552	19	41903805	19	41397900	1089552	1084750		NC_000019.10:41397899:C:T
NM_000709.4(BCKDHA):c.115C>T (p.Pro39Ser)	BCKDHA	P39S	Maple syrup urine disease	Likely benign(Last reviewed: Jul 31, 2020)	criteria provided, single submitter	VCV001088802	19	41916548	19	41410643	1088802	1084752		NC_000019.10:41410642:C:T
NM_000709.4(BCKDHA):c.921C>T (p.Tyr307=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001087749	19	41928601	19	41422696	1087749	1084768		NC_000019.10:41422695:C:T
NM_000709.4(BCKDHA):c.165A>G (p.Pro55=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001085976	19	41916598	19	41410693	1085976	1084754		NC_000019.10:41410692:A:G
NM_000709.4(BCKDHA):c.109-4C>G	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Apr 12, 2020)	criteria provided, single submitter	VCV001085816	19	41916538	19	41410633	1085816	1084751		NC_000019.10:41410632:C:G
NM_000709.4(BCKDHA):c.828T>G (p.Ser276=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001085623	19	41928250	19	41422345	1085623	1084767		NC_000019.10:41422344:T:G
NM_000709.4(BCKDHA):c.699C>A (p.Ile233=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, single submitter	VCV001085524	19	41928121	19	41422216	1085524	1084762		NC_000019.10:41422215:C:A
NM_000709.4(BCKDHA):c.1224C>T (p.Leu408=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV001084513	19	41930399	19	41424494	1084513	1084771		NC_000019.10:41424493:C:T
NM_000709.4(BCKDHA):c.765A>G (p.Thr255=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV001082269	19	41928187	19	41422282	1082269	1084766		NC_000019.10:41422281:A:G
NM_000709.4(BCKDHA):c.735C>T (p.Asp245=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV001082165	19	41928157	19	41422252	1082165	1084764		NC_000019.10:41422251:C:T
NM_000709.4(BCKDHA):c.231C>G (p.Pro77=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jun 10, 2020)	criteria provided, single submitter	VCV001081710	19	41916664	19	41410759	1081710	1084756		NC_000019.10:41410758:C:G
NM_000709.4(BCKDHA):c.756C>T (p.Phe252=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 4, 2019)	criteria provided, single submitter	VCV001081301	19	41928178	19	41422273	1081301	1084765		NC_000019.10:41422272:C:T
NM_000709.4(BCKDHA):c.117C>G (p.Pro39=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, single submitter	VCV001080941	19	41916550	19	41410645	1080941	1084753		NC_000019.10:41410644:C:G
NM_000709.4(BCKDHA):c.348C>T (p.Asp116=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV001079767	19	41916887	19	41410982	1079767	1084757		NC_000019.10:41410981:C:T
NM_000709.4(BCKDHA):c.485-10C>A	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 11, 2019)	criteria provided, single submitter	VCV001078418	19	41925030	19	41419125	1078418	1084759		NC_000019.10:41419124:C:A
NM_000709.4(BCKDHA):c.1314C>T (p.Tyr438=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jan 23, 2019)	criteria provided, single submitter	VCV001077989	19	41930489	19	41424584	1077989	1084772		NC_000019.10:41424583:C:T
NM_000709.4(BCKDHA):c.884C>A (p.Ser295Ter)	BCKDHA	S294*, S295*	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 18, 2020)	criteria provided, single submitter	VCV001073900	19	41928564	19	41422659	1073900	1064721		NC_000019.10:41422658:C:A
NM_000709.4(BCKDHA):c.1306G>T (p.Glu436Ter)	BCKDHA	E435*, E436*	Maple syrup urine disease	Pathogenic(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001072888	19	41930481	19	41424576	1072888	1064722		NC_000019.10:41424575:G:T
NM_000709.4(BCKDHA):c.130C>T (p.Gln44Ter)	BCKDHA	Q44*	Maple syrup urine disease	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV001069052	19	41916563	19	41410658	1069052	1064719		NC_000019.10:41410657:C:T
NM_000709.4(BCKDHA):c.109-1G>A	BCKDHA		Maple syrup urine disease	Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001067117	19	41916541	19	41410636	1067117	1056580		NC_000019.10:41410635:G:A
NM_000709.4(BCKDHA):c.1227C>G (p.Phe409Leu)	BCKDHA	F408L, F409L	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jul 28, 2020)	criteria provided, single submitter	VCV001066997	19	41930402	19	41424497	1066997	1056582		NC_000019.10:41424496:C:G
NM_000709.4(BCKDHA):c.794G>A (p.Arg265Gln)	BCKDHA	R265Q	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jun 27, 2020)	criteria provided, single submitter	VCV001065902	19	41928216	19	41422311	1065902	1056581		NC_000019.10:41422310:G:A
NM_000709.4(BCKDHA):c.434C>T (p.Ala145Val)	BCKDHA	A145V	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 21, 2020)	criteria provided, single submitter	VCV001062897	19	41920012	19	41414107	1062897	1051332		NC_000019.10:41414106:C:T
NM_000709.4(BCKDHA):c.508C>T (p.Pro170Ser)	BCKDHA	P170S	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001053503	19	41925063	19	41419158	1053503	1051333		NC_000019.10:41419157:C:T
NM_000709.4(BCKDHA):c.947G>A (p.Arg316Gln)	BCKDHA	R316Q, R315Q	Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 10, 2020)	criteria provided, single submitter	VCV001035138	19	41928627	19	41422722	1035138	1034324		NC_000019.10:41422721:G:A
NM_000709.4(BCKDHA):c.1262G>A (p.Arg421His)	BCKDHA	R420H, R421H	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001024613	19	41930437	19	41424532	1024613	1013753		NC_000019.10:41424531:G:A
NM_000709.4(BCKDHA):c.996-9C>G	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001024568	19	41928894	19	41422989	1024568	1013751		NC_000019.10:41422988:C:G
NM_000709.4(BCKDHA):c.1195C>T (p.Arg399Trp)	BCKDHA	R398W, R399W	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001015529	19	41930370	19	41424465	1015529	1013752		NC_000019.10:41424464:C:T
NM_000709.4(BCKDHA):c.939C>T (p.Ala313=)	BCKDHA		Maple syrup urine disease|Maple syrup urine disease type 1A	Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, single submitter	VCV000990529	19	41928619	19	41422714	990529	979985		NC_000019.10:41422713:C:T
NM_000709.4(BCKDHA):c.798C>T (p.Asn266=)	BCKDHA		Maple syrup urine disease type 1A	Uncertain significance(Last reviewed: Sep 3, 2020)	no assertion criteria provided	VCV000990528	19	41928220	19	41422315	990528	979984		NC_000019.10:41422314:C:T
NM_000709.4(BCKDHA):c.428G>A (p.Gly143Glu)	BCKDHA	G143E	Maple syrup urine disease type 1A	Uncertain significance(Last reviewed: Aug 14, 2020)	no assertion criteria provided	VCV000990527	19	41920006	19	41414101	990527	979983		NC_000019.10:41414100:G:A
NM_000709.4(BCKDHA):c.405T>A (p.Tyr135Ter)	BCKDHA	Y135*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 31, 2020)	no assertion criteria provided	VCV000984331	19	41919983	19	41414078	984331	972336		NC_000019.10:41414077:T:A
NM_000709.4(BCKDHA):c.196G>T (p.Glu66Ter)	BCKDHA	E66*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Dec 28, 2019)	no assertion criteria provided	VCV000984330	19	41916629	19	41410724	984330	972335		NC_000019.10:41410723:G:T
NM_000709.4(BCKDHA):c.931A>T (p.Lys311Ter)	BCKDHA	K310*, K311*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Sep 29, 2019)	no assertion criteria provided	VCV000983564	19	41928611	19	41422706	983564	972339		NC_000019.10:41422705:A:T
NM_000709.4(BCKDHA):c.712G>T (p.Glu238Ter)	BCKDHA	E238*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Dec 4, 2019)	no assertion criteria provided	VCV000983563	19	41928134	19	41422229	983563	972338		NC_000019.10:41422228:G:T
NM_000709.4(BCKDHA):c.585C>A (p.Tyr195Ter)	BCKDHA	Y195*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Feb 1, 2020)	no assertion criteria provided	VCV000983562	19	41925140	19	41419235	983562	972337		NC_000019.10:41419234:C:A
NM_000709.4(BCKDHA):c.740A>G (p.His247Arg)	BCKDHA	H247R	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000982806	19	41928162	19	41422257	982806	971135		NC_000019.10:41422256:A:G
NM_000709.4(BCKDHA):c.607G>A (p.Val203Ile)	BCKDHA	V203I	Maple syrup urine disease	Uncertain significance(Last reviewed: Apr 1, 2020)	criteria provided, single submitter	VCV000973433	19	41925162	19	41419257	973433	961791		NC_000019.10:41419256:G:A
NM_000709.4(BCKDHA):c.47G>A (p.Gly16Asp)	BCKDHA	G16D	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV000972611	19	41903779	19	41397874	972611	958646		NC_000019.10:41397873:G:A
NM_000709.4(BCKDHA):c.736G>A (p.Ala246Thr)	BCKDHA	A246T	Maple syrup urine disease	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000971839	19	41928158	19	41422253	971839	958648		NC_000019.10:41422252:G:A
NM_000709.4(BCKDHA):c.43C>T (p.Arg15Cys)	BCKDHA	R15C	Maple syrup urine disease	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000970887	19	41903775	19	41397870	970887	958645		NC_000019.10:41397869:C:T
NM_000709.4(BCKDHA):c.1093C>T (p.Arg365Trp)	BCKDHA	R364W, R365W	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 30, 2019)	criteria provided, single submitter	VCV000970723	19	41929000	19	41423095	970723	958649		NC_000019.10:41423094:C:T
NM_000709.4(BCKDHA):c.1167+1G>C	BCKDHA		Maple syrup urine disease	Likely pathogenic(Last reviewed: Oct 1, 2019)	criteria provided, single submitter	VCV000969269	19	41929075	19	41423170	969269	960919		NC_000019.10:41423169:G:C
NM_000709.4(BCKDHA):c.449A>G (p.Asn150Ser)	BCKDHA	N150S	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 29, 2019)	criteria provided, single submitter	VCV000967678	19	41920027	19	41414122	967678	958647		NC_000019.10:41414121:A:G
NM_000709.4(BCKDHA):c.1094G>A (p.Arg365Gln)	BCKDHA	R364Q, R365Q	Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000965929	19	41929001	19	41423096	965929	958650		NC_000019.10:41423095:G:A
NM_000709.4(BCKDHA):c.367C>T (p.Gln123Ter)	BCKDHA	Q123*	Maple syrup urine disease	Pathogenic(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000961802	19	41916906	19	41411001	961802	950804		NC_000019.10:41411000:C:T
NM_000709.4(BCKDHA):c.978C>A (p.Ile326=)	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 22, 2019)	criteria provided, single submitter	VCV000957223	19	41928658	19	41422753	957223	950805		NC_000019.10:41422752:C:A
NM_000709.4(BCKDHA):c.919T>C (p.Tyr307His)	BCKDHA	Y306H, Y307H	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV000950733	19	41928599	19	41422694	950733	928977		NC_000019.10:41422693:T:C
NM_000709.4(BCKDHA):c.135T>G (p.Phe45Leu)	BCKDHA	F45L	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000950042	19	41916568	19	41410663	950042	928975		NC_000019.10:41410662:T:G
NM_000709.4(BCKDHA):c.968C>G (p.Pro323Arg)	BCKDHA	P322R, P323R	Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 13, 2019)	criteria provided, single submitter	VCV000945488	19	41928648	19	41422743	945488	928978		NC_000019.10:41422742:C:G
NM_000709.4(BCKDHA):c.484G>A (p.Gly162Ser)	BCKDHA	G162S	Maple syrup urine disease	Likely pathogenic(Last reviewed: Sep 10, 2019)	criteria provided, single submitter	VCV000940379	19	41920062	19	41414157	940379	938699		NC_000019.10:41414156:G:A
NM_000709.4(BCKDHA):c.1061G>A (p.Trp354Ter)	BCKDHA	W354*, W353*	Maple syrup urine disease	Pathogenic(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV000936117	19	41928968	19	41423063	936117	938701		NC_000019.10:41423062:G:A
NM_000709.4(BCKDHA):c.497A>T (p.Tyr166Phe)	BCKDHA	Y166F	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 18, 2019)	criteria provided, single submitter	VCV000935899	19	41925052	19	41419147	935899	938700		NC_000019.10:41419146:A:T
NM_000709.4(BCKDHA):c.359A>G (p.Tyr120Cys)	BCKDHA	Y120C	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV000934307	19	41916898	19	41410993	934307	938698		NC_000019.10:41410992:A:G
NM_000709.4(BCKDHA):c.1168-1G>A	BCKDHA		Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000931233	19	41930342	19	41424437	931233	920408		NC_000019.10:41424436:G:A
NM_000709.4(BCKDHA):c.*314A>G	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000894414	19	41930827	19	41424922	894414	882092		NC_000019.10:41424921:A:G
NM_000709.4(BCKDHA):c.*301G>A	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894413	19	41930814	19	41424909	894413	882091		NC_000019.10:41424908:G:A
NM_000709.4(BCKDHA):c.*244C>T	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894412	19	41930757	19	41424852	894412	882090		NC_000019.10:41424851:C:T
NM_000709.4(BCKDHA):c.*134C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000894411	19	41930647	19	41424742	894411	882089		NC_000019.10:41424741:C:T
NM_000709.4(BCKDHA):c.*126G>A	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000894410	19	41930639	19	41424734	894410	882088		NC_000019.10:41424733:G:A
NM_000709.4(BCKDHA):c.664G>A (p.Ala222Thr)	BCKDHA	A222T	Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000894372	19	41928086	19	41422181	894372	882084		NC_000019.10:41422180:G:A
NM_000709.4(BCKDHA):c.441C>G (p.Ala147=)	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000894371	19	41920019	19	41414114	894371	882083		NC_000019.10:41414113:C:G
NM_000709.4(BCKDHA):c.261G>T (p.Gln87His)	BCKDHA	Q87H	Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000893709	19	41916694	19	41410789	893709	882082		NC_000019.10:41410788:G:T
NM_000709.4(BCKDHA):c.125A>G (p.Gln42Arg)	BCKDHA	Q42R	Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Aug 29, 2020)	criteria provided, conflicting interpretations	VCV000893708	19	41916558	19	41410653	893708	882081		NC_000019.10:41410652:A:G
NM_000709.4(BCKDHA):c.995+9C>G	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893164	19	41928684	19	41422779	893164	882895		NC_000019.10:41422778:C:G
NM_000709.4(BCKDHA):c.976A>G (p.Ile326Val)	BCKDHA	I325V, I326V	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000893163	19	41928656	19	41422751	893163	882087		NC_000019.10:41422750:A:G
NM_000709.4(BCKDHA):c.*384C>T	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000892972	19	41930897	19	41424992	892972	882093		NC_000019.10:41424991:C:T
NM_000709.4(BCKDHA):c.925G>A (p.Ala309Thr)	BCKDHA	A308T, A309T	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892931	19	41928605	19	41422700	892931	882086		NC_000019.10:41422699:G:A
NM_000709.4(BCKDHA):c.882G>A (p.Met294Ile)	BCKDHA	M294I, M293I	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892930	19	41928562	19	41422657	892930	882085		NC_000019.10:41422656:G:A
NM_000709.4(BCKDHA):c.108+12G>A	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000892894	19	41903852	19	41397947	892894	882894		NC_000019.10:41397946:G:A
NM_000709.4(BCKDHA):c.653G>C (p.Gly218Ala)	BCKDHA	G218A	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV000834598	19	41928075	19	41422170	834598	847726		NC_000019.10:41422169:G:C
NM_000709.4(BCKDHA):c.293C>T (p.Pro98Leu)	BCKDHA	P98L	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)	criteria provided, conflicting interpretations	VCV000808587	19	41916832	19	41410927	808587	797863	rs532803527	NC_000019.10:41410926:C:T
NM_000709.4(BCKDHA):c.647-6C>T	BCKDHA		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000799247	19	41928063	19	41422158	799247	788281	rs1304412476	NC_000019.10:41422157:C:T
NM_000709.4(BCKDHA):c.87G>A (p.Gly29=)	BCKDHA		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Jan 5, 2019)	criteria provided, single submitter	VCV000797614	19	41903819	19	41397914	797614	786201	rs1599945255	NC_000019.10:41397913:G:A
NM_000709.4(BCKDHA):c.1149G>A (p.Arg383=)	BCKDHA		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Dec 8, 2018)	criteria provided, single submitter	VCV000796729	19	41929056	19	41423151	796729	786205	rs190202447	NC_000019.10:41423150:G:A
NM_000709.4(BCKDHA):c.657G>A (p.Ala219=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000796353	19	41928079	19	41422174	796353	786203	rs770514966	NC_000019.10:41422173:G:A
NM_000709.4(BCKDHA):c.927C>T (p.Ala309=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jan 7, 2020)	criteria provided, single submitter	VCV000794424	19	41928607	19	41422702	794424	786204	rs763842430	NC_000019.10:41422701:C:T
NM_000709.4(BCKDHA):c.1302C>T (p.Tyr434=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease|not provided	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV000794247	19	41930477	19	41424572	794247	786206	rs398123491	NC_000019.10:41424571:C:T
NM_000709.4(BCKDHA):c.633G>A (p.Thr211=)	BCKDHA		Maple syrup urine disease type 1A|not provided|Maple syrup urine disease	Likely benign(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000792555	19	41925188	19	41419283	792555	786202	rs750729027	NC_000019.10:41419282:G:A
NM_000709.4(BCKDHA):c.693C>T (p.Val231=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease	Likely benign(Last reviewed: Sep 27, 2020)	criteria provided, single submitter	VCV000766671	19	41928115	19	41422210	766671	772710	rs763610087	NC_000019.10:41422209:C:T
NM_000709.4(BCKDHA):c.732G>A (p.Gly244=)	BCKDHA		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000765410	19	41928154	19	41422249	765410	772712	rs1192566664	NC_000019.10:41422248:G:A
NM_000709.4(BCKDHA):c.726T>C (p.Ser242=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease	Likely benign(Last reviewed: Nov 16, 2020)	criteria provided, single submitter	VCV000765210	19	41928148	19	41422243	765210	772711	rs750023394	NC_000019.10:41422242:T:C
NM_000709.4(BCKDHA):c.891C>T (p.Arg297=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, single submitter	VCV000764670	19	41928571	19	41422666	764670	772713	rs187669174	NC_000019.10:41422665:C:T
NM_000709.4(BCKDHA):c.1041G>A (p.Ser347=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 3, 2020)	criteria provided, single submitter	VCV000764160	19	41928948	19	41423043	764160	772714	rs144276456	NC_000019.10:41423042:G:A
NM_000709.4(BCKDHA):c.402C>T (p.Asn134=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000763603	19	41919980	19	41414075	763603	772707	rs201638798	NC_000019.10:41414074:C:T
NM_000709.4(BCKDHA):c.618C>T (p.Ser206=)	BCKDHA		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000753737	19	41925173	19	41419268	753737	772709	rs144995574	NC_000019.10:41419267:C:T
NM_000709.4(BCKDHA):c.75G>A (p.Leu25=)	BCKDHA		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000753160	19	41903807	19	41397902	753160	772706	rs1599945228	NC_000019.10:41397901:G:A
NM_000709.4(BCKDHA):c.615C>T (p.Ile205=)	BCKDHA		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000753066	19	41925170	19	41419265	753066	772708	rs768600012	NC_000019.10:41419264:C:T
NM_000709.4(BCKDHA):c.606C>T (p.Phe202=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000736694	19	41925161	19	41419256	736694	757047	rs370068964	NC_000019.10:41419255:C:T
NM_000709.4(BCKDHA):c.528C>A (p.Ala176=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000733056	19	41925083	19	41419178	733056	741917	rs755611354	NC_000019.10:41419177:C:A
NM_000709.4(BCKDHA):c.924C>T (p.Asn308=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000732140	19	41928604	19	41422699	732140	741919	rs139390622	NC_000019.10:41422698:C:T
NM_000709.4(BCKDHA):c.1020C>T (p.Asp340=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jul 12, 2019)	criteria provided, single submitter	VCV000729964	19	41928927	19	41423022	729964	741920	rs548045051	NC_000019.10:41423021:C:T
NM_000709.4(BCKDHA):c.819G>T (p.Thr273=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV000729265	19	41928241	19	41422336	729265	741918	rs201991385	NC_000019.10:41422335:G:T
NM_000709.4(BCKDHA):c.330A>T (p.Thr110=)	BCKDHA		Maple syrup urine disease|Maple syrup urine disease type 1A	Conflicting interpretations of pathogenicity(Last reviewed: Nov 27, 2020)	criteria provided, conflicting interpretations	VCV000724214	19	41916869	19	41410964	724214	741916	rs201366184	NC_000019.10:41410963:A:T
NM_000709.4(BCKDHA):c.174G>A (p.Ser58=)	BCKDHA		Maple syrup urine disease|Maple syrup urine disease type 1A	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000722083	19	41916607	19	41410702	722083	741915	rs576803251	NC_000019.10:41410701:G:A
NM_000709.4(BCKDHA):c.1329C>T (p.Phe443=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV000719481	19	41930504	19	41424599	719481	728208	rs148224513	NC_000019.10:41424598:C:T
NM_000709.4(BCKDHA):c.843C>T (p.Gly281=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV000714807	19	41928265	19	41422360	714807	728207	rs371343548	NC_000019.10:41422359:C:T
NM_000709.4(BCKDHA):c.294G>A (p.Pro98=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Nov 24, 2020)	criteria provided, conflicting interpretations	VCV000709510	19	41916833	19	41410928	709510	728206	rs142967869	NC_000019.10:41410927:G:A
NM_000709.4(BCKDHA):c.375+10G>A	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000706503	19	41916924	19	41411019	706503	695825	rs933606851	NC_000019.10:41411018:G:A
NM_000709.4(BCKDHA):c.744C>T (p.Ala248=)	BCKDHA		Maple syrup urine disease|Maple syrup urine disease type 1A	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000703003	19	41928166	19	41422261	703003	694431	rs137960127	NC_000019.10:41422260:C:T
NM_000709.4(BCKDHA):c.1317A>G (p.Pro439=)	BCKDHA		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Dec 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000681460	19	41930492	19	41424587	681460	656572	rs749795206	NC_000019.10:41424586:A:G
NM_000709.4(BCKDHA):c.787T>C (p.Phe263Leu)	BCKDHA	F263L	Maple syrup urine disease|Maple syrup urine disease type 1A	Uncertain significance(Last reviewed: Jul 23, 2018)	criteria provided, single submitter	VCV000652667	19	41928209	19	41422304	652667	648139	rs771360993	NC_000019.10:41422303:T:C
NM_000709.4(BCKDHA):c.1252G>A (p.Ala418Thr)	BCKDHA	A417T, A418T	Maple syrup urine disease	Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, single submitter	VCV000651417	19	41930427	19	41424522	651417	648141	rs368567109	NC_000019.10:41424521:G:A
NM_000709.4(BCKDHA):c.1069C>T (p.Gln357Ter)	BCKDHA	Q357*, Q356*	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2019)	criteria provided, single submitter	VCV000634552	19	41928976	19	41423071	634552	622463	rs762199542	NC_000019.10:41423070:C:T
NM_000709.4(BCKDHA):c.332T>C (p.Leu111Pro)	BCKDHA	L111P	Maple syrup urine disease	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623384	19	41916871	19	41410966	623384	612330	rs1568503938	NC_000019.10:41410965:T:C
NM_000709.4(BCKDHA):c.656C>T (p.Ala219Val)	BCKDHA	A219V	Maple syrup urine disease	Uncertain significance(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000578797	19	41928078	19	41422173	578797	574981	rs532361185	NC_000019.10:41422172:C:T
NM_000709.4(BCKDHA):c.108+5G>C	BCKDHA		Maple syrup urine disease	Likely pathogenic(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000573260	19	41903845	19	41397940	573260	570808	rs1568499702	NC_000019.10:41397939:G:C
NM_000709.4(BCKDHA):c.1087C>T (p.Arg363Trp)	BCKDHA	R363W, R362W	Maple syrup urine disease	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000558581	19	41928994	19	41423089	558581	549361	rs942815730	NC_000019.10:41423088:C:T
NM_000709.4(BCKDHA):c.757G>A (p.Ala253Thr)	BCKDHA	A253T	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jun 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000558191	19	41928179	19	41422274	558191	548799	rs199599175	NC_000019.10:41422273:G:A
NM_000709.4(BCKDHA):c.1119G>A (p.Trp373Ter)	BCKDHA	W373*, W372*	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000557583	19	41929026	19	41423121	557583	548842	rs765543886	NC_000019.10:41423120:G:A
NM_000709.4(BCKDHA):c.794G>C (p.Arg265Pro)	BCKDHA	R265P	Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000556887	19	41928216	19	41422311	556887	549165	rs761996996	NC_000019.10:41422310:G:C
NM_000709.4(BCKDHA):c.3G>A (p.Met1Ile)	BCKDHA	M1I	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000556147	19	41903735	19	41397830	556147	549164	rs1555764014	NC_000019.10:41397829:G:A
NM_000709.4(BCKDHA):c.889C>T (p.Arg297Cys)	BCKDHA	R297C, R296C	Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Aug 25, 2020)	criteria provided, conflicting interpretations	VCV000555477	19	41928569	19	41422664	555477	548829	rs145901144	NC_000019.10:41422663:C:T
NM_000709.4(BCKDHA):c.892G>A (p.Val298Met)	BCKDHA	V298M, V297M	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000554265	19	41928572	19	41422667	554265	548838	rs1253348004	NC_000019.10:41422666:G:A
NM_000709.4(BCKDHA):c.859C>T (p.Arg287Ter)	BCKDHA	R287*, R286*	Maple syrup urine disease	Pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553989	19	41928539	19	41422634	553989	548802	rs764247545	NC_000019.10:41422633:C:T
NM_000709.4(BCKDHA):c.853+1G>T	BCKDHA		Maple syrup urine disease	Likely pathogenic(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000553830	19	41928276	19	41422371	553830	549167	rs1555767028	NC_000019.10:41422370:G:T
NM_000709.4(BCKDHA):c.475C>T (p.Arg159Trp)	BCKDHA	R159W	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000553759	19	41920053	19	41414148	553759	548791	rs769688327	NC_000019.10:41414147:C:T
NM_000709.4(BCKDHA):c.1192G>T (p.Glu398Ter)	BCKDHA	E398*, E397*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Sep 6, 2017)	criteria provided, single submitter	VCV000553717	19	41930367	19	41424462	553717	549177	rs201168715	NC_000019.10:41424461:G:T
NM_000709.4(BCKDHA):c.500G>A (p.Arg167Gln)	BCKDHA	R167Q	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 24, 2017)	criteria provided, single submitter	VCV000552984	19	41925055	19	41419150	552984	548795	rs377517768	NC_000019.10:41419149:G:A
NM_000709.4(BCKDHA):c.562G>T (p.Gly188Trp)	BCKDHA	G188W	Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 15, 2017)	criteria provided, single submitter	VCV000551071	19	41925117	19	41419212	551071	548805	rs1555766625	NC_000019.10:41419211:G:T
NM_000709.4(BCKDHA):c.127C>T (p.Gln43Ter)	BCKDHA	Q43*	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000550878	19	41916560	19	41410655	550878	549360	rs374625613	NC_000019.10:41410654:C:T
NM_000709.4(BCKDHA):c.*223T>A	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 17, 2017)	criteria provided, single submitter	VCV000550781	19	41930736	19	41424831	550781	548803	rs373164531	NC_000019.10:41424830:T:A
NM_000709.4(BCKDHA):c.825C>T (p.Thr275=)	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000527138	19	41928247	19	41422342	527138	533054	rs1555767021	NC_000019.10:41422341:C:T
NM_000709.4(BCKDHA):c.943C>T (p.Arg315Trp)	BCKDHA	R315W, R314W	Maple syrup urine disease	Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522678	19	41928623	19	41422718	522678	513376	rs373336888	NC_000019.10:41422717:C:T
NM_000709.4(BCKDHA):c.420G>A (p.Thr140=)	BCKDHA		Maple syrup urine disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2020)	criteria provided, conflicting interpretations	VCV000515505	19	41919998	19	41414093	515505	506845	rs143608852	NC_000019.10:41414092:G:A
NM_000709.4(BCKDHA):c.1233C>T (p.Asp411=)	BCKDHA		Maple syrup urine disease|not specified	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000514918	19	41930408	19	41424503	514918	507846	rs200363605	NC_000019.10:41424502:C:T
NM_000709.4(BCKDHA):c.289-5C>T	BCKDHA		Maple syrup urine disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000506733	19	41916823	19	41410918	506733	506843	rs200646708	NC_000019.10:41410917:C:T
NM_000709.4(BCKDHA):c.854-2A>G	BCKDHA		Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000500713	19	41928532	19	41422627	500713	492137	rs760494152	NC_000019.10:41422626:A:G
NM_000709.4(BCKDHA):c.647-8C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Mar 27, 2017)	criteria provided, single submitter	VCV000457144	19	41928061	19	41422156	457144	470251	rs763820194	NC_000019.10:41422155:C:T
NM_000709.4(BCKDHA):c.349C>T (p.Arg117Cys)	BCKDHA	R117C	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000457143	19	41916888	19	41410983	457143	468824	rs188135164	NC_000019.10:41410982:C:T
NM_000709.4(BCKDHA):c.1167+4A>C	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 16, 2018)	criteria provided, single submitter	VCV000457142	19	41929078	19	41423173	457142	470256	rs546655391	NC_000019.10:41423172:A:C
NM_000709.4(BCKDHA):c.1081A>G (p.Ile361Val)	BCKDHA	I361V, I360V	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000457140	19	41928988	19	41423083	457140	469856	rs61736656	NC_000019.10:41423082:A:G
NM_000709.4(BCKDHA):c.1168-2A>G	BCKDHA		Maple syrup urine disease|Maple syrup urine disease type 1A|not provided	Likely pathogenic(Last reviewed: Aug 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000431986	19	41930341	19	41424436	431986	426317	rs1555767285	NC_000019.10:41424435:A:G
NM_000709.4(BCKDHA):c.647-1G>C	BCKDHA		Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000431985	19	41928068	19	41422163	431985	426316	rs753216964	NC_000019.10:41422162:G:C
NM_000709.4(BCKDHA):c.213C>T (p.Asn71=)	BCKDHA		Maple syrup urine disease|not specified	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000392392	19	41916646	19	41410741	392392	379597	rs138025447	NC_000019.10:41410740:C:T
NM_000709.4(BCKDHA):c.336T>G (p.Leu112=)	BCKDHA		Maple syrup urine disease|not specified	Likely benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000389804	19	41916875	19	41410970	389804	377548	rs150700696	NC_000019.10:41410969:T:G
NM_000709.4(BCKDHA):c.807C>T (p.Tyr269=)	BCKDHA		not specified|Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000386706	19	41928229	19	41422324	386706	376574	rs775754845	NC_000019.10:41422323:C:T
NM_000709.4(BCKDHA):c.15C>T (p.Ile5=)	BCKDHA		not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000385661	19	41903747	19	41397842	385661	379596	rs17173144	NC_000019.10:41397841:C:T
NM_000709.4(BCKDHA):c.63C>G (p.Ala21=)	BCKDHA		Maple syrup urine disease|not provided|not specified	Likely benign(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000384774	19	41903795	19	41397890	384774	377718	rs140322984	NC_000019.10:41397889:C:G
NM_000709.4(BCKDHA):c.117C>A (p.Pro39=)	BCKDHA		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000382383	19	41916550	19	41410645	382383	376568	rs80014754	NC_000019.10:41410644:C:A
NM_000709.4(BCKDHA):c.840C>T (p.Arg280=)	BCKDHA		not provided|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, multiple submitters, no conflicts	VCV000381845	19	41928262	19	41422357	381845	379598	rs61737367	NC_000019.10:41422356:C:T
NM_000709.4(BCKDHA):c.996-18C>T	BCKDHA		not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000379672	19	41928885	19	41422980	379672	377554	rs201511678	NC_000019.10:41422979:C:T
NM_000709.4(BCKDHA):c.137C>A (p.Ser46Ter)	BCKDHA	S46*	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370729	19	41916570	19	41410665	370729	358619	rs376456598	NC_000019.10:41410664:C:A
NM_000709.4(BCKDHA):c.*365A>G	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000329378	19	41930878	19	41424973	329378	343683	rs886054464	NC_000019.10:41424972:A:G
NM_000709.4(BCKDHA):c.*335G>A	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000329377	19	41930848	19	41424943	329377	349915	rs886054463	NC_000019.10:41424942:G:A
NM_000709.4(BCKDHA):c.*334C>T	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000329376	19	41930847	19	41424942	329376	349914	rs528816040	NC_000019.10:41424941:C:T
NM_000709.4(BCKDHA):c.*324G>A	BCKDHA		Maple syrup urine disease	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000329375	19	41930837	19	41424932	329375	333674	rs564517344	NC_000019.10:41424931:G:A
NM_000709.4(BCKDHA):c.*309A>G	BCKDHA		not provided|Maple syrup urine disease	Benign(Last reviewed: Sep 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000329374	19	41930822	19	41424917	329374	343680	rs10421626	NC_000019.10:41424916:A:G
NM_000709.4(BCKDHA):c.*213G>A	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000329373	19	41930726	19	41424821	329373	333662	rs766667517	NC_000019.10:41424820:G:A
NM_000709.4(BCKDHA):c.*125C>T	BCKDHA		not provided|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Jul 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000329372	19	41930638	19	41424733	329372	333646	rs140867211	NC_000019.10:41424732:C:T
NM_000709.4(BCKDHA):c.*68G>A	BCKDHA		not provided|Maple syrup urine disease	Benign/Likely benign(Last reviewed: May 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000329371	19	41930581	19	41424676	329371	333643	rs375492462	NC_000019.10:41424675:G:A
NM_000709.4(BCKDHA):c.*20C>A	BCKDHA		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000329370	19	41930533	19	41424628	329370	349018	rs370480422	NC_000019.10:41424627:C:A
NM_000709.4(BCKDHA):c.*17C>T	BCKDHA		not provided|Maple syrup urine disease	Benign(Last reviewed: Mar 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000329369	19	41930530	19	41424625	329369	349012	rs372125840	NC_000019.10:41424624:C:T
NM_000709.4(BCKDHA):c.1192G>A (p.Glu398Lys)	BCKDHA	E398K, E397K	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000329368	19	41930367	19	41424462	329368	349913	rs201168715	NC_000019.10:41424461:G:A
NM_000709.4(BCKDHA):c.1191C>T (p.Ala397=)	BCKDHA		Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000329367	19	41930366	19	41424461	329367	349912	rs374403946	NC_000019.10:41424460:C:T
NM_000709.4(BCKDHA):c.995+8C>T	BCKDHA		Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000329366	19	41928683	19	41422778	329366	333641	rs886054462	NC_000019.10:41422777:C:T
NM_000709.4(BCKDHA):c.842G>T (p.Gly281Val)	BCKDHA	G281V	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000329365	19	41928264	19	41422359	329365	343679	rs886054461	NC_000019.10:41422358:G:T
NM_000709.4(BCKDHA):c.648G>T (p.Ala216=)	BCKDHA		not provided|Maple syrup urine disease	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000329364	19	41928070	19	41422165	329364	349910	rs114716391	NC_000019.10:41422164:G:T
NM_000709.4(BCKDHA):c.448A>G (p.Asn150Asp)	BCKDHA	N150D	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000329363	19	41920026	19	41414121	329363	349908	rs140612545	NC_000019.10:41414120:A:G
NM_000709.4(BCKDHA):c.436G>A (p.Ala146Thr)	BCKDHA	A146T	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000329362	19	41920014	19	41414109	329362	343673	rs373078413	NC_000019.10:41414108:G:A
NM_000709.4(BCKDHA):c.435C>T (p.Ala145=)	BCKDHA		Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Apr 7, 2020)	criteria provided, conflicting interpretations	VCV000329361	19	41920013	19	41414108	329361	349008	rs369278165	NC_000019.10:41414107:C:T
NM_000709.4(BCKDHA):c.288+10G>A	BCKDHA		Maple syrup urine disease|Maple syrup urine disease type 1A|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000329360	19	41916731	19	41410826	329360	349906	rs376894084	NC_000019.10:41410825:G:A
NM_000709.4(BCKDHA):c.159G>C (p.Gln53His)	BCKDHA	Q53H	Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000329359	19	41916592	19	41410687	329359	333637	rs775471043	NC_000019.10:41410686:G:C
NM_000709.4(BCKDHA):c.143T>C (p.Leu48Pro)	BCKDHA	L48P	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000329358	19	41916576	19	41410671	329358	333635	rs879103338	NC_000019.10:41410670:T:C
NM_000709.4(BCKDHA):c.63C>T (p.Ala21=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2020)	criteria provided, conflicting interpretations	VCV000329357	19	41903795	19	41397890	329357	333630	rs140322984	NC_000019.10:41397889:C:T
NM_000709.3(BCKDHA):c.-25G>C	BCKDHA		Maple syrup urine disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2018)	criteria provided, conflicting interpretations	VCV000329356	19	41903708	19	41397803	329356	349007	rs202084220	NC_000019.10:41397802:G:C
NM_000709.4(BCKDHA):c.1211A>G (p.Asn404Ser)	BCKDHA	N404S, N403S	Maple syrup urine disease|not specified	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000283770	19	41930386	19	41424481	283770	268007	rs148090804	NC_000019.10:41424480:A:G
NM_000709.4(BCKDHA):c.940C>T (p.Arg314Ter)	BCKDHA	R314*, R313*	Maple syrup urine disease type 1A|Maple syrup urine disease	Pathogenic(Last reviewed: May 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000224072	19	41928620	19	41422715	224072	225801	rs753698250	NC_000019.10:41422714:C:T
NM_000709.4(BCKDHA):c.470A>C (p.Gln157Pro)	BCKDHA	Q157P	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000204380	19	41920048	19	41414143	204380	200771	rs869312125	NC_000019.10:41414142:A:C
NM_000709.4(BCKDHA):c.1198A>T (p.Lys400Ter)	BCKDHA	K400*, K399*	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000204379	19	41930373	19	41424468	204379	200774	rs863225262	NC_000019.10:41424467:A:T
NM_000709.4(BCKDHA):c.476G>A (p.Arg159Gln)	BCKDHA	R159Q	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	VCV000204378	19	41920054	19	41414149	204378	200772	rs773048903	NC_000019.10:41414148:G:A
NM_000709.4(BCKDHA):c.844G>C (p.Asp282His)	BCKDHA	D282H	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2011)	criteria provided, single submitter	VCV000204377	19	41928266	19	41422361	204377	200773	rs869312124	NC_000019.10:41422360:G:C
NM_000709.4(BCKDHA):c.1080C>T (p.Pro360=)	BCKDHA		Maple syrup urine disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 2, 2020)	criteria provided, conflicting interpretations	VCV000198748	19	41928987	19	41423082	198748	195908	rs373390136	NC_000019.10:41423081:C:T
NM_000709.4(BCKDHA):c.1251C>T (p.Pro417=)	BCKDHA		Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000166742	19	41930426	19	41424521	166742	177516	rs147021347	NC_000019.10:41424520:C:T
NM_000709.4(BCKDHA):c.1312T>A (p.Tyr438Asn)	BCKDHA	Y438N, Y437N	Maple syrup urine disease type 1A|Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000100009	19	41930487	19	41424582	100009	17414	rs137852870	NC_000019.10:41424581:T:A
NM_000709.4(BCKDHA):c.996-6G>A	BCKDHA		not specified|Maple syrup urine disease type 1A|Maple syrup urine disease	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093390	19	41928897	19	41422992	93390	99297	rs74586298	NC_000019.10:41422991:G:A
NM_000709.4(BCKDHA):c.995+9C>T	BCKDHA		not specified|Maple syrup urine disease type 1A|Maple syrup urine disease	Benign(Last reviewed: Nov 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093388	19	41928684	19	41422779	93388	99295	rs13343330	NC_000019.10:41422778:C:T
NM_000709.4(BCKDHA):c.995+49G>A	BCKDHA		not specified|not provided|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093387	19	41928724	19	41422819	93387	99294	rs284654	NC_000019.10:41422818:G:A
NM_000709.4(BCKDHA):c.995+26C>T	BCKDHA		Maple syrup urine disease|not specified|not provided	Benign/Likely benign(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093386	19	41928701	19	41422796	93386	99293	rs284653	NC_000019.10:41422795:C:T
NM_000709.4(BCKDHA):c.979G>A (p.Glu327Lys)	BCKDHA	E327K, E326K	Maple syrup urine disease|not provided|Maple syrup urine disease type 1A	Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093385	19	41928659	19	41422754	93385	99292	rs398123515	NC_000019.10:41422753:G:A
NM_000709.4(BCKDHA):c.978C>T (p.Ile326=)	BCKDHA		Maple syrup urine disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 19, 2020)	criteria provided, conflicting interpretations	VCV000093384	19	41928658	19	41422753	93384	99291	rs398123514	NC_000019.10:41422752:C:T
NM_000709.4(BCKDHA):c.975C>T (p.Leu325=)	BCKDHA		not provided|Maple syrup urine disease|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093383	19	41928655	19	41422750	93383	99290	rs55940366	NC_000019.10:41422749:C:T
NM_000709.4(BCKDHA):c.972C>T (p.Phe324=)	BCKDHA		not provided|Maple syrup urine disease|not specified	Benign(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093382	19	41928652	19	41422747	93382	99289	rs284652	NC_000019.10:41422746:C:T
NM_000709.4(BCKDHA):c.905A>C (p.Asp302Ala)	BCKDHA	D302A, D301A	Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Aug 25, 2013)	criteria provided, single submitter	VCV000093377	19	41928585	19	41422680	93377	99284	rs398123509	NC_000019.10:41422679:A:C
NM_000709.4(BCKDHA):c.890G>A (p.Arg297His)	BCKDHA	R297H, R296H	not provided|Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093376	19	41928570	19	41422665	93376	99283	rs200137189	NC_000019.10:41422664:G:A
NM_000709.4(BCKDHA):c.853G>C (p.Ala285Pro)	BCKDHA	A285P	not provided|Maple syrup urine disease type 1A|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093375	19	41928275	19	41422370	93375	99282	rs398123508	NC_000019.10:41422369:G:C
NM_000709.4(BCKDHA):c.761C>A (p.Ala254Asp)	BCKDHA	A254D	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 20, 2018)	criteria provided, conflicting interpretations	VCV000093371	19	41928183	19	41422278	93371	99278	rs373713279	NC_000019.10:41422277:C:A
NM_000709.4(BCKDHA):c.708C>T (p.Phe236=)	BCKDHA		Maple syrup urine disease|not provided|Maple syrup urine disease type 1A	Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)	criteria provided, conflicting interpretations	VCV000093369	19	41928130	19	41422225	93369	99276	rs146932786	NC_000019.10:41422224:C:T
NM_000709.4(BCKDHA):c.663C>T (p.Tyr221=)	BCKDHA		Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2020)	criteria provided, conflicting interpretations	VCV000093368	19	41928085	19	41422180	93368	99275	rs151227241	NC_000019.10:41422179:C:T
NM_000709.4(BCKDHA):c.659C>T (p.Ala220Val)	BCKDHA	A220V	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093367	19	41928081	19	41422176	93367	99274	rs375785084	NC_000019.10:41422175:C:T
NM_000709.4(BCKDHA):c.639C>T (p.Ile213=)	BCKDHA		Maple syrup urine disease|not provided|Maple syrup urine disease type 1A|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093366	19	41925194	19	41419289	93366	99273	rs10404506	NC_000019.10:41419288:C:T
NM_000709.4(BCKDHA):c.632C>T (p.Thr211Met)	BCKDHA	T211M	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093365	19	41925187	19	41419282	93365	99272	rs398123503	NC_000019.10:41419281:C:T
NM_000709.4(BCKDHA):c.484+5G>A	BCKDHA		Maple syrup urine disease type 1A|not specified|Maple syrup urine disease|not provided	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093362	19	41920067	19	41414162	93362	99269	rs149899007	NC_000019.10:41414161:G:A
NM_000709.4(BCKDHA):c.452C>T (p.Thr151Met)	BCKDHA	T151M	not specified|Maple syrup urine disease|Maple syrup urine disease type 1A|not provided	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093361	19	41920030	19	41414125	93361	99268	rs34442879	NC_000019.10:41414124:C:T
NM_000709.4(BCKDHA):c.376-4C>T	BCKDHA		not specified|Maple syrup urine disease type 1A|Maple syrup urine disease	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093359	19	41919950	19	41414045	93359	99266	rs199725420	NC_000019.10:41414044:C:T
NM_000709.4(BCKDHA):c.376-10A>C	BCKDHA		not provided|not specified|Maple syrup urine disease	Benign(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093357	19	41919944	19	41414039	93357	99264	rs3213861	NC_000019.10:41414038:A:C
NM_000709.4(BCKDHA):c.34C>A (p.Arg12=)	BCKDHA		Maple syrup urine disease|Maple syrup urine disease type 1A|not specified	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093355	19	41903766	19	41397861	93355	99262	rs34541442	NC_000019.10:41397860:C:A
NM_000709.4(BCKDHA):c.347A>G (p.Asp116Gly)	BCKDHA	D116G	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2020)	criteria provided, conflicting interpretations	VCV000093354	19	41916886	19	41410981	93354	99261	rs398123498	NC_000019.10:41410980:A:G
NM_000709.4(BCKDHA):c.288C>T (p.His96=)	BCKDHA		Maple syrup urine disease|not provided|Maple syrup urine disease type 1A	Conflicting interpretations of pathogenicity(Last reviewed: Jan 6, 2019)	criteria provided, conflicting interpretations	VCV000093353	19	41916721	19	41410816	93353	99260	rs148571328	NC_000019.10:41410815:C:T
NM_000709.4(BCKDHA):c.288+9C>T	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 26, 2020)	criteria provided, conflicting interpretations	VCV000093352	19	41916730	19	41410825	93352	99259	rs398123497	NC_000019.10:41410824:C:T
NM_000709.4(BCKDHA):c.288+1G>A	BCKDHA		not provided|Maple syrup urine disease type 1A|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093351	19	41916722	19	41410817	93351	99258	rs398123496	NC_000019.10:41410816:G:A
NM_000709.4(BCKDHA):c.249C>T (p.Asp83=)	BCKDHA		Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 13, 2019)	criteria provided, conflicting interpretations	VCV000093350	19	41916682	19	41410777	93350	99257	rs398123495	NC_000019.10:41410776:C:T
NM_000709.4(BCKDHA):c.1260C>T (p.Leu420=)	BCKDHA		not specified|Maple syrup urine disease type 1A|Maple syrup urine disease	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093345	19	41930435	19	41424530	93345	99252	rs34492894	NC_000019.10:41424529:C:T
NM_000709.4(BCKDHA):c.1234G>A (p.Val412Met)	BCKDHA	V412M, V411M	not provided|Maple syrup urine disease|Maple syrup urine disease type 1A	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093344	19	41930409	19	41424504	93344	99251	rs398123490	NC_000019.10:41424503:G:A
NM_000709.4(BCKDHA):c.1221A>G (p.Leu407=)	BCKDHA		Maple syrup urine disease|not provided|not specified	Benign(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093343	19	41930396	19	41424491	93343	99250	rs4674	NC_000019.10:41424490:A:G
NM_000709.4(BCKDHA):c.116C>A (p.Pro39His)	BCKDHA	P39H	Maple syrup urine disease|not provided|Maple syrup urine disease type 1A|not specified	Benign/Likely benign(Last reviewed: Jun 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093341	19	41916549	19	41410644	93341	99248	rs11549936	NC_000019.10:41410643:C:A
NM_000709.4(BCKDHA):c.114C>T (p.Pro38=)	BCKDHA		Maple syrup urine disease type 1A|Maple syrup urine disease|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093338	19	41916547	19	41410642	93338	99245	rs11549935	NC_000019.10:41410641:C:T
NM_000709.4(BCKDHA):c.114C>G (p.Pro38=)	BCKDHA		not specified|Maple syrup urine disease type 1A|Maple syrup urine disease	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093337	19	41916547	19	41410642	93337	99244	rs11549935	NC_000019.10:41410641:C:G
NM_000709.4(BCKDHA):c.1037G>A (p.Arg346His)	BCKDHA	R346H, R345H	not provided|Maple syrup urine disease	Likely pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000093336	19	41928944	19	41423039	93336	99243	rs398123486	NC_000019.10:41423038:G:A
NM_000709.4(BCKDHA):c.1036C>T (p.Arg346Cys)	BCKDHA	R346C, R345C	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093335	19	41928943	19	41423038	93335	99242	rs182923857	NC_000019.10:41423037:C:T
NM_000709.3(BCKDHA):c.-34T>G	BCKDHA		Maple syrup urine disease|not specified	Benign/Likely benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093334	19	41903699	19	41397794	93334	99241	rs45500792	NC_000019.10:41397793:T:G
NM_000709.4(BCKDHA):c.792C>G (p.Cys264Trp)	BCKDHA	C264W	Maple syrup urine disease type 1A	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000002382	19	41928214	19	41422309	2382	17421	rs137852876	NC_000019.10:41422308:C:G
NM_000709.4(BCKDHA):c.929C>G (p.Thr310Arg)	BCKDHA	T309R, T310R	Maple syrup urine disease type 1A|not provided	Pathogenic(Last reviewed: Aug 25, 2013)	criteria provided, single submitter	VCV000002381	19	41928609	19	41422704	2381	17420	rs137852875	NC_000019.10:41422703:C:G
NM_000709.4(BCKDHA):c.745G>A (p.Gly249Ser)	BCKDHA	G249S	Maple syrup urine disease type 1A|Maple syrup urine disease	Likely pathogenic(Last reviewed: Oct 31, 2020)	criteria provided, single submitter	VCV000002380	19	41928167	19	41422262	2380	17419	rs137852874	NC_000019.10:41422261:G:A
NM_000709.4(BCKDHA):c.793C>T (p.Arg265Trp)	BCKDHA	R265W	not provided|Maple syrup urine disease type 1A|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2020)	criteria provided, conflicting interpretations	VCV000002379	19	41928215	19	41422310	2379	17418	rs137852873	NC_000019.10:41422309:C:T
NM_000709.4(BCKDHA):c.1226T>G (p.Phe409Cys)	BCKDHA	F408C, F409C	Maple syrup urine disease type 1A|Maple syrup urine disease|MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE IA	Likely pathogenic(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV000002378	19	41930401	19	41424496	2378	17417	rs137852872	NC_000019.10:41424495:T:G
NM_000709.4(BCKDHA):c.868G>A (p.Gly290Arg)	BCKDHA	G289R, G290R	Maple syrup urine disease type 1A|MAPLE SYRUP URINE DISEASE, INTERMEDIATE, TYPE IA|Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000002377	19	41928548	19	41422643	2377	17416	rs137852871	NC_000019.10:41422642:G:A
NM_183050.4(BCKDHB):c.-15C>T	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001195927	6	80816396	6	80106679	1195927	1185912		NC_000006.12:80106678:C:T
NM_183050.4(BCKDHB):c.193T>G (p.Tyr65Asp)	BCKDHB	Y65D	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001195926	6	80816603	6	80106886	1195926	1185913		NC_000006.12:80106885:T:G
NM_183050.4(BCKDHB):c.854G>A (p.Arg285Gln)	BCKDHB	R215Q, R285Q	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001195925	6	80912832	6	80203115	1195925	1185914		NC_000006.12:80203114:G:A
NM_183050.4(BCKDHB):c.952-151G>A	BCKDHB		Maple syrup urine disease|not provided	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001175367	6	80982701	6	80272984	1175367	1164837		NC_000006.12:80272983:G:A
NM_183050.4(BCKDHB):c.344-88C>T	BCKDHB		Maple syrup urine disease|not provided	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001175353	6	80877307	6	80167590	1175353	1164836		NC_000006.12:80167589:C:T
NM_183050.4(BCKDHB):c.483T>C (p.Val161=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001160041	6	80878597	6	80168880	1160041	1138140		NC_000006.12:80168879:T:C
NM_183050.4(BCKDHB):c.43A>C (p.Arg15=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Sep 18, 2020)	criteria provided, single submitter	VCV001159274	6	80816453	6	80106736	1159274	1138132		NC_000006.12:80106735:A:C
NM_183050.4(BCKDHB):c.111C>T (p.His37=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 18, 2020)	criteria provided, single submitter	VCV001159064	6	80816521	6	80106804	1159064	1138133		NC_000006.12:80106803:C:T
NM_183050.4(BCKDHB):c.976C>T (p.Leu326=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV001155411	6	80982876	6	80273159	1155411	1138145		NC_000006.12:80273158:C:T
NM_183050.4(BCKDHB):c.117C>T (p.Ala39=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV001154375	6	80816527	6	80106810	1154375	1138134		NC_000006.12:80106809:C:T
NM_183050.4(BCKDHB):c.344-9T>C	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV001153829	6	80877386	6	80167669	1153829	1138136		NC_000006.12:80167668:T:C
NM_183050.4(BCKDHB):c.765A>T (p.Pro255=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Apr 28, 2020)	criteria provided, single submitter	VCV001152119	6	80910673	6	80200956	1152119	1138144		NC_000006.12:80200955:A:T
NM_183050.4(BCKDHB):c.743-8G>A	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV001149866	6	80910643	6	80200926	1149866	1138143		NC_000006.12:80200925:G:A
NM_183050.4(BCKDHB):c.285T>C (p.Gly95=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001148962	6	80838888	6	80129171	1148962	1138135		NC_000006.12:80129170:T:C
NM_183050.4(BCKDHB):c.478-6C>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Mar 24, 2020)	criteria provided, single submitter	VCV001146657	6	80878586	6	80168869	1146657	1138139		NC_000006.12:80168868:C:T
NM_183050.4(BCKDHB):c.369A>G (p.Pro123=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jun 14, 2020)	criteria provided, single submitter	VCV001145563	6	80877420	6	80167703	1145563	1138138		NC_000006.12:80167702:A:G
NM_183050.4(BCKDHB):c.6G>A (p.Ala2=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 25, 2019)	criteria provided, single submitter	VCV001145214	6	80816416	6	80106699	1145214	1138130		NC_000006.12:80106698:G:A
NM_183050.4(BCKDHB):c.24C>G (p.Ala8=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 19, 2019)	criteria provided, single submitter	VCV001144893	6	80816434	6	80106717	1144893	1138131		NC_000006.12:80106716:C:G
NM_183050.4(BCKDHB):c.636G>A (p.Val212=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001143484	6	80881001	6	80171284	1143484	1138142		NC_000006.12:80171283:G:A
NM_183050.4(BCKDHB):c.634-6T>C	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Dec 2, 2019)	criteria provided, single submitter	VCV001142404	6	80880993	6	80171276	1142404	1138141		NC_000006.12:80171275:T:C
NM_183050.4(BCKDHB):c.344-4T>G	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 4, 2019)	criteria provided, single submitter	VCV001141431	6	80877391	6	80167674	1141431	1138137		NC_000006.12:80167673:T:G
NM_183050.4(BCKDHB):c.657C>T (p.Phe219=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: May 27, 2020)	criteria provided, single submitter	VCV001139211	6	80881022	6	80171305	1139211	1117231		NC_000006.12:80171304:C:T
NM_183050.4(BCKDHB):c.861A>G (p.Val287=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 25, 2020)	criteria provided, single submitter	VCV001138004	6	80912839	6	80203122	1138004	1117235		NC_000006.12:80203121:A:G
NM_183050.4(BCKDHB):c.274+8T>G	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001136883	6	80837349	6	80127632	1136883	1117223		NC_000006.12:80127631:T:G
NM_183050.4(BCKDHB):c.615C>T (p.Ala205=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Sep 29, 2020)	criteria provided, single submitter	VCV001136474	6	80878729	6	80169012	1136474	1117230		NC_000006.12:80169011:C:T
NM_183050.4(BCKDHB):c.102C>T (p.Gly34=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001136297	6	80816512	6	80106795	1136297	1117219		NC_000006.12:80106794:C:T
NM_183050.4(BCKDHB):c.504C>T (p.Arg168=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Feb 27, 2020)	criteria provided, single submitter	VCV001135835	6	80878618	6	80168901	1135835	1117228		NC_000006.12:80168900:C:T
NM_183050.4(BCKDHB):c.197-5C>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001134991	6	80837259	6	80127542	1134991	1117221		NC_000006.12:80127541:C:T
NM_183050.4(BCKDHB):c.474T>C (p.Asp158=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 23, 2019)	criteria provided, single submitter	VCV001134530	6	80877525	6	80167808	1134530	1117227		NC_000006.12:80167807:T:C
NM_183050.4(BCKDHB):c.681A>C (p.Ser227=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV001134211	6	80881046	6	80171329	1134211	1117232		NC_000006.12:80171328:A:C
NM_183050.4(BCKDHB):c.714T>C (p.Phe238=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001133666	6	80881079	6	80171362	1133666	1117233		NC_000006.12:80171361:T:C
NM_183050.4(BCKDHB):c.258C>T (p.Ala86=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001133153	6	80837325	6	80127608	1133153	1117222		NC_000006.12:80127607:C:T
NM_183050.4(BCKDHB):c.196+7C>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001129979	6	80816613	6	80106896	1129979	1117220		NC_000006.12:80106895:C:T
NM_183050.4(BCKDHB):c.840+10A>G	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 11, 2020)	criteria provided, single submitter	VCV001127271	6	80910758	6	80201041	1127271	1117234		NC_000006.12:80201040:A:G
NM_183050.4(BCKDHB):c.333A>G (p.Arg111=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001126805	6	80838936	6	80129219	1126805	1117225		NC_000006.12:80129218:A:G
NM_183050.4(BCKDHB):c.274+10A>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001125441	6	80837351	6	80127634	1125441	1117224		NC_000006.12:80127633:A:T
NM_183050.4(BCKDHB):c.72T>G (p.Arg24=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jun 26, 2020)	criteria provided, single submitter	VCV001123481	6	80816482	6	80106765	1123481	1117217		NC_000006.12:80106764:T:G
NM_183050.4(BCKDHB):c.15G>C (p.Ala5=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jul 1, 2020)	criteria provided, single submitter	VCV001122934	6	80816425	6	80106708	1122934	1117216		NC_000006.12:80106707:G:C
NM_183050.4(BCKDHB):c.1032A>G (p.Thr344=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Aug 9, 2020)	criteria provided, single submitter	VCV001122541	6	80982932	6	80273215	1122541	1117236		NC_000006.12:80273214:A:G
NM_183050.4(BCKDHB):c.378A>G (p.Glu126=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV001122446	6	80877429	6	80167712	1122446	1117226		NC_000006.12:80167711:A:G
NM_183050.4(BCKDHB):c.12A>G (p.Val4=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV001122382	6	80816422	6	80106705	1122382	1117215		NC_000006.12:80106704:A:G
NM_183050.4(BCKDHB):c.1158T>G (p.Leu386=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001122150	6	81053500	6	80343783	1122150	1117237		NC_000006.12:80343782:T:G
NM_183050.4(BCKDHB):c.516G>A (p.Gly172=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001121268	6	80878630	6	80168913	1121268	1117229		NC_000006.12:80168912:G:A
NM_183050.4(BCKDHB):c.96G>A (p.Ala32=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV001120507	6	80816506	6	80106789	1120507	1117218		NC_000006.12:80106788:G:A
NM_183050.4(BCKDHB):c.174A>G (p.Pro58=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001119500	6	80816584	6	80106867	1119500	1095650		NC_000006.12:80106866:A:G
NM_183050.4(BCKDHB):c.24C>A (p.Ala8=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001115249	6	80816434	6	80106717	1115249	1095648		NC_000006.12:80106716:C:A
NM_183050.4(BCKDHB):c.432T>C (p.Ile144=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001114388	6	80877483	6	80167766	1114388	1095652		NC_000006.12:80167765:T:C
NM_183050.4(BCKDHB):c.1038+8A>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: May 7, 2020)	criteria provided, single submitter	VCV001109411	6	80982946	6	80273229	1109411	1095658		NC_000006.12:80273228:A:T
NM_183050.4(BCKDHB):c.841-9T>G	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV001108625	6	80912810	6	80203093	1108625	1095657		NC_000006.12:80203092:T:G
NM_183050.4(BCKDHB):c.331C>A (p.Arg111=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001107683	6	80838934	6	80129217	1107683	1095651		NC_000006.12:80129216:C:A
NM_183050.4(BCKDHB):c.573T>C (p.His191=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV001106970	6	80878687	6	80168970	1106970	1095653		NC_000006.12:80168969:T:C
NM_183050.4(BCKDHB):c.678G>A (p.Leu226=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Sep 6, 2020)	criteria provided, single submitter	VCV001104720	6	80881043	6	80171326	1104720	1095655		NC_000006.12:80171325:G:A
NM_183050.4(BCKDHB):c.651C>T (p.Ser217=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001103447	6	80881016	6	80171299	1103447	1095654		NC_000006.12:80171298:C:T
NM_183050.4(BCKDHB):c.1092C>T (p.Asp364=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Feb 4, 2020)	criteria provided, single submitter	VCV001103187	6	81053434	6	80343717	1103187	1095659		NC_000006.12:80343716:C:T
NM_183050.4(BCKDHB):c.63G>C (p.Gly21=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001101567	6	80816473	6	80106756	1101567	1095649		NC_000006.12:80106755:G:C
NM_183050.4(BCKDHB):c.768C>T (p.Tyr256=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Apr 18, 2020)	criteria provided, single submitter	VCV001099224	6	80910676	6	80200959	1099224	1095656		NC_000006.12:80200958:C:T
NM_183050.4(BCKDHB):c.478-9G>A	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 29, 2020)	criteria provided, single submitter	VCV001096732	6	80878583	6	80168866	1096732	1074081		NC_000006.12:80168865:G:A
NM_183050.4(BCKDHB):c.1002A>G (p.Thr334=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 2, 2020)	criteria provided, single submitter	VCV001094208	6	80982902	6	80273185	1094208	1074089		NC_000006.12:80273184:A:G
NM_183050.4(BCKDHB):c.555T>A (p.Pro185=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV001093904	6	80878669	6	80168952	1093904	1074083		NC_000006.12:80168951:T:A
NM_183050.4(BCKDHB):c.42C>T (p.Leu14=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jun 4, 2020)	criteria provided, single submitter	VCV001092257	6	80816452	6	80106735	1092257	1074078		NC_000006.12:80106734:C:T
NM_183050.4(BCKDHB):c.1095A>G (p.Thr365=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: May 8, 2019)	criteria provided, single submitter	VCV001089840	6	81053437	6	80343720	1089840	1074091		NC_000006.12:80343719:A:G
NM_183050.4(BCKDHB):c.1039-5T>C	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Apr 30, 2020)	criteria provided, single submitter	VCV001089484	6	81053376	6	80343659	1089484	1074090		NC_000006.12:80343658:T:C
NM_183050.4(BCKDHB):c.15G>A (p.Ala5=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV001088902	6	80816425	6	80106708	1088902	1074076		NC_000006.12:80106707:G:A
NM_183050.4(BCKDHB):c.27C>G (p.Gly9=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV001087526	6	80816437	6	80106720	1087526	1074077		NC_000006.12:80106719:C:G
NM_183050.4(BCKDHB):c.253T>C (p.Leu85=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Aug 27, 2020)	criteria provided, single submitter	VCV001086863	6	80837320	6	80127603	1086863	1074080		NC_000006.12:80127602:T:C
NM_183050.4(BCKDHB):c.495C>T (p.Ala165=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001084586	6	80878609	6	80168892	1084586	1074082		NC_000006.12:80168891:C:T
NM_183050.4(BCKDHB):c.951+7A>C	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jun 30, 2020)	criteria provided, single submitter	VCV001084570	6	80912936	6	80203219	1084570	1074088		NC_000006.12:80203218:A:C
NM_183050.4(BCKDHB):c.861A>T (p.Val287=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Mar 29, 2020)	criteria provided, single submitter	VCV001083037	6	80912839	6	80203122	1083037	1074087		NC_000006.12:80203121:A:T
NM_183050.4(BCKDHB):c.48G>C (p.Ala16=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV001080950	6	80816458	6	80106741	1080950	1074079		NC_000006.12:80106740:G:C
NM_183050.4(BCKDHB):c.743-8G>C	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV001080699	6	80910643	6	80200926	1080699	1074086		NC_000006.12:80200925:G:C
NM_183050.4(BCKDHB):c.634-10G>A	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Sep 2, 2020)	criteria provided, single submitter	VCV001079482	6	80880989	6	80171272	1079482	1074084		NC_000006.12:80171271:G:A
NM_183050.4(BCKDHB):c.196G>A (p.Gly66Arg)	BCKDHB	G66R	Maple syrup urine disease	Pathogenic(Last reviewed: May 8, 2020)	criteria provided, single submitter	VCV001069097	6	80816606	6	80106889	1069097	1060906		NC_000006.12:80106888:G:A
NM_183050.4(BCKDHB):c.77T>C (p.Leu26Pro)	BCKDHB	L26P	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001053087	6	80816487	6	80106770	1053087	1044455		NC_000006.12:80106769:T:C
NM_183050.4(BCKDHB):c.866C>T (p.Ser289Phe)	BCKDHB	S219F, S289F	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV001044868	6	80912844	6	80203127	1044868	1027502		NC_000006.12:80203126:C:T
NM_183050.4(BCKDHB):c.827C>G (p.Ala276Gly)	BCKDHB	A276G, A206G	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001043216	6	80910735	6	80201018	1043216	1027501		NC_000006.12:80201017:C:G
NM_183050.4(BCKDHB):c.410C>A (p.Ala137Glu)	BCKDHB	A137E, A67E	not specified|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Mar 9, 2021)	criteria provided, conflicting interpretations	VCV001027626	6	80877461	6	80167744	1027626	1015362		NC_000006.12:80167743:C:A
NM_183050.4(BCKDHB):c.1133A>G (p.Asp378Gly)	BCKDHB	D308G, D378G	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001016143	6	81053475	6	80343758	1016143	1006985		NC_000006.12:80343757:A:G
NM_183050.4(BCKDHB):c.315A>G (p.Arg105=)	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001016004	6	80838918	6	80129201	1016004	1006984		NC_000006.12:80129200:A:G
NM_183050.4(BCKDHB):c.1039-10C>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 18, 2020)	criteria provided, single submitter	VCV001008229	6	81053371	6	80343654	1008229	991811		NC_000006.12:80343653:C:G
NM_183050.4(BCKDHB):c.1025G>C (p.Ser342Thr)	BCKDHB	S272T, S342T	Maple syrup urine disease type 1B	Uncertain significance(Last reviewed: Aug 13, 2020)	no assertion criteria provided	VCV000992186	6	80982925	6	80273208	992186	978365		NC_000006.12:80273207:G:C
NM_183050.4(BCKDHB):c.951+4T>C	BCKDHB		Maple syrup urine disease type 1B	Uncertain significance(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000992185	6	80912933	6	80203216	992185	978364		NC_000006.12:80203215:T:C
NM_183050.4(BCKDHB):c.434C>T (p.Ala145Val)	BCKDHB	A145V, A75V	Maple syrup urine disease type 1B	Uncertain significance(Last reviewed: Jun 1, 2020)	no assertion criteria provided	VCV000992184	6	80877485	6	80167768	992184	978363		NC_000006.12:80167767:C:T
NM_183050.4(BCKDHB):c.268A>G (p.Thr90Ala)	BCKDHB	T20A, T90A	Maple syrup urine disease type 1B	Uncertain significance(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000992183	6	80837335	6	80127618	992183	978362		NC_000006.12:80127617:A:G
NM_183050.4(BCKDHB):c.119C>T (p.Ala40Val)	BCKDHB	A40V	Maple syrup urine disease type 1B	Uncertain significance(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000992182	6	80816529	6	80106812	992182	978361		NC_000006.12:80106811:C:T
NM_183050.4(BCKDHB):c.79C>T (p.Pro27Ser)	BCKDHB	P27S	Maple syrup urine disease type 1B	Uncertain significance(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000992181	6	80816489	6	80106772	992181	978360		NC_000006.12:80106771:C:T
NM_183050.4(BCKDHB):c.36C>G (p.Leu12=)	BCKDHB		Maple syrup urine disease type 1B	Uncertain significance(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000992180	6	80816446	6	80106729	992180	978359		NC_000006.12:80106728:C:G
NM_183050.4(BCKDHB):c.25G>A (p.Gly9Ser)	BCKDHB	G9S	not provided|Maple syrup urine disease type 1B	Conflicting interpretations of pathogenicity(Last reviewed: Apr 13, 2020)	no assertion criteria provided	VCV000992179	6	80816435	6	80106718	992179	978358		NC_000006.12:80106717:G:A
NM_183050.4(BCKDHB):c.830G>A (p.Trp277Ter)	BCKDHB	W207*, W277*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 16, 2019)	no assertion criteria provided	VCV000983850	6	80910738	6	80201021	983850	971973		NC_000006.12:80201020:G:A
NM_183050.4(BCKDHB):c.790G>T (p.Glu264Ter)	BCKDHB	E194*, E264*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Oct 11, 2019)	no assertion criteria provided	VCV000983849	6	80910698	6	80200981	983849	971972		NC_000006.12:80200980:G:T
NM_183050.4(BCKDHB):c.732C>A (p.Tyr244Ter)	BCKDHB	Y174*, Y244*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 15, 2019)	no assertion criteria provided	VCV000983568	6	80881097	6	80171380	983568	971971		NC_000006.12:80171379:C:A
NM_183050.4(BCKDHB):c.625G>T (p.Gly209Ter)	BCKDHB	G139*, G209*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 20, 2020)	no assertion criteria provided	VCV000983567	6	80878739	6	80169022	983567	971970		NC_000006.12:80169021:G:T
NM_183050.4(BCKDHB):c.501T>G (p.Tyr167Ter)	BCKDHB	Y167*, Y97*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Mar 23, 2020)	no assertion criteria provided	VCV000983566	6	80878615	6	80168898	983566	971969		NC_000006.12:80168897:T:G
NM_183050.4(BCKDHB):c.352A>T (p.Arg118Ter)	BCKDHB	R118*, R48*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 23, 2020)	no assertion criteria provided	VCV000983565	6	80877403	6	80167686	983565	971968		NC_000006.12:80167685:A:T
NM_183050.4(BCKDHB):c.5C>T (p.Ala2Val)	BCKDHB	A2V	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 9, 2019)	criteria provided, single submitter	VCV000968447	6	80816415	6	80106698	968447	954929		NC_000006.12:80106697:C:T
NM_183050.4(BCKDHB):c.10G>A (p.Val4Ile)	BCKDHB	V4I	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 11, 2019)	criteria provided, single submitter	VCV000966957	6	80816420	6	80106703	966957	954930		NC_000006.12:80106702:G:A
NM_183050.4(BCKDHB):c.274+5C>T	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 6, 2019)	criteria provided, single submitter	VCV000966544	6	80837346	6	80127629	966544	960614		NC_000006.12:80127628:C:T
NM_183050.4(BCKDHB):c.26G>C (p.Gly9Ala)	BCKDHB	G9A	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000962563	6	80816436	6	80106719	962563	945250		NC_000006.12:80106718:G:C
NM_183050.4(BCKDHB):c.989A>G (p.Glu330Gly)	BCKDHB	E260G, E330G	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 21, 2019)	criteria provided, single submitter	VCV000961515	6	80982889	6	80273172	961515	945251		NC_000006.12:80273171:A:G
NM_183050.4(BCKDHB):c.951+1G>A	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: May 20, 2020)	criteria provided, single submitter	VCV000959196	6	80912930	6	80203213	959196	959820		NC_000006.12:80203212:G:A
NM_183050.4(BCKDHB):c.1132G>A (p.Asp378Asn)	BCKDHB	D378N, D308N	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 8, 2019)	criteria provided, single submitter	VCV000953083	6	81053474	6	80343757	953083	945252		NC_000006.12:80343756:G:A
NM_183050.4(BCKDHB):c.658C>T (p.Gln220Ter)	BCKDHB	Q150*, Q220*	Maple syrup urine disease	Pathogenic(Last reviewed: Jun 11, 2019)	criteria provided, single submitter	VCV000952105	6	80881023	6	80171306	952105	924520		NC_000006.12:80171305:C:T
NM_183050.4(BCKDHB):c.895T>A (p.Cys299Ser)	BCKDHB	C299S, C229S	Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 24, 2019)	criteria provided, single submitter	VCV000947518	6	80912873	6	80203156	947518	924521		NC_000006.12:80203155:T:A
NM_183050.4(BCKDHB):c.745G>T (p.Glu249Ter)	BCKDHB	E249*, E179*	Maple syrup urine disease	Pathogenic(Last reviewed: Sep 1, 2019)	criteria provided, single submitter	VCV000942899	6	80910653	6	80200936	942899	933529		NC_000006.12:80200935:G:T
NM_183050.4(BCKDHB):c.862G>C (p.Ala288Pro)	BCKDHB	A218P, A288P	Maple syrup urine disease	Uncertain significance(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000940138	6	80912840	6	80203123	940138	933530		NC_000006.12:80203122:G:C
NM_183050.4(BCKDHB):c.92T>C (p.Leu31Pro)	BCKDHB	L31P	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 21, 2019)	criteria provided, single submitter	VCV000938174	6	80816502	6	80106785	938174	933525		NC_000006.12:80106784:T:C
NM_183050.4(BCKDHB):c.496A>T (p.Lys166Ter)	BCKDHB	K96*, K166*	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000935244	6	80878610	6	80168893	935244	933528		NC_000006.12:80168892:A:T
NM_183050.4(BCKDHB):c.449C>T (p.Ala150Val)	BCKDHB	A150V, A80V	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 26, 2019)	criteria provided, single submitter	VCV000934001	6	80877500	6	80167783	934001	933527		NC_000006.12:80167782:C:T
NM_183050.4(BCKDHB):c.331C>T (p.Arg111Ter)	BCKDHB	R111*, R41*	Maple syrup urine disease type 1B|Maple syrup urine disease	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000928847	6	80838934	6	80129217	928847	916978		NC_000006.12:80129216:C:T
NM_183050.4(BCKDHB):c.1A>G (p.Met1Val)	BCKDHB	M1V	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV000917659	6	80816411	6	80106694	917659	905914		NC_000006.12:80106693:A:G
NM_183050.4(BCKDHB):c.*2245C>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000911749	6	81055766	6	80346049	911749	897007		NC_000006.12:80346048:C:G
NM_183050.4(BCKDHB):c.*2224T>A	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000911748	6	81055745	6	80346028	911748	897006		NC_000006.12:80346027:T:A
NM_183050.4(BCKDHB):c.*2212T>C	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000911747	6	81055733	6	80346016	911747	897005		NC_000006.12:80346015:T:C
NM_183050.4(BCKDHB):c.*2072C>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000911746	6	81055593	6	80345876	911746	897004		NC_000006.12:80345875:C:T
NM_183050.4(BCKDHB):c.*2018A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000911745	6	81055539	6	80345822	911745	897003		NC_000006.12:80345821:A:G
NM_183050.4(BCKDHB):c.*1909T>C	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000911744	6	81055430	6	80345713	911744	897002		NC_000006.12:80345712:T:C
NM_183050.4(BCKDHB):c.*1908A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000911743	6	81055429	6	80345712	911743	897001		NC_000006.12:80345711:A:G
NM_183050.4(BCKDHB):c.1112T>C (p.Phe371Ser)	BCKDHB	F371S, F301S	Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000911612	6	81053454	6	80343737	911612	896990		NC_000006.12:80343736:T:C
NM_183050.4(BCKDHB):c.732C>T (p.Tyr244=)	BCKDHB		Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Oct 11, 2020)	criteria provided, conflicting interpretations	VCV000911611	6	80881097	6	80171380	911611	896989		NC_000006.12:80171379:C:T
NM_183050.4(BCKDHB):c.*777G>C	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910453	6	81054298	6	80344581	910453	896996		NC_000006.12:80344580:G:C
NM_183050.4(BCKDHB):c.*1603G>A	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000909580	6	81055124	6	80345407	909580	897000		NC_000006.12:80345406:G:A
NM_183050.4(BCKDHB):c.*1279A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909579	6	81054800	6	80345083	909579	896999		NC_000006.12:80345082:A:G
NM_183050.4(BCKDHB):c.*574A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000909521	6	81054095	6	80344378	909521	896995		NC_000006.12:80344377:A:G
NM_183050.4(BCKDHB):c.*569G>A	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909520	6	81054090	6	80344373	909520	896994		NC_000006.12:80344372:G:A
NM_183050.4(BCKDHB):c.*540T>C	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000909519	6	81054061	6	80344344	909519	896993		NC_000006.12:80344343:T:C
NM_183050.4(BCKDHB):c.*501A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909518	6	81054022	6	80344305	909518	896992		NC_000006.12:80344304:A:G
NM_183050.4(BCKDHB):c.*1143A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000908724	6	81054664	6	80344947	908724	896998		NC_000006.12:80344946:A:G
NM_183050.4(BCKDHB):c.*1008T>C	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908723	6	81054529	6	80344812	908723	896997		NC_000006.12:80344811:T:C
NM_183050.4(BCKDHB):c.*263C>A	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000908662	6	81053784	6	80344067	908662	896991		NC_000006.12:80344066:C:A
NM_183050.4(BCKDHB):c.1097C>T (p.Pro366Leu)	BCKDHB	P296L, P366L	Maple syrup urine disease	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000862849	6	81053439	6	80343722	862849	832589		NC_000006.12:80343721:C:T
NM_183050.4(BCKDHB):c.1038+2T>C	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000861027	6	80982940	6	80273223	861027	851102		NC_000006.12:80273222:T:C
NM_183050.4(BCKDHB):c.398G>A (p.Gly133Glu)	BCKDHB	G133E, G63E	Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000857327	6	80877449	6	80167732	857327	832585		NC_000006.12:80167731:G:A
NM_183050.4(BCKDHB):c.617A>C (p.His206Pro)	BCKDHB	H136P, H206P	Maple syrup urine disease	Uncertain significance(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000846897	6	80878731	6	80169014	846897	832587		NC_000006.12:80169013:A:C
NM_183050.4(BCKDHB):c.343+1G>C	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: May 14, 2019)	criteria provided, single submitter	VCV000846896	6	80838947	6	80129230	846896	852040		NC_000006.12:80129229:G:C
NM_183050.4(BCKDHB):c.263A>T (p.Asp88Val)	BCKDHB	D18V, D88V	Maple syrup urine disease type 1B|Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000844352	6	80837330	6	80127613	844352	832583		NC_000006.12:80127612:A:T
NM_183050.4(BCKDHB):c.301G>A (p.Gly101Ser)	BCKDHB	G101S, G31S	Maple syrup urine disease	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000834271	6	80838904	6	80129187	834271	832584		NC_000006.12:80129186:G:A
NM_183050.4(BCKDHB):c.528C>G (p.Asn176Lys)	BCKDHB	N106K, N176K	Maple syrup urine disease	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802246	6	80878642	6	80168925	802246	790662	rs763645251	NC_000006.12:80168924:C:G
NM_183050.4(BCKDHB):c.478A>T (p.Ile160Phe)	BCKDHB	I90F, I160F	Maple syrup urine disease	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802245	6	80878592	6	80168875	802245	790661	rs1582275277	NC_000006.12:80168874:A:T
NM_183050.4(BCKDHB):c.115G>A (p.Ala39Thr)	BCKDHB	A39T	Maple syrup urine disease	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802244	6	80816525	6	80106808	802244	790660	rs914935376	NC_000006.12:80106807:G:A
NM_183050.4(BCKDHB):c.1107C>T (p.His369=)	BCKDHB		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000799591	6	81053449	6	80343732	799591	782675	rs1582600540	NC_000006.12:80343731:C:T
NM_183050.4(BCKDHB):c.534A>G (p.Gly178=)	BCKDHB		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000798487	6	80878648	6	80168931	798487	782673	rs1582275612	NC_000006.12:80168930:A:G
NM_183050.4(BCKDHB):c.33A>T (p.Leu11=)	BCKDHB		Maple syrup urine disease|Maple syrup urine disease type 1B	Likely benign(Last reviewed: Jul 25, 2020)	criteria provided, single submitter	VCV000796782	6	80816443	6	80106726	796782	782671	rs755140913	NC_000006.12:80106725:A:T
NM_183050.4(BCKDHB):c.48G>T (p.Ala16=)	BCKDHB		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV000793956	6	80816458	6	80106741	793956	782672	rs998893388	NC_000006.12:80106740:G:T
NM_183050.4(BCKDHB):c.969G>C (p.Gly323=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Aug 25, 2020)	criteria provided, single submitter	VCV000793241	6	80982869	6	80273152	793241	782674	rs764707388	NC_000006.12:80273151:G:C
NM_183050.4(BCKDHB):c.633G>C (p.Lys211Asn)	BCKDHB	K141N, K211N	Maple syrup urine disease type 1B|Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000790932	6	80878747	6	80169030	790932	710621	rs143427811	NC_000006.12:80169029:G:C
NM_183050.4(BCKDHB):c.411G>A (p.Ala137=)	BCKDHB		Maple syrup urine disease type 1B|Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000790931	6	80877462	6	80167745	790931	710620	rs142858149	NC_000006.12:80167744:G:A
NM_183050.4(BCKDHB):c.17C>T (p.Ala6Val)	BCKDHB	A6V	not provided|Maple syrup urine disease|Maple syrup urine disease type 1B	Likely benign(Last reviewed: Oct 19, 2020)	criteria provided, multiple submitters, no conflicts	VCV000771663	6	80816427	6	80106710	771663	699678	rs534975518	NC_000006.12:80106709:C:T
NM_183050.4(BCKDHB):c.402C>T (p.Ile134=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000763939	6	80877453	6	80167736	763939	765883	rs759881863	NC_000006.12:80167735:C:T
NM_183050.4(BCKDHB):c.429C>T (p.Ala143=)	BCKDHB		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2020)	criteria provided, single submitter	VCV000763673	6	80877480	6	80167763	763673	765884	rs1582272242	NC_000006.12:80167762:C:T
NM_183050.4(BCKDHB):c.435G>T (p.Ala145=)	BCKDHB		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000763392	6	80877486	6	80167769	763392	765885	rs370267903	NC_000006.12:80167768:G:T
NM_183050.4(BCKDHB):c.36C>T (p.Leu12=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV000755432	6	80816446	6	80106729	755432	765880	rs1464497822	NC_000006.12:80106728:C:T
NM_183050.4(BCKDHB):c.537C>T (p.Ser179=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, single submitter	VCV000753951	6	80878651	6	80168934	753951	765886	rs1260482947	NC_000006.12:80168933:C:T
NM_183050.4(BCKDHB):c.858G>A (p.Glu286=)	BCKDHB		not provided|Maple syrup urine disease type 1B|Maple syrup urine disease	Likely benign(Last reviewed: Sep 25, 2020)	criteria provided, single submitter	VCV000752848	6	80912836	6	80203119	752848	765888	rs765019762	NC_000006.12:80203118:G:A
NM_183050.4(BCKDHB):c.24C>T (p.Ala8=)	BCKDHB		Maple syrup urine disease type 1B|Maple syrup urine disease	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV000752728	6	80816434	6	80106717	752728	765879	rs558448066	NC_000006.12:80106716:C:T
NM_183050.4(BCKDHB):c.267T>C (p.Pro89=)	BCKDHB		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Sep 14, 2018)	criteria provided, single submitter	VCV000752141	6	80837334	6	80127617	752141	765882	rs1582191955	NC_000006.12:80127616:T:C
NM_183050.4(BCKDHB):c.753C>A (p.Val251=)	BCKDHB		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000752139	6	80910661	6	80200944	752139	765887	rs1582341919	NC_000006.12:80200943:C:A
NM_183050.4(BCKDHB):c.90G>A (p.Gly30=)	BCKDHB		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Oct 8, 2020)	criteria provided, single submitter	VCV000748446	6	80816500	6	80106783	748446	750243	rs553058134	NC_000006.12:80106782:G:A
NM_183050.4(BCKDHB):c.555T>C (p.Pro185=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV000739150	6	80878669	6	80168952	739150	750244	rs749123579	NC_000006.12:80168951:T:C
NM_183050.4(BCKDHB):c.168C>T (p.Phe56=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV000712903	6	80816578	6	80106861	712903	722152	rs747705382	NC_000006.12:80106860:C:T
NM_183050.4(BCKDHB):c.1143G>A (p.Lys381=)	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Apr 30, 2020)	criteria provided, single submitter	VCV000706527	6	81053485	6	80343768	706527	692073	rs143579400	NC_000006.12:80343767:G:A
NM_183050.4(BCKDHB):c.196G>T (p.Gly66Trp)	BCKDHB	G66W	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000664073	6	80816606	6	80106889	664073	635311	rs1328608014	NC_000006.12:80106888:G:T
NM_183050.4(BCKDHB):c.821T>C (p.Leu274Pro)	BCKDHB	L274P, L204P	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 16, 2019)	criteria provided, single submitter	VCV000661217	6	80910729	6	80201012	661217	635313	rs1582342243	NC_000006.12:80201011:T:C
NM_183050.4(BCKDHB):c.239C>G (p.Ala80Gly)	BCKDHB	A10G, A80G	Maple syrup urine disease	Uncertain significance(Last reviewed: Dec 31, 2018)	criteria provided, single submitter	VCV000656501	6	80837306	6	80127589	656501	635312	rs371131253	NC_000006.12:80127588:C:G
NM_183050.4(BCKDHB):c.1145G>A (p.Cys382Tyr)	BCKDHB	C382Y, C312Y	Maple syrup urine disease	Likely pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623329	6	81053487	6	80343770	623329	612278	rs1202365275	NC_000006.12:80343769:G:A
NM_183050.4(BCKDHB):c.744G>A (p.Ala248=)	BCKDHB		not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)	criteria provided, conflicting interpretations	VCV000617991	6	80910652	6	80200935	617991	609633	rs147719822	NC_000006.12:80200934:G:A
NM_183050.4(BCKDHB):c.564T>A (p.Cys188Ter)	BCKDHB	C188*, C118*	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000580585	6	80878678	6	80168961	580585	563824	rs774306610	NC_000006.12:80168960:T:A
NM_183050.4(BCKDHB):c.953C>T (p.Ser318Phe)	BCKDHB	S318F, S248F	Maple syrup urine disease	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000568559	6	80982853	6	80273136	568559	563826	rs1562193767	NC_000006.12:80273135:C:T
NM_183050.4(BCKDHB):c.931G>C (p.Asp311His)	BCKDHB	D311H, D241H	Maple syrup urine disease	Uncertain significance(Last reviewed: May 30, 2018)	criteria provided, single submitter	VCV000558532	6	80912909	6	80203192	558532	544328	rs1246984003	NC_000006.12:80203191:G:C
NM_183050.4(BCKDHB):c.181G>T (p.Glu61Ter)	BCKDHB	E61*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Mar 27, 2018)	criteria provided, single submitter	VCV000557496	6	80816591	6	80106874	557496	544265	rs774916970	NC_000006.12:80106873:G:T
NM_183050.4(BCKDHB):c.988G>A (p.Glu330Lys)	BCKDHB	E330K, E260K	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000557381	6	80982888	6	80273171	557381	544274	rs1224101411	NC_000006.12:80273170:G:A
NM_183050.4(BCKDHB):c.196+1G>T	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Mar 1, 2018)	criteria provided, single submitter	VCV000556885	6	80816607	6	80106890	556885	544267	rs1554181203	NC_000006.12:80106889:G:T
NM_183050.4(BCKDHB):c.742+1G>A	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Jul 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000556618	6	80881108	6	80171391	556618	544323	rs1554190322	NC_000006.12:80171390:G:A
NM_183050.4(BCKDHB):c.196+1G>C	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000556524	6	80816607	6	80106890	556524	544330	rs1554181203	NC_000006.12:80106889:G:C
NM_183050.4(BCKDHB):c.343+2T>G	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Feb 7, 2018)	criteria provided, single submitter	VCV000556442	6	80838948	6	80129231	556442	544332	rs1554184237	NC_000006.12:80129230:T:G
NM_183050.4(BCKDHB):c.1067C>T (p.Pro356Leu)	BCKDHB	P356L, P286L	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 11, 2018)	criteria provided, single submitter	VCV000556079	6	81053409	6	80343692	556079	544276	rs1304667430	NC_000006.12:80343691:C:T
NM_183050.4(BCKDHB):c.1159C>T (p.Arg387Ter)	BCKDHB	R387*, R317*	Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)	criteria provided, conflicting interpretations	VCV000555909	6	81053501	6	80343784	555909	544358	rs751599203	NC_000006.12:80343783:C:T
NM_183050.4(BCKDHB):c.169C>T (p.Gln57Ter)	BCKDHB	Q57*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000555903	6	80816579	6	80106862	555903	544264	rs1554181192	NC_000006.12:80106861:C:T
NM_183050.4(BCKDHB):c.517G>T (p.Asp173Tyr)	BCKDHB	D173Y, D103Y	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 7, 2017)	criteria provided, single submitter	VCV000553998	6	80878631	6	80168914	553998	544268	rs1554189815	NC_000006.12:80168913:G:T
NM_183050.4(BCKDHB):c.2T>C (p.Met1Thr)	BCKDHB	M1T	Maple syrup urine disease	Likely pathogenic(Last reviewed: Aug 29, 2017)	criteria provided, single submitter	VCV000553562	6	80816412	6	80106695	553562	544329	rs940391887	NC_000006.12:80106694:T:C
NM_183050.4(BCKDHB):c.633+1G>T	BCKDHB		Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 9, 2021)	criteria provided, multiple submitters, no conflicts	VCV000553536	6	80878748	6	80169031	553536	544349	rs398124589	NC_000006.12:80169030:G:T
NM_183050.4(BCKDHB):c.599C>T (p.Pro200Leu)	BCKDHB	P200L, P130L	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 22, 2017)	criteria provided, single submitter	VCV000553513	6	80878713	6	80168996	553513	543978	rs1554189861	NC_000006.12:80168995:C:T
NM_183050.4(BCKDHB):c.1149T>A (p.Tyr383Ter)	BCKDHB	Y383*, Y313*	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 27, 2020)	criteria provided, multiple submitters, no conflicts	VCV000553268	6	81053491	6	80343774	553268	544000	rs190867671	NC_000006.12:80343773:T:A
NM_183050.4(BCKDHB):c.841-1G>C	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000551468	6	80912818	6	80203101	551468	544273	rs962489830	NC_000006.12:80203100:G:C
NM_183050.4(BCKDHB):c.1A>T (p.Met1Leu)	BCKDHB	M1L	Maple syrup urine disease	Likely pathogenic(Last reviewed: Apr 11, 2017)	criteria provided, single submitter	VCV000551456	6	80816411	6	80106694	551456	544243	rs1005542482	NC_000006.12:80106693:A:T
NM_183050.4(BCKDHB):c.633+1G>C	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Feb 14, 2017)	criteria provided, single submitter	VCV000550752	6	80878748	6	80169031	550752	543979	rs398124589	NC_000006.12:80169030:G:C
NM_183050.4(BCKDHB):c.952-2A>G	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Feb 1, 2017)	criteria provided, single submitter	VCV000550562	6	80982850	6	80273133	550562	543988	rs1554205499	NC_000006.12:80273132:A:G
NM_183050.4(BCKDHB):c.1039-10C>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000527137	6	81053371	6	80343654	527137	522618	rs760262704	NC_000006.12:80343653:C:T
NM_183050.4(BCKDHB):c.548G>A (p.Arg183Gln)	BCKDHB	R183Q, R113Q	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jul 15, 2020)	criteria provided, single submitter	VCV000527135	6	80878662	6	80168945	527135	522228	rs79761867	NC_000006.12:80168944:G:A
NM_183050.4(BCKDHB):c.1042G>A (p.Glu348Lys)	BCKDHB	E348K, E278K	Maple syrup urine disease	Uncertain significance(Last reviewed: May 21, 2019)	criteria provided, single submitter	VCV000527134	6	81053384	6	80343667	527134	522251	rs989873156	NC_000006.12:80343666:G:A
NM_183050.4(BCKDHB):c.1115A>T (p.Glu372Val)	BCKDHB	E372V, E302V	Maple syrup urine disease	Uncertain significance(Last reviewed: Dec 23, 2017)	criteria provided, single submitter	VCV000527133	6	81053457	6	80343740	527133	522264	rs1554216344	NC_000006.12:80343739:A:T
NM_183050.4(BCKDHB):c.1130C>T (p.Pro377Leu)	BCKDHB	P377L, P307L	Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, single submitter	VCV000527131	6	81053472	6	80343755	527131	521867	rs1554216354	NC_000006.12:80343754:C:T
NM_183050.4(BCKDHB):c.672T>G (p.Leu224=)	BCKDHB		Maple syrup urine disease|not specified	Likely benign(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000512545	6	80881037	6	80171320	512545	501813	rs1488608145	NC_000006.12:80171319:T:G
NM_183050.4(BCKDHB):c.393A>T (p.Gly131=)	BCKDHB		Maple syrup urine disease|not specified	Likely benign(Last reviewed: Jul 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000512544	6	80877444	6	80167727	512544	502100	rs934559515	NC_000006.12:80167726:A:T
NM_183050.4(BCKDHB):c.196+8C>G	BCKDHB		not specified|Maple syrup urine disease	Likely benign(Last reviewed: Sep 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000506774	6	80816614	6	80106897	506774	502098	rs1337392511	NC_000006.12:80106896:C:G
NM_183050.4(BCKDHB):c.403G>A (p.Gly135Arg)	BCKDHB	G135R, G65R	not provided|Maple syrup urine disease type 1B	Pathogenic/Likely pathogenic(Last reviewed: Mar 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000496569	6	80877454	6	80167737	496569	487098	rs751953459	NC_000006.12:80167736:G:A
NM_183050.4(BCKDHB):c.503G>A (p.Arg168His)	BCKDHB	R168H, R98H	Maple syrup urine disease	Pathogenic(Last reviewed: May 22, 2019)	criteria provided, single submitter	VCV000457149	6	80878617	6	80168900	457149	456437	rs749033513	NC_000006.12:80168899:G:A
NM_183050.4(BCKDHB):c.275-2A>G	BCKDHB		not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Nov 29, 2017)	criteria provided, multiple submitters, no conflicts	VCV000449661	6	80838876	6	80129159	449661	444020	rs1554184224	NC_000006.12:80129158:A:G
NM_183050.4(BCKDHB):c.995C>T (p.Pro332Leu)	BCKDHB	P332L, P262L	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 1, 2018)	criteria provided, conflicting interpretations	VCV000432059	6	80982895	6	80273178	432059	425715	rs1554205541	NC_000006.12:80273177:C:T
NM_183050.4(BCKDHB):c.1090G>A (p.Asp364Asn)	BCKDHB	D364N, D294N	Maple syrup urine disease	Likely pathogenic	no assertion criteria provided	VCV000397610	6	81053432	6	80343715	397610	384485	rs1060499715	NC_000006.12:80343714:G:A
NM_183050.4(BCKDHB):c.365C>A (p.Thr122Asn)	BCKDHB	T122N, T52N	Maple syrup urine disease	Uncertain significance(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000397609	6	80877416	6	80167699	397609	384484	rs398124575	NC_000006.12:80167698:C:A
NM_183050.4(BCKDHB):c.637G>T (p.Val213Phe)	BCKDHB	V213F, V143F	Maple syrup urine disease|not provided	Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000390609	6	80881002	6	80171285	390609	368765	rs994415333	NC_000006.12:80171284:G:T
NM_183050.4(BCKDHB):c.742+7A>T	BCKDHB		not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000384206	6	80881114	6	80171397	384206	369320	rs111903796	NC_000006.12:80171396:A:T
NM_183050.4(BCKDHB):c.447T>C (p.Phe149=)	BCKDHB		not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000384204	6	80877498	6	80167781	384204	368762	rs35969420	NC_000006.12:80167780:T:C
NM_183050.4(BCKDHB):c.1014A>G (p.Ala338=)	BCKDHB		not specified|Maple syrup urine disease	Likely benign(Last reviewed: Oct 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000382425	6	80982914	6	80273197	382425	369088	rs904277226	NC_000006.12:80273196:A:G
NM_183050.4(BCKDHB):c.122C>T (p.Thr41Ile)	BCKDHB	T41I	Maple syrup urine disease type 1B|not specified|Maple syrup urine disease	Benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377557	6	80816532	6	80106815	377557	369081	rs35470366	NC_000006.12:80106814:C:T
NM_183050.4(BCKDHB):c.410C>T (p.Ala137Val)	BCKDHB	A137V, A67V	Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Sep 11, 2020)	criteria provided, multiple submitters, no conflicts	VCV000370949	6	80877461	6	80167744	370949	357520	rs776631396	NC_000006.12:80167743:C:T
NM_183050.4(BCKDHB):c.487G>T (p.Glu163Ter)	BCKDHB	E163*, E93*	Maple syrup urine disease type 1B|Maple syrup urine disease	Pathogenic(Last reviewed: Oct 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000370827	6	80878601	6	80168884	370827	357521	rs1057516799	NC_000006.12:80168883:G:T
NM_183050.4(BCKDHB):c.840+1G>A	BCKDHB		Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 26, 2016)	criteria provided, single submitter	VCV000370370	6	80910749	6	80201032	370370	357523	rs760538465	NC_000006.12:80201031:G:A
NM_183050.4(BCKDHB):c.840+1G>T	BCKDHB		not provided|Maple syrup urine disease	Pathogenic(Last reviewed: Dec 22, 2017)	criteria provided, single submitter	VCV000370274	6	80910749	6	80201032	370274	357524	rs760538465	NC_000006.12:80201031:G:T
NM_183050.4(BCKDHB):c.*2282C>T	BCKDHB		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000358213	6	81055803	6	80346086	358213	304349	rs10864	NC_000006.12:80346085:C:T
NM_183050.4(BCKDHB):c.*2271G>A	BCKDHB		not provided|Maple syrup urine disease	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000358212	6	81055792	6	80346075	358212	304347	rs15062	NC_000006.12:80346074:G:A
NM_183050.4(BCKDHB):c.*1892T>C	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358210	6	81055413	6	80345696	358210	304346	rs7740958	NC_000006.12:80345695:T:C
NM_183050.4(BCKDHB):c.*1875G>A	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358209	6	81055396	6	80345679	358209	309090	rs7759304	NC_000006.12:80345678:G:A
NM_183050.4(BCKDHB):c.*1810T>C	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358208	6	81055331	6	80345614	358208	309088	rs7740932	NC_000006.12:80345613:T:C
NM_183050.4(BCKDHB):c.*1798C>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358207	6	81055319	6	80345602	358207	304345	rs535334878	NC_000006.12:80345601:C:T
NM_183050.4(BCKDHB):c.*1778A>G	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358206	6	81055299	6	80345582	358206	309086	rs7758761	NC_000006.12:80345581:A:G
NM_183050.4(BCKDHB):c.*1554C>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358205	6	81055075	6	80345358	358205	309085	rs563993638	NC_000006.12:80345357:C:G
NM_183050.4(BCKDHB):c.*1444T>C	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358204	6	81054965	6	80345248	358204	301207	rs3805848	NC_000006.12:80345247:T:C
NM_183050.4(BCKDHB):c.*1315G>A	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358203	6	81054836	6	80345119	358203	304341	rs760136719	NC_000006.12:80345118:G:A
NM_183050.4(BCKDHB):c.*1241A>G	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358202	6	81054762	6	80345045	358202	301205	rs1042368	NC_000006.12:80345044:A:G
NM_183050.4(BCKDHB):c.*1162T>C	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358200	6	81054683	6	80344966	358200	309080	rs886061812	NC_000006.12:80344965:T:C
NM_183050.4(BCKDHB):c.*1158T>G	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358199	6	81054679	6	80344962	358199	301201	rs74705661	NC_000006.12:80344961:T:G
NM_183050.4(BCKDHB):c.*1142C>G	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358198	6	81054663	6	80344946	358198	301200	rs1042367	NC_000006.12:80344945:C:G
NM_183050.4(BCKDHB):c.*1010A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358197	6	81054531	6	80344814	358197	309064	rs536048070	NC_000006.12:80344813:A:G
NM_183050.4(BCKDHB):c.*994G>A	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358196	6	81054515	6	80344798	358196	304336	rs4502885	NC_000006.12:80344797:G:A
NM_183050.4(BCKDHB):c.*922A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358195	6	81054443	6	80344726	358195	308974	rs371667903	NC_000006.12:80344725:A:G
NM_183050.4(BCKDHB):c.*921C>T	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358194	6	81054442	6	80344725	358194	309063	rs542630714	NC_000006.12:80344724:C:T
NM_183050.4(BCKDHB):c.*896A>G	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358193	6	81054417	6	80344700	358193	309062	rs886061811	NC_000006.12:80344699:A:G
NM_183050.4(BCKDHB):c.*832C>T	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358192	6	81054353	6	80344636	358192	304332	rs60566469	NC_000006.12:80344635:C:T
NM_183050.4(BCKDHB):c.*805T>C	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358191	6	81054326	6	80344609	358191	309058	rs4706839	NC_000006.12:80344608:T:C
NM_183050.4(BCKDHB):c.*789C>T	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358190	6	81054310	6	80344593	358190	309050	rs4706118	NC_000006.12:80344592:C:T
NM_183050.4(BCKDHB):c.*763G>A	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358189	6	81054284	6	80344567	358189	301195	rs563470467	NC_000006.12:80344566:G:A
NM_183050.4(BCKDHB):c.*731C>T	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358188	6	81054252	6	80344535	358188	301194	rs4706117	NC_000006.12:80344534:C:T
NM_183050.4(BCKDHB):c.*726A>G	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358187	6	81054247	6	80344530	358187	304324	rs147544283	NC_000006.12:80344529:A:G
NM_183050.4(BCKDHB):c.*644C>T	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358186	6	81054165	6	80344448	358186	304317	rs535962304	NC_000006.12:80344447:C:T
NM_183050.4(BCKDHB):c.*627T>C	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358185	6	81054148	6	80344431	358185	309049	rs4706838	NC_000006.12:80344430:T:C
NM_183050.4(BCKDHB):c.*466G>T	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358181	6	81053987	6	80344270	358181	304304	rs886061809	NC_000006.12:80344269:G:T
NM_183050.4(BCKDHB):c.*440A>T	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358180	6	81053961	6	80344244	358180	301184	rs113404985	NC_000006.12:80344243:A:T
NM_183050.4(BCKDHB):c.*395G>T	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358179	6	81053916	6	80344199	358179	309048	rs4706116	NC_000006.12:80344198:G:T
NM_183050.4(BCKDHB):c.*345C>T	BCKDHB		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358178	6	81053866	6	80344149	358178	301182	rs1811844	NC_000006.12:80344148:C:T
NM_183050.4(BCKDHB):c.*304G>A	BCKDHB		not provided|Maple syrup urine disease	Benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000358177	6	81053825	6	80344108	358177	304303	rs926731	NC_000006.12:80344107:G:A
NM_183050.4(BCKDHB):c.*293T>C	BCKDHB		not provided|Maple syrup urine disease	Benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000358176	6	81053814	6	80344097	358176	304289	rs926732	NC_000006.12:80344096:T:C
NM_183050.4(BCKDHB):c.*236G>A	BCKDHB		not provided|Maple syrup urine disease	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000358175	6	81053757	6	80344040	358175	308961	rs145101575	NC_000006.12:80344039:G:A
NM_183050.4(BCKDHB):c.*121G>A	BCKDHB		not provided|Maple syrup urine disease	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000358174	6	81053642	6	80343925	358174	304288	rs926733	NC_000006.12:80343924:G:A
NM_183050.4(BCKDHB):c.*83C>T	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358173	6	81053604	6	80343887	358173	304282	rs564127416	NC_000006.12:80343886:C:T
NM_183050.4(BCKDHB):c.1031C>T (p.Thr344Ile)	BCKDHB	T344I, T274I	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358172	6	80982931	6	80273214	358172	301176	rs761138547	NC_000006.12:80273213:C:T
NM_183050.4(BCKDHB):c.987C>T (p.His329=)	BCKDHB		not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: May 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000358171	6	80982887	6	80273170	358171	304273	rs138670449	NC_000006.12:80273169:C:T
NM_183050.4(BCKDHB):c.245A>G (p.Asp82Gly)	BCKDHB	D82G, D12G	Maple syrup urine disease type 1B|Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358170	6	80837312	6	80127595	358170	308960	rs150769284	NC_000006.12:80127594:A:G
NM_183050.4(BCKDHB):c.63G>T (p.Gly21=)	BCKDHB		not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000358169	6	80816473	6	80106756	358169	308957	rs368345065	NC_000006.12:80106755:G:T
NM_183050.4(BCKDHB):c.51A>G (p.Ala17=)	BCKDHB		Maple syrup urine disease|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000358168	6	80816461	6	80106744	358168	304272	rs376293687	NC_000006.12:80106743:A:G
NM_001318975.1(BCKDHB):c.-45C>T	BCKDHB		Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000358167	6	80816370	6	80106653	358167	309046	rs763746493	NC_000006.12:80106652:C:T
NM_183050.4(BCKDHB):c.51A>C (p.Ala17=)	BCKDHB		Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 1, 2020)	criteria provided, conflicting interpretations	VCV000281334	6	80816461	6	80106744	281334	265571	rs376293687	NC_000006.12:80106743:A:C
NM_183050.4(BCKDHB):c.86C>T (p.Ala29Val)	BCKDHB	A29V	not specified|Maple syrup urine disease	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000263077	6	80816496	6	80106779	263077	252539	rs9448884	NC_000006.12:80106778:C:T
NM_183050.4(BCKDHB):c.964A>G (p.Thr322Ala)	BCKDHB	T322A, T252A	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000224061	6	80982864	6	80273147	224061	225788	rs869312131	NC_000006.12:80273146:A:G
NM_183050.4(BCKDHB):c.401T>A (p.Ile134Asn)	BCKDHB	I134N, I64N	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2011)	criteria provided, single submitter	VCV000224060	6	80877452	6	80167735	224060	225786	rs869312130	NC_000006.12:80167734:T:A
NM_183050.4(BCKDHB):c.3G>A (p.Met1Ile)	BCKDHB	M1I	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2014)	criteria provided, single submitter	VCV000224057	6	80816413	6	80106696	224057	225783	rs869312128	NC_000006.12:80106695:G:A
NM_183050.4(BCKDHB):c.197-2A>G	BCKDHB		Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2012)	criteria provided, single submitter	VCV000224056	6	80837262	6	80127545	224056	225784	rs869312127	NC_000006.12:80127544:A:G
NM_183050.4(BCKDHB):c.554C>T (p.Pro185Leu)	BCKDHB	P185L, P115L	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2010)	criteria provided, single submitter	VCV000224055	6	80878668	6	80168951	224055	225787	rs148905512	NC_000006.12:80168950:C:T
NM_183050.4(BCKDHB):c.293T>G (p.Val98Gly)	BCKDHB	V98G, V28G	Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Jul 24, 2017)	criteria provided, conflicting interpretations	VCV000224054	6	80838896	6	80129179	224054	225785	rs869312126	NC_000006.12:80129178:T:G
NM_183050.4(BCKDHB):c.1022T>A (p.Ile341Asn)	BCKDHB	I341N, I271N	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Mar 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000203639	6	80982922	6	80273205	203639	200129	rs796051939	NC_000006.12:80273204:T:A
NM_183050.4(BCKDHB):c.1144T>C (p.Cys382Arg)	BCKDHB	C382R, C312R	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 22, 2014)	criteria provided, conflicting interpretations	VCV000166743	6	81053486	6	80343769	166743	176981	rs727503822	NC_000006.12:80343768:T:C
NM_183050.4(BCKDHB):c.951+27209A>G	BCKDHB		Maple syrup urine disease	Likely benign(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000110939	6	80940138	6	80230421	110939	116675	rs207467187	NC_000006.12:80230420:A:G
NM_183050.4(BCKDHB):c.974T>G (p.Leu325Arg)	BCKDHB	L325R, L255R	Maple syrup urine disease|not provided	Likely pathogenic(Last reviewed: Jan 27, 2016)	criteria provided, single submitter	VCV000096622	6	80982874	6	80273157	96622	102515	rs398124604	NC_000006.12:80273156:T:G
NM_183050.4(BCKDHB):c.970C>T (p.Arg324Ter)	BCKDHB	R324*, R254*	Maple syrup urine disease|not provided|Maple syrup urine disease type 1B	Pathogenic/Likely pathogenic(Last reviewed: May 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096621	6	80982870	6	80273153	96621	102514	rs398124603	NC_000006.12:80273152:C:T
NM_183050.4(BCKDHB):c.951+48C>T	BCKDHB		not provided|not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096619	6	80912977	6	80203260	96619	102512	rs3749896	NC_000006.12:80203259:C:T
NM_183050.4(BCKDHB):c.853C>T (p.Arg285Ter)	BCKDHB	R285*, R215*	Maple syrup urine disease type 1B|Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 13, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096615	6	80912831	6	80203114	96615	102508	rs398124598	NC_000006.12:80203113:C:T
NM_183050.4(BCKDHB):c.841-73C>T	BCKDHB		not specified|Maple syrup urine disease|not provided	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096613	6	80912746	6	80203029	96613	102506	rs3828753	NC_000006.12:80203028:C:T
NM_183050.4(BCKDHB):c.840+2T>G	BCKDHB		Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jan 25, 2016)	criteria provided, multiple submitters, no conflicts	VCV000096611	6	80910750	6	80201033	96611	102504	rs398124596	NC_000006.12:80201032:T:G
NM_183050.4(BCKDHB):c.799C>T (p.Gln267Ter)	BCKDHB	Q267*, Q197*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Aug 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096609	6	80910707	6	80200990	96609	102502	rs398124594	NC_000006.12:80200989:C:T
NM_183050.4(BCKDHB):c.752T>C (p.Val251Ala)	BCKDHB	V251A, V181A	not provided|Maple syrup urine disease type 1B|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jul 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096608	6	80910660	6	80200943	96608	102501	rs398124593	NC_000006.12:80200942:T:C
NM_183050.4(BCKDHB):c.748G>T (p.Glu250Ter)	BCKDHB	E250*, E180*	not provided|Maple syrup urine disease	Pathogenic(Last reviewed: Mar 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096607	6	80910656	6	80200939	96607	102500	rs398124592	NC_000006.12:80200938:G:T
NM_183050.4(BCKDHB):c.727C>T (p.Leu243Phe)	BCKDHB	L243F, L173F	not specified|Maple syrup urine disease|not provided	Uncertain significance(Last reviewed: Mar 15, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096605	6	80881092	6	80171375	96605	102498	rs398124591	NC_000006.12:80171374:C:T
NM_183050.4(BCKDHB):c.674T>C (p.Leu225Pro)	BCKDHB	L225P, L155P	Maple syrup urine disease|not provided	Uncertain significance(Last reviewed: Jul 15, 2014)	criteria provided, single submitter	VCV000096604	6	80881039	6	80171322	96604	102497	rs398124590	NC_000006.12:80171321:T:C
NM_183050.4(BCKDHB):c.633+1G>A	BCKDHB		not provided|Maple syrup urine disease	Pathogenic(Last reviewed: Sep 8, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096602	6	80878748	6	80169031	96602	102495	rs398124589	NC_000006.12:80169030:G:A
NM_183050.4(BCKDHB):c.547C>T (p.Arg183Trp)	BCKDHB	R183W, R113W	not provided	Likely pathogenic(Last reviewed: Jun 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096595	6	80878661	6	80168944	96595	102488	rs149766077	NC_000006.12:80168943:C:T
NM_183050.4(BCKDHB):c.526A>T (p.Asn176Tyr)	BCKDHB	N176Y, N106Y	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096593	6	80878640	6	80168923	96593	102486	rs398124582	NC_000006.12:80168922:A:T
NM_183050.4(BCKDHB):c.509G>C (p.Arg170Pro)	BCKDHB	R170P, R100P	Maple syrup urine disease|not provided	Uncertain significance(Last reviewed: Nov 1, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096592	6	80878623	6	80168906	96592	102485	rs371518124	NC_000006.12:80168905:G:C
NM_183050.4(BCKDHB):c.509G>A (p.Arg170His)	BCKDHB	R170H, R100H	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000096591	6	80878623	6	80168906	96591	102484	rs371518124	NC_000006.12:80168905:G:A
NM_183050.4(BCKDHB):c.508C>T (p.Arg170Cys)	BCKDHB	R170C, R100C	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096590	6	80878622	6	80168905	96590	102483	rs398124581	NC_000006.12:80168904:C:T
NM_183050.4(BCKDHB):c.506A>G (p.Tyr169Cys)	BCKDHB	Y169C, Y99C	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Aug 7, 2020)	criteria provided, conflicting interpretations	VCV000096587	6	80878620	6	80168903	96587	102480	rs398124580	NC_000006.12:80168902:A:G
NM_183050.4(BCKDHB):c.502C>T (p.Arg168Cys)	BCKDHB	R168C, R98C	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 3, 2021)	criteria provided, conflicting interpretations	VCV000096586	6	80878616	6	80168899	96586	102479	rs398124579	NC_000006.12:80168898:C:T
NM_183050.4(BCKDHB):c.365C>T (p.Thr122Ile)	BCKDHB	T122I, T52I	not provided|Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096582	6	80877416	6	80167699	96582	102475	rs398124575	NC_000006.12:80167698:C:T
NM_183050.4(BCKDHB):c.344-24C>T	BCKDHB		not specified|Maple syrup urine disease|not provided	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096581	6	80877371	6	80167654	96581	102474	rs73479953	NC_000006.12:80167653:C:T
NM_183050.4(BCKDHB):c.342T>G (p.Tyr114Ter)	BCKDHB	Y114*, Y44*	not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Apr 27, 2016)	criteria provided, multiple submitters, no conflicts	VCV000096579	6	80838945	6	80129228	96579	102472	rs398124573	NC_000006.12:80129227:T:G
NM_183050.4(BCKDHB):c.302G>A (p.Gly101Asp)	BCKDHB	G101D, G31D	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000096576	6	80838905	6	80129188	96576	102469	rs398124571	NC_000006.12:80129187:G:A
NM_183050.4(BCKDHB):c.197-25A>G	BCKDHB		not specified|not provided|Maple syrup urine disease	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096573	6	80837239	6	80127522	96573	102466	rs9448893	NC_000006.12:80127521:A:G
NM_183050.4(BCKDHB):c.197-11G>T	BCKDHB		not specified|Maple syrup urine disease	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000096572	6	80837253	6	80127536	96572	102465	rs9448894	NC_000006.12:80127535:G:T
NM_183050.4(BCKDHB):c.1087T>A (p.Tyr363Asn)	BCKDHB	Y363N, Y293N	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Jul 13, 2020)	criteria provided, conflicting interpretations	VCV000096568	6	81053429	6	80343712	96568	102461	rs398124565	NC_000006.12:80343711:T:A
NM_183050.4(BCKDHB):c.1046G>A (p.Cys349Tyr)	BCKDHB	C349Y, C279Y	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 9, 2019)	criteria provided, conflicting interpretations	VCV000096564	6	81053388	6	80343671	96564	102457	rs398124562	NC_000006.12:80343670:G:A
NM_183050.4(BCKDHB):c.1016C>T (p.Ser339Leu)	BCKDHB	S339L, S269L	not provided|Maple syrup urine disease	Pathogenic(Last reviewed: Aug 3, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096563	6	80982916	6	80273199	96563	102456	rs398124561	NC_000006.12:80273198:C:T
NM_183050.4(BCKDHB):c.1006G>A (p.Gly336Ser)	BCKDHB	G336S, G266S	Maple syrup urine disease|Maple syrup urine disease type 1B|not provided	Pathogenic/Likely pathogenic(Last reviewed: Sep 21, 2020)	criteria provided, multiple submitters, no conflicts	VCV000096562	6	80982906	6	80273189	96562	102455	rs398124560	NC_000006.12:80273188:G:A
NM_183050.4(BCKDHB):c.*13G>A	BCKDHB		Maple syrup urine disease|not provided	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000096561	6	81053534	6	80343817	96561	102454	rs398124559	NC_000006.12:80343816:G:A
NM_183050.4(BCKDHB):c.832G>A (p.Gly278Ser)	BCKDHB	G278S, G208S	Maple syrup urine disease type 1B|Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Mar 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000065771	6	80910740	6	80201023	65771	76679	rs386834233	NC_000006.12:80201022:G:A
NM_183050.4(BCKDHB):c.1114G>T (p.Glu372Ter)	BCKDHB	E372*, E302*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Jul 18, 2016)	criteria provided, multiple submitters, no conflicts	VCV000065770	6	81053456	6	80343739	65770	76678	rs386834234	NC_000006.12:80343738:G:T
NM_183050.4(BCKDHB):c.356T>G (p.Val119Gly)	BCKDHB	V119G, V49G	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011939	6	80877407	6	80167690	11939	26978	rs121965005	NC_000006.12:80167689:T:G
NM_183050.4(BCKDHB):c.616C>T (p.His206Tyr)	BCKDHB	H206Y, H136Y	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011938	6	80878730	6	80169013	11938	26977	rs121965004	NC_000006.12:80169012:C:T
NM_183050.4(BCKDHB):c.548G>C (p.Arg183Pro)	BCKDHB	R183P, R113P	MAPLE SYRUP URINE DISEASE, CLASSIC, TYPE IB|Maple syrup urine disease|not provided|Maple syrup urine disease type 1B	Pathogenic/Likely pathogenic(Last reviewed: Oct 14, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011937	6	80878662	6	80168945	11937	26976	rs79761867	NC_000006.12:80168944:G:C
NM_001918.5(DBT):c.1282-4C>T	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV001161625	1	100661982	1	100196426	1161625	1130089		NC_000001.11:100196425:G:A
NM_001918.5(DBT):c.1281+10T>C	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Apr 9, 2019)	criteria provided, single submitter	VCV001159211	1	100671776	1	100206220	1159211	1130090		NC_000001.11:100206219:A:G
NM_001918.5(DBT):c.39T>C (p.Asn13=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Feb 13, 2019)	criteria provided, single submitter	VCV001158882	1	100715338	1	100249782	1158882	1130100		NC_000001.11:100249781:A:G
NM_001918.5(DBT):c.747C>G (p.Gly249=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 23, 2020)	criteria provided, single submitter	VCV001156347	1	100681564	1	100216008	1156347	1130094		NC_000001.11:100216007:G:C
NM_001918.5(DBT):c.744A>C (p.Thr248=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV001153641	1	100681567	1	100216011	1153641	1130095		NC_000001.11:100216010:T:G
NM_001918.5(DBT):c.6T>G (p.Ala2=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, single submitter	VCV001152325	1	100715371	1	100249815	1152325	1130101		NC_000001.11:100249814:A:C
NM_001918.5(DBT):c.176-4G>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV001148035	1	100701071	1	100235515	1148035	1130098		NC_000001.11:100235514:C:T
NM_001918.5(DBT):c.765C>T (p.Pro255=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001147997	1	100681546	1	100215990	1147997	1130093		NC_000001.11:100215989:G:A
NM_001918.5(DBT):c.939+9C>T	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 13, 2019)	criteria provided, single submitter	VCV001146039	1	100680364	1	100214808	1146039	1130092		NC_000001.11:100214807:G:A
NM_001918.5(DBT):c.282G>A (p.Gln94=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV001142725	1	100696440	1	100230884	1142725	1130096		NC_000001.11:100230883:C:T
NM_001918.5(DBT):c.273A>C (p.Thr91=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Apr 5, 2020)	criteria provided, single submitter	VCV001142715	1	100696449	1	100230893	1142715	1130097		NC_000001.11:100230892:T:G
NM_001918.5(DBT):c.940-5A>C	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001141644	1	100676332	1	100210776	1141644	1130091		NC_000001.11:100210775:T:G
NM_001918.5(DBT):c.1098T>G (p.Ser366=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 11, 2019)	criteria provided, single submitter	VCV001136777	1	100672112	1	100206556	1136777	1109181		NC_000001.11:100206555:A:C
NM_001918.5(DBT):c.15T>C (p.Arg5=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 27, 2020)	criteria provided, single submitter	VCV001130610	1	100715362	1	100249806	1130610	1109186		NC_000001.11:100249805:A:G
NM_001918.5(DBT):c.483T>C (p.His161=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV001130376	1	100684254	1	100218698	1130376	1109185		NC_000001.11:100218697:A:G
NM_001918.5(DBT):c.1398G>A (p.Leu466=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 22, 2020)	criteria provided, single submitter	VCV001130030	1	100661862	1	100196306	1130030	1109176		NC_000001.11:100196305:C:T
NM_001918.5(DBT):c.1138T>C (p.Leu380=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001129604	1	100672072	1	100206516	1129604	1109180		NC_000001.11:100206515:A:G
NM_001918.5(DBT):c.1158C>T (p.Leu386=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Mar 1, 2019)	criteria provided, single submitter	VCV001129224	1	100672052	1	100206496	1129224	1109179		NC_000001.11:100206495:G:A
NM_001918.5(DBT):c.514C>T (p.Leu172=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001125555	1	100684223	1	100218667	1125555	1109184		NC_000001.11:100218666:G:A
NM_001918.5(DBT):c.733C>A (p.Pro245Thr)	DBT	P245T	Maple syrup urine disease	Likely benign(Last reviewed: Nov 12, 2020)	criteria provided, single submitter	VCV001123285	1	100681578	1	100216022	1123285	1109183		NC_000001.11:100216021:G:T
NM_001918.5(DBT):c.940-10T>C	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV001122244	1	100676337	1	100210781	1122244	1109182		NC_000001.11:100210780:A:G
NM_001918.5(DBT):c.1410T>C (p.Tyr470=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Aug 3, 2020)	criteria provided, single submitter	VCV001121919	1	100661850	1	100196294	1121919	1109175		NC_000001.11:100196293:A:G
NM_001918.5(DBT):c.495G>A (p.Glu165=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 23, 2019)	criteria provided, single submitter	VCV001115277	1	100684242	1	100218686	1115277	1087694		NC_000001.11:100218685:C:T
NM_001918.5(DBT):c.555+8C>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 28, 2020)	criteria provided, single submitter	VCV001112211	1	100684174	1	100218618	1112211	1087692		NC_000001.11:100218617:G:T
NM_001918.5(DBT):c.54T>C (p.Ile18=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Apr 6, 2019)	criteria provided, single submitter	VCV001111920	1	100706438	1	100240882	1111920	1087700		NC_000001.11:100240881:A:G
NM_001918.5(DBT):c.549A>G (p.Glu183=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Feb 18, 2020)	criteria provided, single submitter	VCV001111371	1	100684188	1	100218632	1111371	1087693		NC_000001.11:100218631:T:C
NM_001918.5(DBT):c.663C>T (p.Pro221=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Mar 4, 2019)	criteria provided, single submitter	VCV001109262	1	100681648	1	100216092	1109262	1087690		NC_000001.11:100216091:G:A
NM_001918.5(DBT):c.1383A>C (p.Ser461=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 12, 2019)	criteria provided, single submitter	VCV001106438	1	100661877	1	100196321	1106438	1087683		NC_000001.11:100196320:T:G
NM_001918.5(DBT):c.123T>C (p.Gly41=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001105881	1	100706369	1	100240813	1105881	1087699		NC_000001.11:100240812:A:G
NM_001918.5(DBT):c.915C>T (p.Leu305=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 16, 2019)	criteria provided, single submitter	VCV001105769	1	100680397	1	100214841	1105769	1087689		NC_000001.11:100214840:G:A
NM_001918.5(DBT):c.945T>C (p.Ala315=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001104499	1	100676322	1	100210766	1104499	1087688		NC_000001.11:100210765:A:G
NM_001918.5(DBT):c.474T>C (p.His158=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: May 30, 2019)	criteria provided, single submitter	VCV001104386	1	100684263	1	100218707	1104386	1087695		NC_000001.11:100218706:A:G
NM_001918.5(DBT):c.1017+8A>G	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Nov 27, 2020)	criteria provided, single submitter	VCV001104043	1	100676242	1	100210686	1104043	1087687		NC_000001.11:100210685:T:C
NM_001918.5(DBT):c.52-4G>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Aug 4, 2020)	criteria provided, single submitter	VCV001102602	1	100706444	1	100240888	1102602	1087701		NC_000001.11:100240887:C:T
NM_001918.5(DBT):c.433+10G>C	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Feb 6, 2020)	criteria provided, single submitter	VCV001102239	1	100696279	1	100230723	1102239	1087696		NC_000001.11:100230722:C:G
NM_001918.5(DBT):c.351C>T (p.Val117=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Mar 16, 2020)	criteria provided, single submitter	VCV001101918	1	100696371	1	100230815	1101918	1087698		NC_000001.11:100230814:G:A
NM_001918.5(DBT):c.384T>C (p.Ile128=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Nov 4, 2019)	criteria provided, single submitter	VCV001100854	1	100696338	1	100230782	1100854	1087697		NC_000001.11:100230781:A:G
NM_001918.5(DBT):c.1320G>A (p.Lys440=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001100263	1	100661940	1	100196384	1100263	1087684		NC_000001.11:100196383:C:T
NM_001918.5(DBT):c.1152T>C (p.Ser384=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 26, 2019)	criteria provided, single submitter	VCV001100142	1	100672058	1	100206502	1100142	1087686		NC_000001.11:100206501:A:G
NM_001918.5(DBT):c.562C>T (p.Leu188=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV001099707	1	100681749	1	100216193	1099707	1087691		NC_000001.11:100216192:G:A
NM_001918.5(DBT):c.159C>T (p.Phe53=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001097324	1	100706333	1	100240777	1097324	1065935		NC_000001.11:100240776:G:A
NM_001918.5(DBT):c.772+9A>G	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Apr 12, 2020)	criteria provided, single submitter	VCV001096058	1	100681530	1	100215974	1096058	1065928		NC_000001.11:100215973:T:C
NM_001918.5(DBT):c.27C>G (p.Thr9=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: May 16, 2019)	criteria provided, single submitter	VCV001093484	1	100715350	1	100249794	1093484	1065937		NC_000001.11:100249793:G:C
NM_001918.5(DBT):c.434-5A>C	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, single submitter	VCV001092376	1	100684308	1	100218752	1092376	1065929		NC_000001.11:100218751:T:G
NM_001918.5(DBT):c.369T>C (p.Tyr123=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001092273	1	100696353	1	100230797	1092273	1065932		NC_000001.11:100230796:A:G
NM_001918.5(DBT):c.427T>C (p.Leu143=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 3, 2020)	criteria provided, single submitter	VCV001090551	1	100696295	1	100230739	1090551	1065930		NC_000001.11:100230738:A:G
NM_001918.5(DBT):c.773-17A>C	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 12, 2020)	criteria provided, single submitter	VCV001089784	1	100680556	1	100215000	1089784	1065927		NC_000001.11:100214999:T:G
NM_001918.5(DBT):c.990T>C (p.Asp330=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Feb 10, 2020)	criteria provided, single submitter	VCV001089616	1	100676277	1	100210721	1089616	1065925		NC_000001.11:100210720:A:G
NM_001918.5(DBT):c.1018-9A>G	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV001086900	1	100672201	1	100206645	1086900	1065924		NC_000001.11:100206644:T:C
NM_001918.5(DBT):c.225G>A (p.Gly75=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, single submitter	VCV001086807	1	100701018	1	100235462	1086807	1065933		NC_000001.11:100235461:C:T
NM_001918.5(DBT):c.378C>T (p.Asp126=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001086605	1	100696344	1	100230788	1086605	1065931		NC_000001.11:100230787:G:A
NM_001918.5(DBT):c.1140G>A (p.Leu380=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jun 12, 2019)	criteria provided, single submitter	VCV001086538	1	100672070	1	100206514	1086538	1065923		NC_000001.11:100206513:C:T
NM_001918.5(DBT):c.42G>T (p.Ala14=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001086204	1	100715335	1	100249779	1086204	1065936		NC_000001.11:100249778:C:A
NM_001918.5(DBT):c.1191T>C (p.Thr397=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV001083051	1	100672019	1	100206463	1083051	1065921		NC_000001.11:100206462:A:G
NM_001918.5(DBT):c.175+9G>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001081539	1	100706308	1	100240752	1081539	1065934		NC_000001.11:100240751:C:T
NM_001918.5(DBT):c.1269T>C (p.Leu423=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Nov 1, 2020)	criteria provided, single submitter	VCV001080046	1	100671798	1	100206242	1080046	1065919		NC_000001.11:100206241:A:G
NM_001918.5(DBT):c.1407C>G (p.Ser469=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 14, 2020)	criteria provided, single submitter	VCV001079117	1	100661853	1	100196297	1079117	1065917		NC_000001.11:100196296:G:C
NM_001918.5(DBT):c.1158C>G (p.Leu386=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Aug 7, 2020)	criteria provided, single submitter	VCV001078700	1	100672052	1	100206496	1078700	1065922		NC_000001.11:100206495:G:C
NM_001918.5(DBT):c.960A>G (p.Leu320=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 3, 2019)	criteria provided, single submitter	VCV001077736	1	100676307	1	100210751	1077736	1065926		NC_000001.11:100210750:T:C
NM_001918.5(DBT):c.1281+2T>A	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: Jun 14, 2020)	criteria provided, single submitter	VCV001076295	1	100671784	1	100206228	1076295	1058365		NC_000001.11:100206227:A:T
NM_001918.5(DBT):c.52-1G>A	DBT		Maple syrup urine disease	Likely pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, single submitter	VCV001067759	1	100706441	1	100240885	1067759	1054723		NC_000001.11:100240884:C:T
NM_001918.5(DBT):c.1281+1G>C	DBT		Maple syrup urine disease	Likely pathogenic(Last reviewed: Aug 2, 2020)	criteria provided, single submitter	VCV001067714	1	100671785	1	100206229	1067714	1054721		NC_000001.11:100206228:C:G
NM_001918.5(DBT):c.252-1G>T	DBT		Maple syrup urine disease	Likely pathogenic(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001066691	1	100696471	1	100230915	1066691	1054722		NC_000001.11:100230914:C:A
NM_001918.5(DBT):c.836G>T (p.Cys279Phe)	DBT	C279F	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001045029	1	100680476	1	100214920	1045029	1022445		NC_000001.11:100214919:C:A
NM_001918.5(DBT):c.962A>T (p.Gln321Leu)	DBT	Q321L	Maple syrup urine disease	Uncertain significance(Last reviewed: May 12, 2020)	criteria provided, single submitter	VCV001043079	1	100676305	1	100210749	1043079	1022444		NC_000001.11:100210748:T:A
NM_001918.5(DBT):c.34A>G (p.Arg12Gly)	DBT	R12G	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001040605	1	100715343	1	100249787	1040605	1022447		NC_000001.11:100249786:T:C
NM_001918.5(DBT):c.815A>G (p.Lys272Arg)	DBT	K272R	Maple syrup urine disease	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001035264	1	100680497	1	100214941	1035264	1022446		NC_000001.11:100214940:T:C
NM_001918.5(DBT):c.1385G>A (p.Arg462His)	DBT	R462H	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV001034868	1	100661875	1	100196319	1034868	1022443		NC_000001.11:100196318:C:T
NM_001918.5(DBT):c.1208C>A (p.Ser403Ter)	DBT	S403*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Oct 1, 2019)	no assertion criteria provided	VCV000984205	1	100672002	1	100206446	984205	971629		NC_000001.11:100206445:G:T
NM_001918.5(DBT):c.70C>T (p.Gln24Ter)	DBT	Q24*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 25, 2020)	no assertion criteria provided	VCV000983644	1	100706422	1	100240866	983644	971636		NC_000001.11:100240865:G:A
NM_001918.5(DBT):c.126T>A (p.Tyr42Ter)	DBT	Y42*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Apr 23, 2019)	no assertion criteria provided	VCV000983643	1	100706366	1	100240810	983643	971635		NC_000001.11:100240809:A:T
NM_001918.5(DBT):c.187C>T (p.Gln63Ter)	DBT	Q63*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jul 15, 2019)	no assertion criteria provided	VCV000983642	1	100701056	1	100235500	983642	971634		NC_000001.11:100235499:G:A
NM_001918.5(DBT):c.196C>T (p.Gln66Ter)	DBT	Q66*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 17, 2020)	no assertion criteria provided	VCV000983641	1	100701047	1	100235491	983641	971633		NC_000001.11:100235490:G:A
NM_001918.5(DBT):c.209C>A (p.Ser70Ter)	DBT	S70*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Mar 31, 2019)	no assertion criteria provided	VCV000983640	1	100701034	1	100235478	983640	971632		NC_000001.11:100235477:G:T
NM_001918.5(DBT):c.298G>T (p.Glu100Ter)	DBT	E100*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Aug 12, 2019)	no assertion criteria provided	VCV000983639	1	100696424	1	100230868	983639	971631		NC_000001.11:100230867:C:A
NM_001918.5(DBT):c.961C>T (p.Gln321Ter)	DBT	Q321*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Sep 17, 2019)	no assertion criteria provided	VCV000983638	1	100676306	1	100210750	983638	971630		NC_000001.11:100210749:G:A
NM_001918.5(DBT):c.1209+1G>A	DBT		Maple syrup urine disease	Pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV000977618	1	100672000	1	100206444	977618	965751		NC_000001.11:100206443:C:T
NM_001918.5(DBT):c.252G>T (p.Trp84Cys)	DBT	W84C	Maple syrup urine disease	Pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV000977617	1	100696470	1	100230914	977617	965750	rs200638406	NC_000001.11:100230913:C:A
NM_001918.5(DBT):c.1184C>T (p.Thr395Ile)	DBT	T395I	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jun 2, 2020)	criteria provided, single submitter	VCV000977616	1	100672026	1	100206470	977616	965749		NC_000001.11:100206469:G:A
NM_001918.5(DBT):c.1171C>T (p.Leu391Phe)	DBT	L391F	Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 29, 2019)	criteria provided, single submitter	VCV000967833	1	100672039	1	100206483	967833	951978		NC_000001.11:100206482:G:A
NM_001918.5(DBT):c.572T>G (p.Val191Gly)	DBT	V191G	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 25, 2019)	criteria provided, single submitter	VCV000966854	1	100681739	1	100216183	966854	951979		NC_000001.11:100216182:A:C
NM_001918.5(DBT):c.1281+5A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 14, 2019)	criteria provided, single submitter	VCV000965930	1	100671781	1	100206225	965930	960395		NC_000001.11:100206224:T:C
NM_001918.5(DBT):c.4G>A (p.Ala2Thr)	DBT	A2T	Maple syrup urine disease	Uncertain significance(Last reviewed: Jul 31, 2019)	criteria provided, single submitter	VCV000948506	1	100715373	1	100249817	948506	921533		NC_000001.11:100249816:C:T
NM_001918.5(DBT):c.932T>C (p.Phe311Ser)	DBT	F311S	Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 27, 2019)	criteria provided, single submitter	VCV000937045	1	100680380	1	100214824	937045	929888		NC_000001.11:100214823:A:G
NM_001918.5(DBT):c.391G>A (p.Val131Met)	DBT	V131M	Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000931508	1	100696331	1	100230775	931508	918537		NC_000001.11:100230774:C:T
NM_001918.5(DBT):c.198G>A (p.Gln66=)	DBT		Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 24, 2020)	criteria provided, conflicting interpretations	VCV000876452	1	100701045	1	100235489	876452	861755		NC_000001.11:100235488:C:T
NM_001918.5(DBT):c.*642T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876401	1	100661169	1	100195613	876401	861749		NC_000001.11:100195612:A:G
NM_001918.5(DBT):c.*918G>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876400	1	100660893	1	100195337	876400	861748		NC_000001.11:100195336:C:A
NM_001918.5(DBT):c.*1322C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000876399	1	100660489	1	100194933	876399	861747		NC_000001.11:100194932:G:A
NM_001918.5(DBT):c.*1332T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876398	1	100660479	1	100194923	876398	861746		NC_000001.11:100194922:A:G
NM_001918.5(DBT):c.*1572A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, single submitter	VCV000876397	1	100660239	1	100194683	876397	861745		NC_000001.11:100194682:T:C
NM_001918.5(DBT):c.*1640C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876396	1	100660171	1	100194615	876396	861744		NC_000001.11:100194614:G:A
NM_001918.5(DBT):c.*3586A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876366	1	100658225	1	100192669	876366	861731		NC_000001.11:100192668:T:C
NM_001918.5(DBT):c.*3693C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000876365	1	100658118	1	100192562	876365	861730		NC_000001.11:100192561:G:C
NM_001918.5(DBT):c.*3789A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876364	1	100658022	1	100192466	876364	861729		NC_000001.11:100192465:T:G
NM_001918.5(DBT):c.*3859T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876363	1	100657952	1	100192396	876363	861728		NC_000001.11:100192395:A:G
NM_001918.5(DBT):c.*5347C>T	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876323	1	100656464	1	100190908	876323	861716		NC_000001.11:100190907:G:A
NM_001918.5(DBT):c.*5380G>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876322	1	100656431	1	100190875	876322	861715		NC_000001.11:100190874:C:G
NM_001918.5(DBT):c.*5784T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876321	1	100656027	1	100190471	876321	861714		NC_000001.11:100190470:A:G
NM_001918.5(DBT):c.*7942G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876276	1	100653869	1	100188313	876276	861699		NC_000001.11:100188312:C:T
NM_001918.5(DBT):c.*8074G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876275	1	100653737	1	100188181	876275	861698		NC_000001.11:100188180:C:T
NM_001918.5(DBT):c.*8080C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876274	1	100653731	1	100188175	876274	861697		NC_000001.11:100188174:G:C
NM_001918.5(DBT):c.*8083C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876273	1	100653728	1	100188172	876273	861696		NC_000001.11:100188171:G:A
NM_001918.5(DBT):c.*8118T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876272	1	100653693	1	100188137	876272	861695		NC_000001.11:100188136:A:G
NM_001918.5(DBT):c.*3995G>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876236	1	100657816	1	100192260	876236	861727		NC_000001.11:100192259:C:A
NM_001918.5(DBT):c.*4094C>A	DBT		Maple syrup urine disease	Benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000876235	1	100657717	1	100192161	876235	861726		NC_000001.11:100192160:G:T
NM_001918.5(DBT):c.*4237A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876234	1	100657574	1	100192018	876234	861725		NC_000001.11:100192017:T:G
NM_001918.5(DBT):c.*4250C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876233	1	100657561	1	100192005	876233	861724		NC_000001.11:100192004:G:A
NM_001918.5(DBT):c.*4291C>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876232	1	100657520	1	100191964	876232	861723		NC_000001.11:100191963:G:T
NM_001918.5(DBT):c.*4313G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876231	1	100657498	1	100191942	876231	861722		NC_000001.11:100191941:C:T
NM_001918.5(DBT):c.*5959A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876179	1	100655852	1	100190296	876179	861713		NC_000001.11:100190295:T:C
NM_001918.5(DBT):c.*5969C>T	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876178	1	100655842	1	100190286	876178	861712		NC_000001.11:100190285:G:A
NM_001918.5(DBT):c.*6270A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000876177	1	100655541	1	100189985	876177	861711		NC_000001.11:100189984:T:C
NM_001918.5(DBT):c.*8471T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876137	1	100653340	1	100187784	876137	861694		NC_000001.11:100187783:A:G
NM_001918.5(DBT):c.*8552A>T	DBT		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000876136	1	100653259	1	100187703	876136	861693		NC_000001.11:100187702:T:A
NM_001918.5(DBT):c.*8663T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876135	1	100653148	1	100187592	876135	861692		NC_000001.11:100187591:A:G
NM_001918.5(DBT):c.*8670A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000876134	1	100653141	1	100187585	876134	861691		NC_000001.11:100187584:T:C
NM_001918.5(DBT):c.1036A>G (p.Ile346Val)	DBT	I346V	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875426	1	100672174	1	100206618	875426	861754		NC_000001.11:100206617:T:C
NM_001918.5(DBT):c.*2021C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875366	1	100659790	1	100194234	875366	861743		NC_000001.11:100194233:G:A
NM_001918.5(DBT):c.*2088A>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 15, 2018)	criteria provided, single submitter	VCV000875365	1	100659723	1	100194167	875365	861742		NC_000001.11:100194166:T:A
NM_001918.5(DBT):c.*2092A>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000875364	1	100659719	1	100194163	875364	861741		NC_000001.11:100194162:T:A
NM_001918.5(DBT):c.*2119G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875363	1	100659692	1	100194136	875363	861740		NC_000001.11:100194135:C:T
NM_001918.5(DBT):c.*2130G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875362	1	100659681	1	100194125	875362	861739		NC_000001.11:100194124:C:T
NM_001918.5(DBT):c.*2213T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875319	1	100659598	1	100194042	875319	861738		NC_000001.11:100194041:A:G
NM_001918.5(DBT):c.*2271A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875318	1	100659540	1	100193984	875318	861737		NC_000001.11:100193983:T:G
NM_001918.5(DBT):c.*2810A>G	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875317	1	100659001	1	100193445	875317	861736		NC_000001.11:100193444:T:C
NM_001918.5(DBT):c.*2851C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875316	1	100658960	1	100193404	875316	861735		NC_000001.11:100193403:G:A
NM_001918.5(DBT):c.*3022G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875315	1	100658789	1	100193233	875315	861734		NC_000001.11:100193232:C:T
NM_001918.5(DBT):c.*4425C>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875276	1	100657386	1	100191830	875276	861721		NC_000001.11:100191829:G:T
NM_001918.5(DBT):c.*4576G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875275	1	100657235	1	100191679	875275	861720		NC_000001.11:100191678:C:T
NM_001918.5(DBT):c.*6413C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875225	1	100655398	1	100189842	875225	861710		NC_000001.11:100189841:G:A
NM_001918.5(DBT):c.*6716C>G	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875224	1	100655095	1	100189539	875224	861709		NC_000001.11:100189538:G:C
NM_001918.5(DBT):c.*6771A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875223	1	100655040	1	100189484	875223	861708		NC_000001.11:100189483:T:G
NM_001918.5(DBT):c.*6771A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875222	1	100655040	1	100189484	875222	861707		NC_000001.11:100189483:T:C
NM_001918.5(DBT):c.*6902T>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875221	1	100654909	1	100189353	875221	861706		NC_000001.11:100189352:A:T
NM_001918.5(DBT):c.*8830T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000875166	1	100652981	1	100187425	875166	861690		NC_000001.11:100187424:A:G
NM_001918.5(DBT):c.*8944A>G	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875165	1	100652867	1	100187311	875165	861689		NC_000001.11:100187310:T:C
NM_001918.5(DBT):c.*9123A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000875164	1	100652688	1	100187132	875164	861688		NC_000001.11:100187131:T:C
NM_001918.5(DBT):c.1364T>C (p.Ile455Thr)	DBT	I455T	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874496	1	100661896	1	100196340	874496	861753		NC_000001.11:100196339:A:G
NM_001918.5(DBT):c.*64A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874495	1	100661747	1	100196191	874495	861752		NC_000001.11:100196190:T:C
NM_001918.5(DBT):c.*293C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874494	1	100661518	1	100195962	874494	861751		NC_000001.11:100195961:G:A
NM_001918.5(DBT):c.*295G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000874493	1	100661516	1	100195960	874493	861750		NC_000001.11:100195959:C:T
NM_001918.5(DBT):c.*3240T>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874407	1	100658571	1	100193015	874407	861733		NC_000001.11:100193014:A:T
NM_001918.5(DBT):c.*3245G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874406	1	100658566	1	100193010	874406	861732		NC_000001.11:100193009:C:T
NM_001918.5(DBT):c.*4576G>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874353	1	100657235	1	100191679	874353	861719		NC_000001.11:100191678:C:G
NM_001918.5(DBT):c.*4688G>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874352	1	100657123	1	100191567	874352	861718		NC_000001.11:100191566:C:A
NM_001918.5(DBT):c.*4864C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874351	1	100656947	1	100191391	874351	861717		NC_000001.11:100191390:G:A
NM_001918.5(DBT):c.*7223C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000874290	1	100654588	1	100189032	874290	861705		NC_000001.11:100189031:G:A
NM_001918.5(DBT):c.*7358C>T	DBT		Maple syrup urine disease	Benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000874289	1	100654453	1	100188897	874289	861704		NC_000001.11:100188896:G:A
NM_001918.5(DBT):c.*7369G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874288	1	100654442	1	100188886	874288	861703		NC_000001.11:100188885:C:T
NM_001918.5(DBT):c.*7469T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 16, 2018)	criteria provided, single submitter	VCV000874287	1	100654342	1	100188786	874287	861702		NC_000001.11:100188785:A:G
NM_001918.5(DBT):c.*7690T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874286	1	100654121	1	100188565	874286	861701		NC_000001.11:100188564:A:G
NM_001918.5(DBT):c.*7698C>T	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874285	1	100654113	1	100188557	874285	861700		NC_000001.11:100188556:G:A
NM_001918.5(DBT):c.*9228C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000874241	1	100652583	1	100187027	874241	861687		NC_000001.11:100187026:G:A
NM_001918.5(DBT):c.*9230T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000874240	1	100652581	1	100187025	874240	861686		NC_000001.11:100187024:A:G
NC_000001.11:g.100249860A>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000873554	1	100715416	1	100249860	873554	864939		NC_000001.11:100249859:A:T
NM_001918.5(DBT):c.1170T>G (p.Asp390Glu)	DBT	D390E	Maple syrup urine disease	Uncertain significance(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV000864493	1	100672040	1	100206484	864493	822356		NC_000001.11:100206483:A:C
NM_001918.5(DBT):c.853A>C (p.Thr285Pro)	DBT	T285P	Maple syrup urine disease	Uncertain significance(Last reviewed: Dec 1, 2019)	criteria provided, single submitter	VCV000862554	1	100680459	1	100214903	862554	822357		NC_000001.11:100214902:T:G
NM_001918.5(DBT):c.442G>T (p.Glu148Ter)	DBT	E148*	Maple syrup urine disease	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801529	1	100684295	1	100218739	801529	789812	rs1570820579	NC_000001.11:100218738:C:A
NM_001918.5(DBT):c.804T>C (p.Ser268=)	DBT		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Sep 3, 2020)	criteria provided, single submitter	VCV000799627	1	100680508	1	100214952	799627	780243	rs1283378890	NC_000001.11:100214951:A:G
NM_001918.5(DBT):c.433+10G>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 15, 2020)	criteria provided, single submitter	VCV000797045	1	100696279	1	100230723	797045	786967	rs1024314250	NC_000001.11:100230722:C:T
NM_001918.5(DBT):c.1392C>T (p.Ser464=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV000796032	1	100661868	1	100196312	796032	780242	rs765967170	NC_000001.11:100196311:G:A
NM_001918.5(DBT):c.336T>C (p.Ser112=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000793173	1	100696386	1	100230830	793173	780245	rs1254104594	NC_000001.11:100230829:A:G
NM_001918.5(DBT):c.300A>G (p.Glu100=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Apr 9, 2020)	criteria provided, single submitter	VCV000792554	1	100696422	1	100230866	792554	780246	rs772023545	NC_000001.11:100230865:T:C
NM_001918.5(DBT):c.510A>G (p.Lys170=)	DBT		Maple syrup urine disease|not provided	Likely benign(Last reviewed: Oct 9, 2018)	criteria provided, single submitter	VCV000792432	1	100684227	1	100218671	792432	780244	rs1570820389	NC_000001.11:100218670:T:C
NM_001918.5(DBT):c.420G>A (p.Thr140=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000764148	1	100696302	1	100230746	764148	761011	rs771792232	NC_000001.11:100230745:C:T
NM_001918.5(DBT):c.891T>C (p.Ile297=)	DBT		Maple syrup urine disease|not provided	Likely benign(Last reviewed: May 15, 2020)	criteria provided, single submitter	VCV000755214	1	100680421	1	100214865	755214	761010	rs1184322880	NC_000001.11:100214864:A:G
NM_001918.5(DBT):c.270T>C (p.Asp90=)	DBT		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Sep 25, 2018)	criteria provided, single submitter	VCV000753520	1	100696452	1	100230896	753520	761012	rs913574975	NC_000001.11:100230895:A:G
NM_001918.5(DBT):c.1275A>G (p.Ser425=)	DBT		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000752702	1	100671792	1	100206236	752702	761009	rs1570806049	NC_000001.11:100206235:T:C
NM_001918.5(DBT):c.42G>A (p.Ala14=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Aug 16, 2020)	criteria provided, single submitter	VCV000748289	1	100715335	1	100249779	748289	745490	rs758610837	NC_000001.11:100249778:C:T
NM_001918.5(DBT):c.318T>G (p.Ala106=)	DBT		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000748203	1	100696404	1	100230848	748203	745489	rs146259768	NC_000001.11:100230847:A:C
NM_001918.5(DBT):c.1282-9C>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000738558	1	100661987	1	100196431	738558	758786	rs1404199687	NC_000001.11:100196430:G:T
NM_001918.5(DBT):c.978C>T (p.Asn326=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Oct 26, 2020)	criteria provided, single submitter	VCV000736451	1	100676289	1	100210733	736451	745488	rs140659494	NC_000001.11:100210732:G:A
NM_001918.5(DBT):c.62G>A (p.Arg21His)	DBT	R21H	Maple syrup urine disease	Likely benign(Last reviewed: Oct 3, 2020)	criteria provided, single submitter	VCV000728290	1	100706430	1	100240874	728290	731504	rs533707792	NC_000001.11:100240873:C:T
NM_001918.5(DBT):c.1282-4C>A	DBT		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000726670	1	100661982	1	100196426	726670	743646	rs1410431336	NC_000001.11:100196425:G:T
NM_001918.5(DBT):c.1110C>T (p.Ile370=)	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000718982	1	100672100	1	100206544	718982	718037	rs771962372	NC_000001.11:100206543:G:A
NM_001918.5(DBT):c.747C>A (p.Gly249=)	DBT		Maple syrup urine disease	Benign/Likely benign(Last reviewed: Nov 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000710713	1	100681564	1	100216008	710713	718038	rs200612682	NC_000001.11:100216007:G:T
NM_001918.5(DBT):c.556-7T>C	DBT		not provided|Maple syrup urine disease	Likely benign(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000668484	1	100681762	1	100216206	668484	656871	rs755448648	NC_000001.11:100216205:A:G
NM_001918.5(DBT):c.673A>C (p.Ile225Leu)	DBT	I225L	Maple syrup urine disease	Uncertain significance(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000663483	1	100681638	1	100216082	663483	626466	rs1472099889	NC_000001.11:100216081:T:G
NM_001918.5(DBT):c.1190C>T (p.Thr397Ile)	DBT	T397I	Maple syrup urine disease type 2	Uncertain significance(Last reviewed: May 15, 2019)	criteria provided, single submitter	VCV000635311	1	100672020	1	100206464	635311	623123	rs1570806466	NC_000001.11:100206463:G:A
NM_001918.5(DBT):c.1281+1G>T	DBT		Maple syrup urine disease	Likely pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623330	1	100671785	1	100206229	623330	612341	rs1557943881	NC_000001.11:100206228:C:A
NM_001918.5(DBT):c.709G>C (p.Val237Leu)	DBT	V237L	Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 8, 2018)	criteria provided, single submitter	VCV000572464	1	100681602	1	100216046	572464	556539	rs947272551	NC_000001.11:100216045:C:G
NM_001918.5(DBT):c.1217G>T (p.Gly406Val)	DBT	G406V	Maple syrup urine disease	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000570521	1	100671850	1	100206294	570521	556537	rs767154711	NC_000001.11:100206293:C:A
NM_001918.5(DBT):c.634C>T (p.Gln212Ter)	DBT	Q212*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Mar 29, 2018)	criteria provided, single submitter	VCV000557560	1	100681677	1	100216121	557560	540659	rs1553230841	NC_000001.11:100216120:G:A
NM_001918.5(DBT):c.1382C>A (p.Ser461Ter)	DBT	S461*	Maple syrup urine disease	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000557174	1	100661878	1	100196322	557174	540628	rs1553228626	NC_000001.11:100196321:G:T
NM_001918.5(DBT):c.1343G>A (p.Trp448Ter)	DBT	W448*	Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000556615	1	100661917	1	100196361	556615	540654	rs749366506	NC_000001.11:100196360:C:T
NM_001918.5(DBT):c.555+1G>A	DBT		Maple syrup urine disease	Likely pathogenic(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000555944	1	100684181	1	100218625	555944	540641	rs1553231037	NC_000001.11:100218624:C:T
NM_001918.5(DBT):c.1126C>T (p.Arg376Cys)	DBT	R376C	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2018)	criteria provided, conflicting interpretations	VCV000554556	1	100672084	1	100206528	554556	540632	rs768389398	NC_000001.11:100206527:G:A
NM_001918.5(DBT):c.1400G>A (p.Trp467Ter)	DBT	W467*	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Aug 31, 2018)	criteria provided, conflicting interpretations	VCV000554036	1	100661860	1	100196304	554036	540630	rs767760099	NC_000001.11:100196303:C:T
NM_001918.5(DBT):c.*358A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Aug 1, 2017)	criteria provided, single submitter	VCV000553085	1	100661453	1	100195897	553085	540624	rs1553228540	NC_000001.11:100195896:T:G
NM_001918.5(DBT):c.1202T>C (p.Ile401Thr)	DBT	I401T	Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000552910	1	100672008	1	100206452	552910	540623	rs1449113689	NC_000001.11:100206451:A:G
NM_001918.5(DBT):c.788T>C (p.Met263Thr)	DBT	M263T	Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 21, 2017)	criteria provided, single submitter	VCV000552494	1	100680524	1	100214968	552494	540634	rs1553230703	NC_000001.11:100214967:A:G
NM_001918.5(DBT):c.434-1G>A	DBT		Maple syrup urine disease	Likely pathogenic(Last reviewed: May 15, 2017)	criteria provided, single submitter	VCV000551754	1	100684304	1	100218748	551754	540643	rs754004231	NC_000001.11:100218747:C:T
NM_001918.5(DBT):c.1195T>G (p.Ser399Ala)	DBT	S399A	Maple syrup urine disease	Uncertain significance(Last reviewed: Apr 24, 2017)	criteria provided, single submitter	VCV000551600	1	100672015	1	100206459	551600	540625	rs1553229654	NC_000001.11:100206458:A:C
NM_001918.5(DBT):c.1017G>A (p.Lys339=)	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 24, 2017)	criteria provided, single submitter	VCV000550402	1	100676250	1	100210694	550402	540655	rs1490661508	NC_000001.11:100210693:C:T
NM_001918.5(DBT):c.311A>G (p.Asp104Gly)	DBT	D104G	Maple syrup urine disease	Likely pathogenic(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000527132	1	100696411	1	100230855	527132	514911	rs1553232188	NC_000001.11:100230854:T:C
NM_001918.5(DBT):c.1210-8A>T	DBT		not provided|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000516771	1	100671865	1	100206309	516771	497915	rs535837017	NC_000001.11:100206308:T:A
NM_001918.5(DBT):c.872G>T (p.Arg291Leu)	DBT	R291L	Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2019)	criteria provided, conflicting interpretations	VCV000457147	1	100680440	1	100214884	457147	446938	rs775808731	NC_000001.11:100214883:C:A
NM_001918.5(DBT):c.902G>A (p.Arg301His)	DBT	R301H	Maple syrup urine disease	Pathogenic(Last reviewed: Jun 7, 2017)	criteria provided, single submitter	VCV000437447	1	100680410	1	100214854	437447	430989	rs770981889	NC_000001.11:100214853:C:T
NM_001918.5(DBT):c.401C>T (p.Pro134Leu)	DBT	P134L	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 16, 2019)	criteria provided, conflicting interpretations	VCV000429606	1	100696321	1	100230765	429606	421147	rs1131691488	NC_000001.11:100230764:G:A
NM_001918.5(DBT):c.725C>G (p.Ser242Ter)	DBT	S242*	Maple syrup urine disease	Likely pathogenic(Last reviewed: Jul 22, 2016)	criteria provided, single submitter	VCV000370744	1	100681586	1	100216030	370744	356979	rs201559874	NC_000001.11:100216029:G:C
NM_001918.5(DBT):c.291C>T (p.Ser97=)	DBT		Maple syrup urine disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)	criteria provided, conflicting interpretations	VCV000291456	1	100696431	1	100230875	291456	275642	rs201318480	NC_000001.11:100230874:G:A
NM_001918.5(DBT):c.506G>A (p.Arg169Gln)	DBT	R169Q	not specified|Maple syrup urine disease	Benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000291455	1	100684231	1	100218675	291455	275614	rs34267966	NC_000001.11:100218674:C:T
NM_001918.5(DBT):c.1111G>A (p.Ala371Thr)	DBT	A371T	Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291454	1	100672099	1	100206543	291454	275639	rs777868718	NC_000001.11:100206542:C:T
NM_001918.5(DBT):c.1210-11T>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291453	1	100671868	1	100206312	291453	275641	rs751951997	NC_000001.11:100206311:A:T
NM_001918.5(DBT):c.1389C>T (p.Phe463=)	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291452	1	100661871	1	100196315	291452	275610	rs886044964	NC_000001.11:100196314:G:A
NM_001918.5(DBT):c.*344G>T	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Mar 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000291451	1	100661467	1	100195911	291451	275640	rs58607634	NC_000001.11:100195910:C:A
NM_001918.5(DBT):c.*347C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291450	1	100661464	1	100195908	291450	275605	rs372982170	NC_000001.11:100195907:G:A
NM_001918.5(DBT):c.*456C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291449	1	100661355	1	100195799	291449	275638	rs886044963	NC_000001.11:100195798:G:C
NM_001918.5(DBT):c.*470G>A	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291448	1	100661341	1	100195785	291448	275631	rs148424011	NC_000001.11:100195784:C:T
NM_001918.5(DBT):c.*488G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291447	1	100661323	1	100195767	291447	275603	rs778739081	NC_000001.11:100195766:C:T
NM_001918.5(DBT):c.*551C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291446	1	100661260	1	100195704	291446	275637	rs756147809	NC_000001.11:100195703:G:A
NM_001918.5(DBT):c.*594A>G	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291445	1	100661217	1	100195661	291445	275598	rs147781191	NC_000001.11:100195660:T:C
NM_001918.5(DBT):c.*635C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291444	1	100661176	1	100195620	291444	275626	rs886044962	NC_000001.11:100195619:G:A
NM_001918.5(DBT):c.*722C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291442	1	100661089	1	100195533	291442	275636	rs886044960	NC_000001.11:100195532:G:A
NM_001918.5(DBT):c.*985C>T	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jul 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291441	1	100660826	1	100195270	291441	275635	rs11166414	NC_000001.11:100195269:G:A
NM_001918.5(DBT):c.*1747A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291438	1	100660064	1	100194508	291438	275623	rs886044958	NC_000001.11:100194507:T:C
NM_001918.5(DBT):c.*1917C>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291437	1	100659894	1	100194338	291437	275584	rs886044957	NC_000001.11:100194337:G:T
NM_001918.5(DBT):c.*2074A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291436	1	100659737	1	100194181	291436	275633	rs536515775	NC_000001.11:100194180:T:G
NM_001918.5(DBT):c.*2114T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291435	1	100659697	1	100194141	291435	275583	rs886044956	NC_000001.11:100194140:A:G
NM_001918.5(DBT):c.*2363G>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291434	1	100659448	1	100193892	291434	275581	rs886044955	NC_000001.11:100193891:C:A
NM_001918.5(DBT):c.*2619G>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291432	1	100659192	1	100193636	291432	275611	rs541064624	NC_000001.11:100193635:C:T
NM_001918.5(DBT):c.*2822T>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291429	1	100658989	1	100193433	291429	275606	rs747199821	NC_000001.11:100193432:A:C
NM_001918.5(DBT):c.*3027A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291428	1	100658784	1	100193228	291428	275632	rs886044954	NC_000001.11:100193227:T:C
NM_001918.5(DBT):c.*3135G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291427	1	100658676	1	100193120	291427	275604	rs886044953	NC_000001.11:100193119:C:T
NM_001918.5(DBT):c.*3187C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291426	1	100658624	1	100193068	291426	275628	rs886044952	NC_000001.11:100193067:G:C
NM_001918.5(DBT):c.*3201G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291425	1	100658610	1	100193054	291425	275577	rs886044951	NC_000001.11:100193053:C:T
NM_001918.5(DBT):c.*3233C>T	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291424	1	100658578	1	100193022	291424	275625	rs2784174	NC_000001.11:100193021:G:A
NM_001918.5(DBT):c.*3455C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291422	1	100658356	1	100192800	291422	275621	rs886044949	NC_000001.11:100192799:G:A
NM_001918.5(DBT):c.*3461A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291421	1	100658350	1	100192794	291421	275619	rs532058526	NC_000001.11:100192793:T:C
NM_001918.5(DBT):c.*3521G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291420	1	100658290	1	100192734	291420	275576	rs754461561	NC_000001.11:100192733:C:T
NM_001918.5(DBT):c.*3652G>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291419	1	100658159	1	100192603	291419	275602	rs755229964	NC_000001.11:100192602:C:G
NM_001918.5(DBT):c.*4124C>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291417	1	100657687	1	100192131	291417	275612	rs139169068	NC_000001.11:100192130:G:T
NM_001918.5(DBT):c.*4273C>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291416	1	100657538	1	100191982	291416	275627	rs12568926	NC_000001.11:100191981:G:T
NM_001918.5(DBT):c.*4321G>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291414	1	100657490	1	100191934	291414	275600	rs886044947	NC_000001.11:100191933:C:A
NM_001918.5(DBT):c.*4377C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291413	1	100657434	1	100191878	291413	275597	rs886044946	NC_000001.11:100191877:G:C
NM_001918.5(DBT):c.*4395G>A	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291412	1	100657416	1	100191860	291412	275609	rs79471979	NC_000001.11:100191859:C:T
NM_001918.5(DBT):c.*4446C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291411	1	100657365	1	100191809	291411	275624	rs752398323	NC_000001.11:100191808:G:C
NM_001918.5(DBT):c.*4506A>G	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291410	1	100657305	1	100191749	291410	275593	rs112901689	NC_000001.11:100191748:T:C
NM_001918.5(DBT):c.*4507T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291409	1	100657304	1	100191748	291409	275592	rs762813875	NC_000001.11:100191747:A:G
NM_001918.5(DBT):c.*4872A>G	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291408	1	100656939	1	100191383	291408	275591	rs12044663	NC_000001.11:100191382:T:C
NM_001918.5(DBT):c.*5150A>G	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291407	1	100656661	1	100191105	291407	275571	rs6701655	NC_000001.11:100191104:T:C
NM_001918.5(DBT):c.*5317T>C	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291406	1	100656494	1	100190938	291406	275601	rs11166413	NC_000001.11:100190937:A:G
NM_001918.5(DBT):c.*5328C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291405	1	100656483	1	100190927	291405	275569	rs150770445	NC_000001.11:100190926:G:C
NM_001918.5(DBT):c.*5546G>A	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291404	1	100656265	1	100190709	291404	275613	rs11166412	NC_000001.11:100190708:C:T
NM_001918.5(DBT):c.*5561A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291403	1	100656250	1	100190694	291403	275565	rs886044945	NC_000001.11:100190693:T:C
NM_001918.5(DBT):c.*5591T>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291402	1	100656220	1	100190664	291402	275608	rs749879959	NC_000001.11:100190663:A:G
NM_001918.5(DBT):c.*5638C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291401	1	100656173	1	100190617	291401	275590	rs886044944	NC_000001.11:100190616:G:A
NM_001918.5(DBT):c.*5838G>A	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291400	1	100655973	1	100190417	291400	275607	rs79887429	NC_000001.11:100190416:C:T
NM_001918.5(DBT):c.*5875T>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291399	1	100655936	1	100190380	291399	275596	rs761370134	NC_000001.11:100190379:A:C
NM_001918.5(DBT):c.*5877G>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291398	1	100655934	1	100190378	291398	275559	rs562874757	NC_000001.11:100190377:C:G
NM_001918.5(DBT):c.*5919A>G	DBT		Maple syrup urine disease|not provided	Benign/Likely benign(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000291397	1	100655892	1	100190336	291397	275588	rs115442245	NC_000001.11:100190335:T:C
NM_001918.5(DBT):c.*6228A>T	DBT		not provided|Maple syrup urine disease	Benign(Last reviewed: Jun 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291395	1	100655583	1	100190027	291395	275557	rs4281338	NC_000001.11:100190026:T:A
NM_001918.5(DBT):c.*6646G>T	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Jun 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000291394	1	100655165	1	100189609	291394	275556	rs72973747	NC_000001.11:100189608:C:A
NM_001918.5(DBT):c.*6901T>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291393	1	100654910	1	100189354	291393	275586	rs200062717	NC_000001.11:100189353:A:T
NM_001918.5(DBT):c.*6903T>A	DBT		Maple syrup urine disease|not provided	Benign(Last reviewed: Feb 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000291392	1	100654908	1	100189352	291392	275574	rs10783125	NC_000001.11:100189351:A:T
NM_001918.5(DBT):c.*7187G>A	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291390	1	100654624	1	100189068	291390	275599	rs886044942	NC_000001.11:100189067:C:T
NM_001918.5(DBT):c.*7307G>C	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291389	1	100654504	1	100188948	291389	275594	rs182980145	NC_000001.11:100188947:C:G
NM_001918.5(DBT):c.*8073C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291388	1	100653738	1	100188182	291388	275587	rs886044941	NC_000001.11:100188181:G:A
NM_001918.5(DBT):c.*8226G>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291387	1	100653585	1	100188029	291387	275572	rs560160662	NC_000001.11:100188028:C:A
NM_001918.5(DBT):c.*8275A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291386	1	100653536	1	100187980	291386	275567	rs189649370	NC_000001.11:100187979:T:C
NM_001918.5(DBT):c.*8385A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291385	1	100653426	1	100187870	291385	275566	rs886044940	NC_000001.11:100187869:T:G
NM_001918.5(DBT):c.*8607G>A	DBT		Maple syrup urine disease	Likely benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000291382	1	100653204	1	100187648	291382	275555	rs150241889	NC_000001.11:100187647:C:T
NM_001918.5(DBT):c.*8642C>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291381	1	100653169	1	100187613	291381	275554	rs886044937	NC_000001.11:100187612:G:C
NM_001918.5(DBT):c.*8734A>C	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291380	1	100653077	1	100187521	291380	275568	rs564195699	NC_000001.11:100187520:T:G
NM_001918.5(DBT):c.*8900A>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291379	1	100652911	1	100187355	291379	275562	rs886044936	NC_000001.11:100187354:T:A
NM_001918.5(DBT):c.*8977T>C	DBT		Maple syrup urine disease	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291378	1	100652834	1	100187278	291378	275553	rs113536022	NC_000001.11:100187277:A:G
NM_001918.5(DBT):c.*9058C>T	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000291376	1	100652753	1	100187197	291376	275564	rs886044935	NC_000001.11:100187196:G:A
NM_001918.5(DBT):c.*9082C>T	DBT		not provided|Maple syrup urine disease	Benign(Last reviewed: Jun 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291375	1	100652729	1	100187173	291375	275560	rs72728160	NC_000001.11:100187172:G:A
NM_001918.5(DBT):c.*9105A>G	DBT		Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000291374	1	100652706	1	100187150	291374	275561	rs574151688	NC_000001.11:100187149:T:C
NM_001918.5(DBT):c.1033G>A (p.Gly345Arg)	DBT	G345R	Maple syrup urine disease	Pathogenic(Last reviewed: Jan 1, 2013)	criteria provided, single submitter	VCV000224073	1	100672177	1	100206621	224073	225800	rs869312132	NC_000001.11:100206620:C:T
NM_001918.5(DBT):c.37A>G (p.Asn13Asp)	DBT	N13D	Maple syrup urine disease|not specified	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000210825	1	100715340	1	100249784	210825	206689	rs140308307	NC_000001.11:100249783:T:C
NM_001918.5(DBT):c.327C>T (p.Thr109=)	DBT		not provided|Maple syrup urine disease|not specified	Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2021)	criteria provided, conflicting interpretations	VCV000210824	1	100696395	1	100230839	210824	206688	rs138796800	NC_000001.11:100230838:G:A
NM_001918.5(DBT):c.1261G>T (p.Gly421Trp)	DBT	G421W	Maple syrup urine disease	Uncertain significance(Last reviewed: Dec 22, 2019)	criteria provided, single submitter	VCV000203669	1	100671806	1	100206250	203669	199937		NC_000001.11:100206249:C:A
NM_001918.5(DBT):c.126T>G (p.Tyr42Ter)	DBT	Y42*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: May 30, 2018)	criteria provided, multiple submitters, no conflicts	VCV000195157	1	100706366	1	100240810	195157	192318	rs794727262	NC_000001.11:100240809:A:C
NM_001918.5(DBT):c.1150A>G (p.Ser384Gly)	DBT		not specified|Maple syrup urine disease|not provided	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000128885	1	100672060	1	100206504	128885	134332	rs12021720	NC_000001.11:100206503:T:C
NM_001918.5(DBT):c.939G>C (p.Lys313Asn)	DBT	K313N	Maple syrup urine disease type 2|not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Feb 18, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094017	1	100680373	1	100214817	94017	99919	rs398123676	NC_000001.11:100214816:C:G
NM_001918.5(DBT):c.901C>T (p.Arg301Cys)	DBT	R301C	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094016	1	100680411	1	100214855	94016	99918	rs185492864	NC_000001.11:100214854:G:A
NM_001918.5(DBT):c.76T>C (p.Cys26Arg)	DBT	C26R	Maple syrup urine disease|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 17, 2021)	criteria provided, multiple submitters, no conflicts	VCV000094013	1	100706416	1	100240860	94013	99915	rs145674833	NC_000001.11:100240859:A:G
NM_001918.5(DBT):c.753C>T (p.Asp251=)	DBT		not specified|Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)	criteria provided, conflicting interpretations	VCV000094012	1	100681558	1	100216002	94012	99914	rs79292123	NC_000001.11:100216001:G:A
NM_001918.5(DBT):c.724T>C (p.Ser242Pro)	DBT	S242P	Maple syrup urine disease|not specified|not provided	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094011	1	100681587	1	100216031	94011	99913	rs146249007	NC_000001.11:100216030:A:G
NM_001918.5(DBT):c.715A>G (p.Ile239Val)	DBT	I239V	Maple syrup urine disease|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094010	1	100681596	1	100216040	94010	99912	rs72973763	NC_000001.11:100216039:T:C
NM_001918.5(DBT):c.670G>T (p.Glu224Ter)	DBT	E224*	Maple syrup urine disease|not provided	Pathogenic(Last reviewed: Oct 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094009	1	100681641	1	100216085	94009	99911	rs74103423	NC_000001.11:100216084:C:A
NM_001918.5(DBT):c.61C>T (p.Arg21Cys)	DBT	R21C	not provided|Maple syrup urine disease	Uncertain significance(Last reviewed: Nov 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094008	1	100706431	1	100240875	94008	99910	rs398123673	NC_000001.11:100240874:G:A
NM_001918.5(DBT):c.5C>T (p.Ala2Val)	DBT	A2V	not provided|Maple syrup urine disease	Conflicting interpretations of pathogenicity(Last reviewed: Jun 2, 2020)	criteria provided, conflicting interpretations	VCV000094007	1	100715372	1	100249816	94007	99909	rs398123672	NC_000001.11:100249815:G:A
NM_001918.5(DBT):c.577G>A (p.Gly193Ser)	DBT	G193S	Maple syrup urine disease|not provided	Uncertain significance(Last reviewed: May 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000094006	1	100681734	1	100216178	94006	99908	rs398123671	NC_000001.11:100216177:C:T
NM_001918.5(DBT):c.51+1G>T	DBT		not provided|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Jan 31, 2020)	criteria provided, multiple submitters, no conflicts	VCV000094003	1	100715325	1	100249769	94003	99905	rs398123669	NC_000001.11:100249768:C:A
NM_001918.5(DBT):c.1430T>G (p.Met477Arg)	DBT	M477R	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 12, 2018)	criteria provided, conflicting interpretations	VCV000093994	1	100661830	1	100196274	93994	99896	rs398123662	NC_000001.11:100196273:A:C
NM_001918.5(DBT):c.1418A>G (p.Asn473Ser)	DBT	N473S	Maple syrup urine disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)	criteria provided, conflicting interpretations	VCV000093993	1	100661842	1	100196286	93993	99895	rs75525811	NC_000001.11:100196285:T:C
NM_001918.5(DBT):c.1348G>A (p.Ala450Thr)	DBT	A450T	not provided|Maple syrup urine disease	Uncertain significance(Last reviewed: Feb 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093992	1	100661912	1	100196356	93992	99894	rs398123661	NC_000001.11:100196355:C:T
NM_001918.5(DBT):c.1291C>T (p.Arg431Ter)	DBT	R431*	Maple syrup urine disease|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000093991	1	100661969	1	100196413	93991	99893	rs398123660	NC_000001.11:100196412:G:A
NM_001918.5(DBT):c.1281+6T>G	DBT		not provided|not specified|Maple syrup urine disease	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093990	1	100671780	1	100206224	93990	99892	rs140115881	NC_000001.11:100206223:A:C
NM_001918.5(DBT):c.1210-9A>T	DBT		not specified|Maple syrup urine disease	Benign(Last reviewed: Nov 26, 2020)	criteria provided, multiple submitters, no conflicts	VCV000093987	1	100671866	1	100206310	93987	99889	rs34229137	NC_000001.11:100206309:T:A
NM_001918.5(DBT):c.1210-10T>A	DBT		not specified|Maple syrup urine disease	Benign(Last reviewed: Sep 10, 2021)	criteria provided, multiple submitters, no conflicts	VCV000093985	1	100671867	1	100206311	93985	99887	rs183058253	NC_000001.11:100206310:A:T
NM_001918.5(DBT):c.1127G>A (p.Arg376His)	DBT	R376H	not provided|Maple syrup urine disease	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000093982	1	100672083	1	100206527	93982	99884	rs150934375	NC_000001.11:100206526:C:T
NM_001918.5(DBT):c.581C>G (p.Ser194Ter)	DBT	S194*	Maple syrup urine disease type 2	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011953	1	100681730	1	100216174	11953	26992	rs121965003	NC_000001.11:100216173:G:C
NM_001918.5(DBT):c.1355A>G (p.His452Arg)	DBT	H452R	Maple syrup urine disease, thiamine-responsive, type II	Pathogenic(Last reviewed: Apr 23, 2004)	no assertion criteria provided	VCV000011952	1	100661905	1	100196349	11952	26991	rs121965002	NC_000001.11:100196348:T:C
NM_001918.5(DBT):c.1150= (p.Ser384=)	DBT		Intermediate maple syrup urine disease type 2|Maple syrup urine disease	Benign(Last reviewed: Dec 4, 2020)	criteria provided, single submitter	VCV000011949	1	100672060	1	100206504	11949	26988	rs12021720	NC_000001.11:100206503:T:T
NM_001918.5(DBT):c.294C>G (p.Ile98Met)	DBT	I98M	Intermediate maple syrup urine disease type 2	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000011948	1	100696428	1	100230872	11948	26987	rs121965001	NC_000001.11:100230871:G:C
NM_001918.5(DBT):c.1448G>T (p.Ter483Leu)	DBT		Intermediate maple syrup urine disease type 2	Pathogenic(Last reviewed: Jan 1, 1998)	no assertion criteria provided	VCV000011947	1	100661812	1	100196256	11947	26986	rs121965000	NC_000001.11:100196255:C:A
NM_001918.5(DBT):c.1018-550A>G	DBT		Maple syrup urine disease|Intermediate maple syrup urine disease type 2	Conflicting interpretations of pathogenicity(Last reviewed: Sep 9, 2020)	criteria provided, conflicting interpretations	VCV000011946	1	100672742	1	100207186	11946	26985	rs796052135	NC_000001.11:100207185:T:C
NM_001918.5(DBT):c.827T>G (p.Phe276Cys)	DBT	F276C	not provided|Maple syrup urine disease, thiamine-responsive, type II|Maple syrup urine disease	Pathogenic/Likely pathogenic(Last reviewed: Dec 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011943	1	100680485	1	100214929	11943	26982	rs121964999	NC_000001.11:100214928:A:C
NM_000108.5(DLD):c.419A>G (p.His140Arg)	DLD	H117R, H140R, H41R	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001199358	7	107545484	7	107905039	1199358	1189318		NC_000007.14:107905038:A:G
NM_000108.5(DLD):c.65A>G (p.His22Arg)	DLD	H22R	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001199357	7	107533670	7	107893225	1199357	1189317		NC_000007.14:107893224:A:G
NM_000108.5(DLD):c.542T>C (p.Ile181Thr)	DLD	I158T, I181T, I82T	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Jul 14, 2021)	criteria provided, single submitter	VCV001199356	7	107545909	7	107905464	1199356	1189319		NC_000007.14:107905463:T:C
NM_000108.5(DLD):c.163G>A (p.Val55Ile)	DLD	V55I	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Jan 4, 2021)	criteria provided, single submitter	VCV001177410	7	107542227	7	107901782	1177410	1166706		NC_000007.14:107901781:G:A
NM_000108.5(DLD):c.438+83G>A	DLD		not provided|Maple syrup urine disease, type 3	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001175369	7	107545586	7	107905141	1175369	1164839		NC_000007.14:107905140:G:A
NM_000108.5(DLD):c.199-108T>C	DLD		not provided|Maple syrup urine disease, type 3	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV001175368	7	107542662	7	107902217	1175368	1164838		NC_000007.14:107902216:T:C
NM_000108.5(DLD):c.1272T>C (p.Ala424=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Aug 9, 2019)	criteria provided, single submitter	VCV001157902	7	107558404	7	107917959	1157902	1138312		NC_000007.14:107917958:T:C
NM_000108.5(DLD):c.417C>G (p.Ala139=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 31, 2020)	criteria provided, single submitter	VCV001157871	7	107545482	7	107905037	1157871	1138306		NC_000007.14:107905036:C:G
NM_000108.5(DLD):c.1014A>G (p.Pro338=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001156164	7	107557377	7	107916932	1156164	1138309		NC_000007.14:107916931:A:G
NM_000108.5(DLD):c.888T>C (p.Ala296=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001155167	7	107557251	7	107916806	1155167	1138308		NC_000007.14:107916805:T:C
NM_000108.5(DLD):c.183C>T (p.Ala61=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 23, 2020)	criteria provided, single submitter	VCV001150464	7	107542247	7	107901802	1150464	1138305		NC_000007.14:107901801:C:T
NM_000108.5(DLD):c.1236+9G>A	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 11, 2020)	criteria provided, single submitter	VCV001149628	7	107557916	7	107917471	1149628	1138311		NC_000007.14:107917470:G:A
NM_000108.5(DLD):c.669A>C (p.Val223=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001147207	7	107546798	7	107906353	1147207	1138307		NC_000007.14:107906352:A:C
NM_000108.5(DLD):c.94C>T (p.Leu32=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Dec 20, 2019)	criteria provided, single submitter	VCV001146258	7	107533699	7	107893254	1146258	1138304		NC_000007.14:107893253:C:T
NM_000108.5(DLD):c.1428C>T (p.Ser476=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 24, 2020)	criteria provided, single submitter	VCV001144621	7	107559508	7	107919063	1144621	1138313		NC_000007.14:107919062:C:T
NM_000108.5(DLD):c.198+10G>C	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: May 23, 2020)	criteria provided, single submitter	VCV001138876	7	107542272	7	107901827	1138876	1117397		NC_000007.14:107901826:G:C
NM_000108.5(DLD):c.685-4G>A	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: May 3, 2020)	criteria provided, single submitter	VCV001137541	7	107555947	7	107915502	1137541	1117400		NC_000007.14:107915501:G:A
NM_000108.5(DLD):c.1101G>A (p.Glu367=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV001136725	7	107557772	7	107917327	1136725	1117401		NC_000007.14:107917326:G:A
NM_000108.5(DLD):c.1467C>A (p.Thr489=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jun 20, 2020)	criteria provided, single submitter	VCV001133422	7	107559641	7	107919196	1133422	1117403		NC_000007.14:107919195:C:A
NM_000108.5(DLD):c.180T>G (p.Ala60=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV001133301	7	107542244	7	107901799	1133301	1117396		NC_000007.14:107901798:T:G
NM_000108.5(DLD):c.119-7A>G	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 4, 2019)	criteria provided, single submitter	VCV001128581	7	107542176	7	107901731	1128581	1117395		NC_000007.14:107901730:A:G
NM_000108.5(DLD):c.30C>T (p.Ser10=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Dec 21, 2019)	criteria provided, single submitter	VCV001126433	7	107531725	7	107891280	1126433	1117393		NC_000007.14:107891279:C:T
NM_000108.5(DLD):c.684+9T>A	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 20, 2020)	criteria provided, single submitter	VCV001126321	7	107546822	7	107906377	1126321	1117398		NC_000007.14:107906376:T:A
NM_000108.5(DLD):c.1465-9C>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Mar 14, 2020)	criteria provided, single submitter	VCV001126133	7	107559630	7	107919185	1126133	1117402		NC_000007.14:107919184:C:T
NM_000108.5(DLD):c.1482T>C (p.Phe494=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001124430	7	107559656	7	107919211	1124430	1117404		NC_000007.14:107919210:T:C
NM_000108.5(DLD):c.118+10T>G	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001122813	7	107533733	7	107893288	1122813	1117394		NC_000007.14:107893287:T:G
NM_000108.5(DLD):c.18T>C (p.Arg6=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001119924	7	107531713	7	107891268	1119924	1095842		NC_000007.14:107891267:T:C
NM_000108.5(DLD):c.723A>G (p.Ala241=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jan 28, 2020)	criteria provided, single submitter	VCV001119548	7	107555989	7	107915544	1119548	1095852		NC_000007.14:107915543:A:G
NM_000108.5(DLD):c.351C>T (p.Arg117=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 13, 2019)	criteria provided, single submitter	VCV001118815	7	107545416	7	107904971	1118815	1095848		NC_000007.14:107904970:C:T
NM_000108.5(DLD):c.609T>C (p.Ser203=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, single submitter	VCV001117818	7	107546738	7	107906293	1117818	1095851		NC_000007.14:107906292:T:C
NM_000108.5(DLD):c.1296T>C (p.Asn432=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 15, 2019)	criteria provided, single submitter	VCV001117558	7	107558428	7	107917983	1117558	1095858		NC_000007.14:107917982:T:C
NM_000108.5(DLD):c.1237-7G>A	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 30, 2020)	criteria provided, single submitter	VCV001116580	7	107558362	7	107917917	1116580	1095856		NC_000007.14:107917916:G:A
NM_000108.5(DLD):c.24C>T (p.Tyr8=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, single submitter	VCV001115179	7	107531719	7	107891274	1115179	1095843		NC_000007.14:107891273:C:T
NM_000108.5(DLD):c.40-10C>G	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jan 27, 2020)	criteria provided, single submitter	VCV001113636	7	107533635	7	107893190	1113636	1095844		NC_000007.14:107893189:C:G
NM_000108.5(DLD):c.1047-4G>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 16, 2020)	criteria provided, single submitter	VCV001112414	7	107557714	7	107917269	1112414	1095855		NC_000007.14:107917268:G:T
NM_000108.5(DLD):c.495G>A (p.Thr165=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Aug 29, 2020)	criteria provided, single submitter	VCV001111262	7	107545862	7	107905417	1111262	1095850		NC_000007.14:107905416:G:A
NM_000108.5(DLD):c.199-4G>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 26, 2020)	criteria provided, single submitter	VCV001109608	7	107542766	7	107902321	1109608	1095847		NC_000007.14:107902320:G:T
NM_000108.5(DLD):c.183C>G (p.Ala61=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001108474	7	107542247	7	107901802	1108474	1095846		NC_000007.14:107901801:C:G
NM_000108.5(DLD):c.1374+10G>A	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jun 3, 2020)	criteria provided, single submitter	VCV001108088	7	107558516	7	107918071	1108088	1095860		NC_000007.14:107918070:G:A
NM_000108.5(DLD):c.474C>A (p.Gly158=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Mar 23, 2019)	criteria provided, single submitter	VCV001106365	7	107545841	7	107905396	1106365	1095849		NC_000007.14:107905395:C:A
NM_000108.5(DLD):c.72A>G (p.Leu24=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, single submitter	VCV001105935	7	107533677	7	107893232	1105935	1095845		NC_000007.14:107893231:A:G
NM_000108.5(DLD):c.807G>T (p.Gly269=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jun 3, 2019)	criteria provided, single submitter	VCV001104734	7	107556073	7	107915628	1104734	1095854		NC_000007.14:107915627:G:T
NM_000108.5(DLD):c.1254T>A (p.Val418=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: May 13, 2020)	criteria provided, single submitter	VCV001104496	7	107558386	7	107917941	1104496	1095857		NC_000007.14:107917940:T:A
NM_000108.5(DLD):c.1320G>A (p.Lys440=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jun 8, 2020)	criteria provided, single submitter	VCV001102588	7	107558452	7	107918007	1102588	1095859		NC_000007.14:107918006:G:A
NM_000108.5(DLD):c.741T>C (p.His247=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, single submitter	VCV001102287	7	107556007	7	107915562	1102287	1095853		NC_000007.14:107915561:T:C
NM_000108.5(DLD):c.1032A>G (p.Gln344=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001098196	7	107557395	7	107916950	1098196	1074253		NC_000007.14:107916949:A:G
NM_000108.5(DLD):c.337+7A>G	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001097795	7	107543999	7	107903554	1097795	1074239		NC_000007.14:107903553:A:G
NM_000108.5(DLD):c.439-4A>G	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Aug 30, 2020)	criteria provided, single submitter	VCV001097692	7	107545802	7	107905357	1097692	1074243		NC_000007.14:107905356:A:G
NM_000108.5(DLD):c.48T>C (p.His16=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 2, 2019)	criteria provided, single submitter	VCV001095111	7	107533653	7	107893208	1095111	1074234		NC_000007.14:107893207:T:C
NM_000108.5(DLD):c.834T>C (p.Val278=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 11, 2020)	criteria provided, single submitter	VCV001093299	7	107556100	7	107915655	1093299	1074251		NC_000007.14:107915654:T:C
NM_000108.5(DLD):c.387T>A (p.Thr129=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 13, 2020)	criteria provided, single submitter	VCV001093138	7	107545452	7	107905007	1093138	1074241		NC_000007.14:107905006:T:A
NM_000108.5(DLD):c.199-10T>C	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Feb 25, 2020)	criteria provided, single submitter	VCV001091202	7	107542760	7	107902315	1091202	1074238		NC_000007.14:107902314:T:C
NM_000108.5(DLD):c.685-4G>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV001087948	7	107555947	7	107915502	1087948	1074248		NC_000007.14:107915501:G:T
NM_000108.5(DLD):c.342C>T (p.Ser114=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 5, 2020)	criteria provided, single submitter	VCV001086464	7	107545407	7	107904962	1086464	1074240		NC_000007.14:107904961:C:T
NM_000108.5(DLD):c.444T>G (p.Val148=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 27, 2020)	criteria provided, single submitter	VCV001086349	7	107545811	7	107905366	1086349	1074244		NC_000007.14:107905365:T:G
NM_000108.5(DLD):c.507C>A (p.Gly169=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Aug 23, 2020)	criteria provided, single submitter	VCV001085930	7	107545874	7	107905429	1085930	1074245		NC_000007.14:107905428:C:A
NM_000108.5(DLD):c.119-5C>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001085479	7	107542178	7	107901733	1085479	1074236		NC_000007.14:107901732:C:T
NM_000108.5(DLD):c.528A>T (p.Thr176=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Mar 17, 2020)	criteria provided, single submitter	VCV001082370	7	107545895	7	107905450	1082370	1074246		NC_000007.14:107905449:A:T
NM_000108.5(DLD):c.699A>G (p.Gln233=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: May 21, 2020)	criteria provided, single submitter	VCV001082207	7	107555965	7	107915520	1082207	1074249		NC_000007.14:107915519:A:G
NM_000108.5(DLD):c.93T>C (p.Pro31=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 30, 2020)	criteria provided, single submitter	VCV001081987	7	107533698	7	107893253	1081987	1074235		NC_000007.14:107893252:T:C
NM_000108.5(DLD):c.954T>C (p.Phe318=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Apr 22, 2020)	criteria provided, single submitter	VCV001081415	7	107557317	7	107916872	1081415	1074252		NC_000007.14:107916871:T:C
NM_000108.5(DLD):c.168T>C (p.Ala56=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Mar 22, 2020)	criteria provided, single submitter	VCV001080435	7	107542232	7	107901787	1080435	1074237		NC_000007.14:107901786:T:C
NM_000108.5(DLD):c.735A>G (p.Leu245=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jun 18, 2019)	criteria provided, single submitter	VCV001080347	7	107556001	7	107915556	1080347	1074250		NC_000007.14:107915555:A:G
NM_000108.5(DLD):c.1359A>G (p.Ala453=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Feb 8, 2020)	criteria provided, single submitter	VCV001080091	7	107558491	7	107918046	1080091	1074254		NC_000007.14:107918045:A:G
NM_000108.5(DLD):c.540T>C (p.Leu180=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Mar 7, 2020)	criteria provided, single submitter	VCV001078457	7	107545907	7	107905462	1078457	1074247		NC_000007.14:107905461:T:C
NM_000108.5(DLD):c.1396G>T (p.Glu466Ter)	DLD	E367*, E418*, E443*, E466*	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Feb 24, 2020)	criteria provided, single submitter	VCV001072157	7	107559476	7	107919031	1072157	1060964		NC_000007.14:107919030:G:T
NM_000108.5(DLD):c.1182C>G (p.Tyr394Ter)	DLD	Y295*, Y346*, Y371*, Y394*	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Sep 15, 2020)	criteria provided, single submitter	VCV001070701	7	107557853	7	107917408	1070701	1060963		NC_000007.14:107917407:C:G
NM_000108.5(DLD):c.338-1G>T	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Sep 17, 2020)	criteria provided, single submitter	VCV001068423	7	107545402	7	107904957	1068423	1055655		NC_000007.14:107904956:G:T
NM_000108.5(DLD):c.1439T>C (p.Ile480Thr)	DLD	I457T, I381T, I432T, I480T	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Aug 7, 2019)	criteria provided, single submitter	VCV001030599	7	107559519	7	107919074	1030599	1016833		NC_000007.14:107919073:T:C
NM_000108.5(DLD):c.656T>C (p.Ile219Thr)	DLD	I196T, I120T, I171T, I219T	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: May 5, 2020)	criteria provided, single submitter	VCV001028071	7	107546785	7	107906340	1028071	1016832		NC_000007.14:107906339:T:C
NM_000108.5(DLD):c.1471T>C (p.Ser491Pro)	DLD	S392P, S443P, S491P, S468P	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Mar 7, 2019)	criteria provided, single submitter	VCV001028070	7	107559645	7	107919200	1028070	1016834		NC_000007.14:107919199:T:C
NM_000108.5(DLD):c.1333A>G (p.Lys445Glu)	DLD	K346E, K397E, K422E, K445E	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Jul 15, 2020)	no assertion criteria provided	VCV000990105	7	107558465	7	107918020	990105	978385		NC_000007.14:107918019:A:G
NM_000108.5(DLD):c.597A>G (p.Thr199=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 1, 2019)	criteria provided, single submitter	VCV000990104	7	107546726	7	107906281	990104	978384		NC_000007.14:107906280:A:G
NM_000108.5(DLD):c.508G>A (p.Gly170Ser)	DLD	G147S, G170S, G71S	Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 28, 2020)	no assertion criteria provided	VCV000990103	7	107545875	7	107905430	990103	978383		NC_000007.14:107905429:G:A
NM_000108.5(DLD):c.191G>C (p.Gly64Ala)	DLD	G64A	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Aug 13, 2020)	no assertion criteria provided	VCV000990102	7	107542255	7	107901810	990102	978382		NC_000007.14:107901809:G:C
NM_000108.5(DLD):c.1119T>A (p.Cys373Ter)	DLD	C274*, C325*, C350*, C373*	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Mar 21, 2019)	no assertion criteria provided	VCV000984093	7	107557790	7	107917345	984093	971980		NC_000007.14:107917344:T:A
NM_000108.5(DLD):c.1105G>T (p.Glu369Ter)	DLD	E270*, E321*, E346*, E369*	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Sep 29, 2019)	no assertion criteria provided	VCV000984092	7	107557776	7	107917331	984092	971979		NC_000007.14:107917330:G:T
NM_000108.5(DLD):c.936C>A (p.Cys312Ter)	DLD	C213*, C264*, C289*, C312*	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Jan 21, 2020)	no assertion criteria provided	VCV000983933	7	107557299	7	107916854	983933	971978		NC_000007.14:107916853:C:A
NM_000108.5(DLD):c.904G>T (p.Glu302Ter)	DLD	E203*, E254*, E279*, E302*	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Dec 4, 2019)	no assertion criteria provided	VCV000983932	7	107557267	7	107916822	983932	971977		NC_000007.14:107916821:G:T
NM_000108.5(DLD):c.802C>T (p.Gln268Ter)	DLD	Q169*, Q220*, Q245*, Q268*	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Jan 4, 2020)	no assertion criteria provided	VCV000983931	7	107556068	7	107915623	983931	971976		NC_000007.14:107915622:C:T
NM_000108.5(DLD):c.748G>T (p.Gly250Ter)	DLD	G151*, G202*, G227*, G250*	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Oct 5, 2019)	no assertion criteria provided	VCV000983930	7	107556014	7	107915569	983930	971975		NC_000007.14:107915568:G:T
NM_000108.5(DLD):c.325A>T (p.Arg109Ter)	DLD	R10*, R109*, R86*	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Mar 29, 2020)	no assertion criteria provided	VCV000983929	7	107543980	7	107903535	983929	971974		NC_000007.14:107903534:A:T
NM_000108.5(DLD):c.583-1G>C	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Oct 9, 2020)	criteria provided, single submitter	VCV000968596	7	107546711	7	107906266	968596	960619		NC_000007.14:107906265:G:C
NM_000108.5(DLD):c.1492A>C (p.Asn498His)	DLD	N399H, N450H, N475H, N498H	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000967330	7	107559666	7	107919221	967330	954980		NC_000007.14:107919220:A:C
NM_000108.5(DLD):c.857A>G (p.Asp286Gly)	DLD	D187G, D238G, D263G, D286G	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000931300	7	107556123	7	107915678	931300	919068		NC_000007.14:107915677:A:G
NM_000108.5(DLD):c.*1640A>G	DLD		Leigh syndrome|Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000911751	7	107561344	7	107920899	911751	897254		NC_000007.14:107920898:A:G
NM_000108.5(DLD):c.*739G>A	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000911618	7	107560443	7	107919998	911618	897242		NC_000007.14:107919997:G:A
NM_000108.5(DLD):c.1313T>C (p.Met438Thr)	DLD	M339T, M415T, M438T, M390T	Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000911498	7	107558445	7	107918000	911498	897237		NC_000007.14:107917999:T:C
NM_000108.5(DLD):c.30C>A (p.Ser10=)	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000911148	7	107531725	7	107891280	911148	897234		NC_000007.14:107891279:C:A
NM_000108.5(DLD):c.*1505C>T	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910509	7	107561209	7	107920764	910509	897253		NC_000007.14:107920763:C:T
NM_000108.5(DLD):c.*1074C>G	DLD		Leigh syndrome|Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency	Benign(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000910455	7	107560778	7	107920333	910455	897247		NC_000007.14:107920332:C:G
NM_000108.5(DLD):c.*1027T>G	DLD		Leigh syndrome|Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000910454	7	107560731	7	107920286	910454	897246		NC_000007.14:107920285:T:G
NM_000108.5(DLD):c.*1876G>A	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Jan 13, 2018)	criteria provided, conflicting interpretations	VCV000909641	7	107561580	7	107921135	909641	897255		NC_000007.14:107921134:G:A
NM_000108.5(DLD):c.*1422C>T	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909586	7	107561126	7	107920681	909586	897252		NC_000007.14:107920680:C:T
NM_000108.5(DLD):c.*1401G>T	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909585	7	107561105	7	107920660	909585	897251		NC_000007.14:107920659:G:T
NM_000108.5(DLD):c.*474T>C	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909455	7	107560178	7	107919733	909455	897241		NC_000007.14:107919732:T:C
NM_000108.5(DLD):c.*470G>T	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909454	7	107560174	7	107919729	909454	897240		NC_000007.14:107919728:G:T
NM_000108.5(DLD):c.226C>T (p.Leu76Phe)	DLD	L76F	Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000909237	7	107542797	7	107902352	909237	897235		NC_000007.14:107902351:C:T
NM_000108.5(DLD):c.-10C>T	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000909173	7	107531686	7	107891241	909173	897233		NC_000007.14:107891240:C:T
NM_000108.5(DLD):c.*1300A>G	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908729	7	107561004	7	107920559	908729	897250		NC_000007.14:107920558:A:G
NM_000108.5(DLD):c.*1231A>G	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908728	7	107560935	7	107920490	908728	897249		NC_000007.14:107920489:A:G
NM_000108.5(DLD):c.*1145A>T	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000908727	7	107560849	7	107920404	908727	897248		NC_000007.14:107920403:A:T
NM_000108.5(DLD):c.*898C>T	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908669	7	107560602	7	107920157	908669	897245		NC_000007.14:107920156:C:T
NM_000108.5(DLD):c.*887T>C	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Benign/Likely benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908668	7	107560591	7	107920146	908668	897244		NC_000007.14:107920145:T:C
NM_000108.5(DLD):c.*845G>A	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908667	7	107560549	7	107920104	908667	897243		NC_000007.14:107920103:G:A
NM_000108.5(DLD):c.*394A>G	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908600	7	107560098	7	107919653	908600	897239		NC_000007.14:107919652:A:G
NM_000108.5(DLD):c.*374G>T	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908599	7	107560078	7	107919633	908599	897238		NC_000007.14:107919632:G:T
NM_000108.5(DLD):c.520A>G (p.Ile174Val)	DLD	I151V, I174V, I75V	Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000908459	7	107545887	7	107905442	908459	897236		NC_000007.14:107905441:A:G
NM_000108.5(DLD):c.946C>T (p.Arg316Ter)	DLD	R217*, R293*, R268*, R316*	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Jan 14, 2019)	criteria provided, single submitter	VCV000854640	7	107557309	7	107916864	854640	832782		NC_000007.14:107916863:C:T
NM_000108.5(DLD):c.305A>T (p.His102Leu)	DLD	H3L, H102L, H79L	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000837401	7	107543960	7	107903515	837401	832781		NC_000007.14:107903514:A:T
NM_000108.5(DLD):c.684+1G>T	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Aug 25, 2019)	no assertion criteria provided	VCV000800815	7	107546814	7	107906369	800815	789369	rs780025714	NC_000007.14:107906368:G:T
NM_000108.5(DLD):c.285T>C (p.Ser95=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV000799485	7	107543940	7	107903495	799485	782725	rs761564212	NC_000007.14:107903494:T:C
NM_000108.5(DLD):c.1374+9T>A	DLD		not provided|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, single submitter	VCV000799345	7	107558515	7	107918070	799345	787622	rs1584473925	NC_000007.14:107918069:T:A
NM_000108.5(DLD):c.1011T>C (p.Ile337=)	DLD		Maple syrup urine disease, type 3|not provided	Likely benign(Last reviewed: Dec 23, 2018)	criteria provided, single submitter	VCV000799218	7	107557374	7	107916929	799218	782726	rs761507009	NC_000007.14:107916928:T:C
NM_000108.5(DLD):c.57A>T (p.Arg19=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Dec 24, 2019)	criteria provided, single submitter	VCV000796711	7	107533662	7	107893217	796711	782723	rs754899464	NC_000007.14:107893216:A:T
NM_000108.5(DLD):c.204C>G (p.Val68=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 24, 2020)	criteria provided, single submitter	VCV000794003	7	107542775	7	107902330	794003	782724	rs553951105	NC_000007.14:107902329:C:G
NM_000108.5(DLD):c.1443T>G (p.Ala481=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV000792550	7	107559523	7	107919078	792550	782727	rs775957704	NC_000007.14:107919077:T:G
NM_000108.5(DLD):c.519T>G (p.Val173=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 14, 2020)	criteria provided, single submitter	VCV000791746	7	107545886	7	107905441	791746	710696	rs148559280	NC_000007.14:107905440:T:G
NM_000108.5(DLD):c.583-3C>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Dec 2, 2020)	criteria provided, single submitter	VCV000791729	7	107546709	7	107906264	791729	779204	rs186031819	NC_000007.14:107906263:C:T
NM_000108.5(DLD):c.1266A>G (p.Pro422=)	DLD		Maple syrup urine disease, type 3|not provided	Likely benign(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000766486	7	107558398	7	107917953	766486	765985	rs766756785	NC_000007.14:107917952:A:G
NM_000108.5(DLD):c.1005T>C (p.Gly335=)	DLD		Maple syrup urine disease, type 3|not provided	Likely benign(Last reviewed: Jun 9, 2020)	criteria provided, single submitter	VCV000762080	7	107557368	7	107916923	762080	765984	rs763878786	NC_000007.14:107916922:T:C
NM_000108.5(DLD):c.199-7G>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000761729	7	107542763	7	107902318	761729	775273	rs1358100638	NC_000007.14:107902317:G:T
NM_000108.5(DLD):c.375G>A (p.Glu125=)	DLD		Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Oct 31, 2020)	criteria provided, conflicting interpretations	VCV000751771	7	107545440	7	107904995	751771	765983	rs559057715	NC_000007.14:107904994:G:A
NM_000108.5(DLD):c.268-7C>T	DLD		not provided|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000751589	7	107543916	7	107903471	751589	775318	rs1584463325	NC_000007.14:107903470:C:T
NM_000108.5(DLD):c.597A>T (p.Thr199=)	DLD		not provided|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 21, 2020)	criteria provided, single submitter	VCV000739537	7	107546726	7	107906281	739537	750334	rs768248572	NC_000007.14:107906280:A:T
NM_000108.5(DLD):c.1500T>C (p.Ala500=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jun 21, 2020)	criteria provided, single submitter	VCV000738009	7	107559674	7	107919229	738009	750335	rs773097788	NC_000007.14:107919228:T:C
NM_000108.5(DLD):c.876-6A>T	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 21, 2020)	criteria provided, single submitter	VCV000736957	7	107557233	7	107916788	736957	759528	rs199944006	NC_000007.14:107916787:A:T
NM_000108.5(DLD):c.549G>A (p.Thr183=)	DLD		not provided|Maple syrup urine disease, type 3	Benign/Likely benign(Last reviewed: Dec 6, 2020)	criteria provided, multiple submitters, no conflicts	VCV000736174	7	107545916	7	107905471	736174	750333	rs150630885	NC_000007.14:107905470:G:A
NM_000108.5(DLD):c.36C>T (p.Ala12=)	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Feb 26, 2020)	criteria provided, single submitter	VCV000732787	7	107531731	7	107891286	732787	735864	rs780127925	NC_000007.14:107891285:C:T
NM_000108.5(DLD):c.267+9G>A	DLD		Maple syrup urine disease, type 3	Likely benign(Last reviewed: Nov 26, 2020)	criteria provided, single submitter	VCV000732197	7	107542847	7	107902402	732197	744168	rs188936529	NC_000007.14:107902401:G:A
NM_000108.5(DLD):c.654T>C (p.Val218=)	DLD		not provided|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jan 17, 2020)	criteria provided, single submitter	VCV000731406	7	107546783	7	107906338	731406	735865	rs1584465590	NC_000007.14:107906337:T:C
NM_000108.5(DLD):c.1452T>C (p.Cys484=)	DLD		Maple syrup urine disease, type 3|not provided	Likely benign(Last reviewed: Nov 20, 2020)	criteria provided, multiple submitters, no conflicts	VCV000724857	7	107559532	7	107919087	724857	735867	rs760982359	NC_000007.14:107919086:T:C
NM_000108.5(DLD):c.951C>G (p.Pro317=)	DLD		not provided|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 21, 2020)	criteria provided, single submitter	VCV000716550	7	107557314	7	107916869	716550	722233	rs778207997	NC_000007.14:107916868:C:G
NM_000108.5(DLD):c.96G>C (p.Leu32=)	DLD		Maple syrup urine disease, type 3|not provided	Likely benign(Last reviewed: Aug 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000680924	7	107533701	7	107893256	680924	655765	rs765623212	NC_000007.14:107893255:G:C
NM_000108.5(DLD):c.814T>C (p.Phe272Leu)	DLD	F173L, F249L, F224L, F272L	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000650628	7	107556080	7	107915635	650628	635449	rs942843326	NC_000007.14:107915634:T:C
NM_000108.5(DLD):c.367A>G (p.Met123Val)	DLD	M123V, M100V, M24V	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000649784	7	107545432	7	107904987	649784	635447	rs111352707	NC_000007.14:107904986:A:G
NM_000108.5(DLD):c.470C>G (p.Thr157Ser)	DLD	T134S, T58S, T157S	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000640413	7	107545837	7	107905392	640413	635448	rs142232609	NC_000007.14:107905391:C:G
NM_000108.5(DLD):c.55C>G (p.Arg19Gly)	DLD	R19G	Pyruvate dehydrogenase complex deficiency|not provided|Leigh syndrome|Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Jun 18, 2021)	criteria provided, multiple submitters, no conflicts	VCV000578582	7	107533660	7	107893215	578582	566277	rs144038427	NC_000007.14:107893214:C:G
NM_000108.5(DLD):c.12G>A (p.Trp4Ter)	DLD	W4*	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Feb 11, 2019)	criteria provided, single submitter	VCV000572549	7	107531707	7	107891262	572549	563929	rs1562908173	NC_000007.14:107891261:G:A
NM_000108.5(DLD):c.118+1G>T	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000557660	7	107533724	7	107893279	557660	544350	rs1554396908	NC_000007.14:107893278:G:T
NM_000108.5(DLD):c.1528T>C (p.Ter510Arg)	DLD		Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Mar 30, 2018)	criteria provided, single submitter	VCV000557409	7	107559702	7	107919257	557409	544367	rs1554400769	NC_000007.14:107919256:T:C
NM_000108.5(DLD):c.198+1G>A	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Jan 24, 2018)	criteria provided, single submitter	VCV000556283	7	107542263	7	107901818	556283	544102	rs1554398193	NC_000007.14:107901817:G:A
NM_000108.5(DLD):c.268-2A>G	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Jan 17, 2018)	criteria provided, single submitter	VCV000556197	7	107543921	7	107903476	556197	544467	rs1554398461	NC_000007.14:107903475:A:G
NM_000108.5(DLD):c.439-6G>C	DLD		Maple syrup urine disease, type 3	Conflicting interpretations of pathogenicity(Last reviewed: Nov 22, 2020)	criteria provided, conflicting interpretations	VCV000555321	7	107545800	7	107905355	555321	544473	rs369208046	NC_000007.14:107905354:G:C
NM_000108.5(DLD):c.1236+1G>T	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000553091	7	107557908	7	107917463	553091	544483	rs1554400483	NC_000007.14:107917462:G:T
NM_000108.5(DLD):c.199-1G>A	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000552664	7	107542769	7	107902324	552664	544104	rs1554398264	NC_000007.14:107902323:G:A
NM_000108.5(DLD):c.1440A>G (p.Ile480Met)	DLD	I480M, I432M, I457M, I381M	Maple syrup urine disease, type 3	Uncertain significance(Last reviewed: Feb 7, 2017)	criteria provided, single submitter	VCV000550498	7	107559520	7	107919075	550498	544107	rs772512477	NC_000007.14:107919074:A:G
NM_000108.5(DLD):c.507C>T (p.Gly169=)	DLD		not provided|Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Benign/Likely benign(Last reviewed: Jan 25, 2021)	criteria provided, multiple submitters, no conflicts	VCV000510967	7	107545874	7	107905429	510967	501526	rs144351432	NC_000007.14:107905428:C:T
NM_000108.5(DLD):c.119-4G>A	DLD		not specified|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000507084	7	107542179	7	107901734	507084	501757	rs376605135	NC_000007.14:107901733:G:A
NM_000108.5(DLD):c.161A>G (p.Tyr54Cys)	DLD	Y54C	Maple syrup urine disease, type 3|not provided	Likely pathogenic(Last reviewed: Apr 3, 2017)	criteria provided, single submitter	VCV000424265	7	107542225	7	107901780	424265	406954	rs763303046	NC_000007.14:107901779:A:G
NM_000108.5(DLD):c.105C>G (p.Tyr35Ter)	DLD	Y35*	not provided|Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: May 5, 2016)	criteria provided, single submitter	VCV000421142	7	107533710	7	107893265	421142	406953	rs747810875	NC_000007.14:107893264:C:G
NM_000108.5(DLD):c.1395T>C (p.Asn465=)	DLD		Maple syrup urine disease, type 3|not specified	Benign/Likely benign(Last reviewed: Dec 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000391374	7	107559475	7	107919030	391374	370677	rs76313180	NC_000007.14:107919029:T:C
NM_000108.5(DLD):c.1182C>T (p.Tyr394=)	DLD		not specified|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Oct 1, 2020)	criteria provided, multiple submitters, no conflicts	VCV000388757	7	107557853	7	107917408	388757	368846	rs757087726	NC_000007.14:107917407:C:T
NM_000108.5(DLD):c.321A>G (p.Ala107=)	DLD		Pyruvate dehydrogenase complex deficiency|not provided|Leigh syndrome|Maple syrup urine disease, type 3	Conflicting interpretations of pathogenicity(Last reviewed: Jun 15, 2021)	criteria provided, conflicting interpretations	VCV000382483	7	107543976	7	107903531	382483	368842	rs138398782	NC_000007.14:107903530:A:G
NM_000108.5(DLD):c.282C>T (p.Asn94=)	DLD		Maple syrup urine disease, type 3|not provided	Likely benign(Last reviewed: Nov 17, 2020)	criteria provided, multiple submitters, no conflicts	VCV000377772	7	107543937	7	107903492	377772	370664	rs144617361	NC_000007.14:107903491:C:T
NM_000108.5(DLD):c.39+1G>A	DLD		Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Nov 2, 2016)	criteria provided, single submitter	VCV000371615	7	107531735	7	107891290	371615	357555	rs111257462	NC_000007.14:107891289:G:A
NM_000108.5(DLD):c.112C>T (p.Gln38Ter)	DLD	Q38*	Maple syrup urine disease, type 3|DLD-Related Disorders	Conflicting interpretations of pathogenicity(Last reviewed: Jul 2, 2019)	criteria provided, conflicting interpretations	VCV000370700	7	107533717	7	107893272	370700	357558	rs1057516698	NC_000007.14:107893271:C:T
NM_000108.5(DLD):c.*1877A>G	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358594	7	107561581	7	107921136	358594	301504	rs182010485	NC_000007.14:107921135:A:G
NM_000108.5(DLD):c.*1857A>C	DLD		Leigh syndrome|Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358593	7	107561561	7	107921116	358593	304760	rs774099916	NC_000007.14:107921115:A:C
NM_000108.5(DLD):c.*1736T>C	DLD		Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000358591	7	107561440	7	107920995	358591	301503	rs190655078	NC_000007.14:107920994:T:C
NM_000108.5(DLD):c.*1724C>G	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358590	7	107561428	7	107920983	358590	304743	rs886061913	NC_000007.14:107920982:C:G
NM_000108.5(DLD):c.*1688G>A	DLD		Maple syrup urine disease, type 3|not provided|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000358589	7	107561392	7	107920947	358589	301501	rs8440	NC_000007.14:107920946:G:A
NM_000108.5(DLD):c.*1451T>C	DLD		Maple syrup urine disease, type 3|not provided|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000358588	7	107561155	7	107920710	358588	301500	rs2108223	NC_000007.14:107920709:T:C
NM_000108.5(DLD):c.*1307C>T	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358587	7	107561011	7	107920566	358587	304742	rs568807016	NC_000007.14:107920565:C:T
NM_000108.5(DLD):c.*1092C>T	DLD		Leigh syndrome|Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358586	7	107560796	7	107920351	358586	301494	rs546777301	NC_000007.14:107920350:C:T
NM_000108.5(DLD):c.*1088A>G	DLD		Leigh syndrome|Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358585	7	107560792	7	107920347	358585	301493	rs886061912	NC_000007.14:107920346:A:G
NM_000108.5(DLD):c.*978T>C	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358584	7	107560682	7	107920237	358584	304740	rs2158835	NC_000007.14:107920236:T:C
NM_000108.5(DLD):c.*947G>T	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358583	7	107560651	7	107920206	358583	301489	rs7777259	NC_000007.14:107920205:G:T
NM_000108.5(DLD):c.*855C>T	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358582	7	107560559	7	107920114	358582	309505	rs116055514	NC_000007.14:107920113:C:T
NM_000108.5(DLD):c.*648G>A	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Benign(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358581	7	107560352	7	107919907	358581	304739	rs57801571	NC_000007.14:107919906:G:A
NM_000108.5(DLD):c.*498T>G	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358580	7	107560202	7	107919757	358580	304738	rs886061911	NC_000007.14:107919756:T:G
NM_000108.5(DLD):c.*487C>T	DLD		Maple syrup urine disease, type 3|not provided|Pyruvate dehydrogenase complex deficiency|Leigh syndrome	Benign(Last reviewed: May 11, 2021)	criteria provided, multiple submitters, no conflicts	VCV000358579	7	107560191	7	107919746	358579	301488	rs4518	NC_000007.14:107919745:C:T
NM_000108.5(DLD):c.*470G>A	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000358578	7	107560174	7	107919729	358578	309371	rs111619940	NC_000007.14:107919728:G:A
NM_000108.5(DLD):c.*355A>G	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358577	7	107560059	7	107919614	358577	309504	rs886061910	NC_000007.14:107919613:A:G
NM_000108.5(DLD):c.*225C>T	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358576	7	107559929	7	107919484	358576	304737	rs553824101	NC_000007.14:107919483:C:T
NM_000108.5(DLD):c.*207G>A	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Benign(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358575	7	107559911	7	107919466	358575	309370	rs4564	NC_000007.14:107919465:G:A
NM_000108.5(DLD):c.*167T>C	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358574	7	107559871	7	107919426	358574	309502	rs886061909	NC_000007.14:107919425:T:C
NM_000108.5(DLD):c.*28G>T	DLD		Leigh syndrome|Maple syrup urine disease, type 3|Pyruvate dehydrogenase complex deficiency	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000358573	7	107559732	7	107919287	358573	304735	rs17154615	NC_000007.14:107919286:G:T
NM_000108.5(DLD):c.1503G>A (p.Ala501=)	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Jun 12, 2019)	criteria provided, conflicting interpretations	VCV000358572	7	107559677	7	107919232	358572	304734	rs766286119	NC_000007.14:107919231:G:A
NM_000108.5(DLD):c.1465-7C>G	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Aug 5, 2020)	criteria provided, conflicting interpretations	VCV000358571	7	107559632	7	107919187	358571	309501	rs886061908	NC_000007.14:107919186:C:G
NM_000108.5(DLD):c.1228A>C (p.Lys410Gln)	DLD	K410Q, K362Q, K387Q, K311Q	Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358570	7	107557899	7	107917454	358570	301484	rs886061907	NC_000007.14:107917453:A:C
NM_000108.5(DLD):c.860G>A (p.Gly287Glu)	DLD	G287E, G239E, G188E, G264E	Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358569	7	107556126	7	107915681	358569	309368	rs202125745	NC_000007.14:107915680:G:A
NM_000108.5(DLD):c.677T>C (p.Val226Ala)	DLD	V226A, V178A, V203A, V127A	Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000358568	7	107546806	7	107906361	358568	304731	rs750449027	NC_000007.14:107906360:T:C
NM_000108.5(DLD):c.117G>A (p.Pro39=)	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358566	7	107533722	7	107893277	358566	304712	rs751621846	NC_000007.14:107893276:G:A
NM_000108.5(DLD):c.116C>T (p.Pro39Leu)	DLD	P39L	Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358565	7	107533721	7	107893276	358565	304711	rs766396602	NC_000007.14:107893275:C:T
NM_000108.5(DLD):c.74A>C (p.Gln25Pro)	DLD	Q25P	Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358564	7	107533679	7	107893234	358564	309367	rs61749951	NC_000007.14:107893233:A:C
NM_000108.5(DLD):c.-8G>T	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000358563	7	107531688	7	107891243	358563	309499	rs372155330	NC_000007.14:107891242:G:T
NM_000108.5(DLD):c.105C>T (p.Tyr35=)	DLD		not specified|Maple syrup urine disease, type 3	Likely benign(Last reviewed: Jul 9, 2020)	criteria provided, multiple submitters, no conflicts	VCV000255129	7	107533710	7	107893265	255129	252560	rs747810875	NC_000007.14:107893264:C:T
NM_000108.5(DLD):c.1382G>A (p.Gly461Glu)	DLD	G461E, G413E, G362E, G438E	Maple syrup urine disease, type 3|not provided	Uncertain significance(Last reviewed: May 16, 2017)	criteria provided, single submitter	VCV000203685	7	107559462	7	107919017	203685	200144	rs757275923	NC_000007.14:107919016:G:A
NM_000108.5(DLD):c.826A>T (p.Thr276Ser)	DLD	T276S, T228S, T177S, T253S	Maple syrup urine disease, type 3|not provided	Likely benign(Last reviewed: Feb 26, 2021)	criteria provided, multiple submitters, no conflicts	VCV000203682	7	107556092	7	107915647	203682	200141	rs148873419	NC_000007.14:107915646:A:T
NM_000108.5(DLD):c.788G>A (p.Arg263His)	DLD	R263H, R215H, R240H, R164H	Maple syrup urine disease, type 3|Leigh syndrome|Pyruvate dehydrogenase complex deficiency|not provided	Uncertain significance(Last reviewed: Sep 24, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203681	7	107556054	7	107915609	203681	200140	rs145670503	NC_000007.14:107915608:G:A
NM_000108.5(DLD):c.763A>C (p.Met255Leu)	DLD	M255L, M232L, M156L, M207L	Leigh syndrome|Maple syrup urine disease, type 3|not provided|Pyruvate dehydrogenase complex deficiency	Conflicting interpretations of pathogenicity(Last reviewed: Oct 6, 2020)	criteria provided, conflicting interpretations	VCV000203680	7	107556029	7	107915584	203680	200139	rs533405046	NC_000007.14:107915583:A:C
NM_000108.5(DLD):c.100A>G (p.Thr34Ala)	DLD	T34A	Maple syrup urine disease, type 3|Leigh syndrome|not provided|not specified|Pyruvate dehydrogenase complex deficiency	Uncertain significance(Last reviewed: Dec 4, 2019)	criteria provided, multiple submitters, no conflicts	VCV000203672	7	107533705	7	107893260	203672	200131	rs138002793	NC_000007.14:107893259:A:G
NM_000108.5(DLD):c.675T>C (p.Gly225=)	DLD		not specified|Maple syrup urine disease, type 3	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000203670	7	107546804	7	107906359	203670	200137	rs73726765	NC_000007.14:107906358:T:C
NM_000108.5(DLD):c.34G>A (p.Ala12Thr)	DLD	A12T	Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|not provided|not specified|Leigh syndrome	Benign/Likely benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137103	7	107531729	7	107891284	137103	140806	rs75077312	NC_000007.14:107891283:G:A
NM_000108.5(DLD):c.*18A>T	DLD		Pyruvate dehydrogenase complex deficiency|not provided|Maple syrup urine disease, type 3|not specified|Leigh syndrome	Benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000137102	7	107559722	7	107919277	137102	140805	rs8721	NC_000007.14:107919276:A:T
NM_000108.5(DLD):c.1422A>C (p.Gly474=)	DLD		Pyruvate dehydrogenase complex deficiency|not provided|not specified|Maple syrup urine disease, type 3|Leigh syndrome	Benign/Likely benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137101	7	107559502	7	107919057	137101	140804	rs34453495	NC_000007.14:107919056:A:C
NM_000108.5(DLD):c.1351C>T (p.Leu451=)	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|not provided|Leigh syndrome|not specified	Benign(Last reviewed: Dec 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137100	7	107558483	7	107918038	137100	140803	rs1803921	NC_000007.14:107918037:C:T
NM_000108.5(DLD):c.1236+13A>G	DLD		not specified|Maple syrup urine disease, type 3	Benign(Last reviewed: Nov 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137099	7	107557920	7	107917475	137099	140802	rs2701026	NC_000007.14:107917474:A:G
NM_000108.5(DLD):c.777A>G (p.Lys259=)	DLD		Pyruvate dehydrogenase complex deficiency|not provided|Maple syrup urine disease, type 3|not specified|Leigh syndrome	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137098	7	107556043	7	107915598	137098	140801	rs1065762	NC_000007.14:107915597:A:G
NM_000108.5(DLD):c.685-14T>A	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|Leigh syndrome|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137097	7	107555937	7	107915492	137097	140800	rs80111449	NC_000007.14:107915491:T:A
NM_000108.5(DLD):c.684+7G>A	DLD		Pyruvate dehydrogenase complex deficiency|not provided|Maple syrup urine disease, type 3|Leigh syndrome|not specified	Benign(Last reviewed: Dec 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137096	7	107546820	7	107906375	137096	140799	rs75123588	NC_000007.14:107906374:G:A
NM_000108.5(DLD):c.543A>T (p.Ile181=)	DLD		not provided|Pyruvate dehydrogenase complex deficiency|Leigh syndrome|Maple syrup urine disease, type 3|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)	criteria provided, conflicting interpretations	VCV000137095	7	107545910	7	107905465	137095	140798	rs61749952	NC_000007.14:107905464:A:T
NM_000108.5(DLD):c.439-7T>C	DLD		Pyruvate dehydrogenase complex deficiency|Maple syrup urine disease, type 3|not provided|Leigh syndrome|not specified	Benign/Likely benign(Last reviewed: Jul 1, 2021)	criteria provided, multiple submitters, no conflicts	VCV000137094	7	107545799	7	107905354	137094	140797	rs10263341	NC_000007.14:107905353:T:C
NM_000108.5(DLD):c.338-18T>A	DLD		Maple syrup urine disease, type 3|not specified	Benign(Last reviewed: Oct 5, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137093	7	107545385	7	107904940	137093	140796	rs184851386	NC_000007.14:107904939:T:A
NM_000108.5(DLD):c.249T>C (p.Val83=)	DLD		Pyruvate dehydrogenase complex deficiency|not specified|Maple syrup urine disease, type 3|Leigh syndrome|not provided	Benign(Last reviewed: Dec 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000137092	7	107542820	7	107902375	137092	140795	rs2228664	NC_000007.14:107902374:T:C
NM_000108.5(DLD):c.140T>C (p.Ile47Thr)	DLD	I47T	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Jul 15, 2006)	no assertion criteria provided	VCV000040188	7	107542204	7	107901759	40188	48685	rs397514651	NC_000007.14:107901758:T:C
NM_000108.5(DLD):c.1444A>G (p.Arg482Gly)	DLD	R482G, R459G, R383G, R434G	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000040187	7	107559524	7	107919079	40187	48684	rs397514650	NC_000007.14:107919078:A:G
NM_000108.5(DLD):c.1436A>T (p.Asp479Val)	DLD	D479V, D456V, D431V, D380V	Maple syrup urine disease, type 3	Likely pathogenic(Last reviewed: Aug 15, 2019)	criteria provided, single submitter	VCV000040186	7	107559516	7	107919071	40186	48683	rs397514649	NC_000007.14:107919070:A:T
NM_000108.5(DLD):c.1081A>G (p.Met361Val)	DLD	M361V, M313V, M338V, M262V	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Nov 1, 2001)	no assertion criteria provided	VCV000011972	7	107557752	7	107917307	11972	27011	rs121964993	NC_000007.14:107917306:A:G
NM_000108.5(DLD):c.1123G>A (p.Glu375Lys)	DLD	E375K, E352K, E276K, E327K	Maple syrup urine disease, type 3|DLD-Related Disorders|Inborn genetic diseases|not provided	Pathogenic/Likely pathogenic(Last reviewed: Dec 30, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011971	7	107557794	7	107917349	11971	27010	rs121964992	NC_000007.14:107917348:G:A
NM_000108.5(DLD):c.875+1G>A	DLD		Maple syrup urine disease, type 3	Pathogenic/Likely pathogenic(Last reviewed: May 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000011970	7	107556142	7	107915697	11970	27009	rs1328820332	NC_000007.14:107915696:G:A
NM_000108.5(DLD):c.1178T>C (p.Ile393Thr)	DLD	I393T, I345T, I370T, I294T	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Mar 1, 2005)	no assertion criteria provided	VCV000011969	7	107557849	7	107917404	11969	27008	rs121964991	NC_000007.14:107917403:T:C
NM_000108.5(DLD):c.1483A>G (p.Arg495Gly)	DLD	R495G, R447G, R396G, R472G	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Dec 1, 1996)	no assertion criteria provided	VCV000011968	7	107559657	7	107919212	11968	27007	rs121964989	NC_000007.14:107919211:A:G
NM_000108.5(DLD):c.685G>T (p.Gly229Cys)	DLD	G229C, G181C, G130C, G206C	Maple syrup urine disease, type 3|Inborn genetic diseases|DLD-Related Disorders|not provided	Pathogenic(Last reviewed: Nov 2, 2020)	criteria provided, multiple submitters, no conflicts	VCV000011966	7	107555951	7	107915506	11966	27005	rs121964990	NC_000007.14:107915505:G:T
NM_000108.5(DLD):c.1463C>T (p.Pro488Leu)	DLD	P488L, P465L, P389L, P440L	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Jun 1, 1993)	no assertion criteria provided	VCV000011965	7	107559543	7	107919098	11965	27004	rs121964988	NC_000007.14:107919097:C:T
NM_000108.5(DLD):c.214A>G (p.Lys72Glu)	DLD	K72E	Maple syrup urine disease, type 3	Pathogenic(Last reviewed: Aug 1, 2011)	no assertion criteria provided	VCV000011964	7	107542785	7	107902340	11964	27003	rs121964987	NC_000007.14:107902339:A:G
NM_002291.3(LAMB1):c.5225-7C>T	LAMB1|DLD		Maple syrup urine disease|not provided|Leigh syndrome|Pyruvate dehydrogenase complex deficiency|not specified|Lissencephaly 5	Benign(Last reviewed: Aug 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000369575	7	107564539	7	107924094	369575	353804	rs3213673	NC_000007.14:107924093:G:A
NM_172250.3(MMAA):c.433C>T (p.Arg145Ter)	MMAA	R145*	Methylmalonic acidemia|Vitamin B12-responsive methylmalonic acidemia type cblA|not provided	Pathogenic/Likely pathogenic(Last reviewed: Feb 24, 2021)	criteria provided, multiple submitters, no conflicts	VCV000003160	4	146560724	4	145639572	3160	18199	rs104893851	NC_000004.12:145639571:C:T
NM_152542.5(PPM1K):c.708-116C>T	PPM1K		Maple syrup urine disease, mild variant	Benign(Last reviewed: Aug 26, 2020)	criteria provided, single submitter	VCV001168507	4	89189602	4	88268450	1168507	1154846		NC_000004.12:88268449:G:A
NM_152542.5(PPM1K):c.708-169G>A	PPM1K		Maple syrup urine disease, mild variant	Benign(Last reviewed: Aug 20, 2020)	criteria provided, single submitter	VCV001168341	4	89189655	4	88268503	1168341	1154847		NC_000004.12:88268502:C:T
NM_152542.5(PPM1K):c.707+7C>T	PPM1K		Maple syrup urine disease, mild variant	Benign(Last reviewed: Sep 7, 2020)	criteria provided, single submitter	VCV001167226	4	89189886	4	88268734	1167226	1154848		NC_000004.12:88268733:G:A
NM_152542.5(PPM1K):c.294C>T (p.Ala98=)	PPM1K		Maple syrup urine disease, mild variant	Benign(Last reviewed: Jun 16, 2020)	criteria provided, single submitter	VCV001166431	4	89199442	4	88278290	1166431	1154849		NC_000004.12:88278289:G:A
NM_152542.5(PPM1K):c.54A>G (p.Arg18=)	PPM1K		Maple syrup urine disease, mild variant	Likely benign(Last reviewed: Jul 8, 2020)	criteria provided, single submitter	VCV001161260	4	89199682	4	88278530	1161260	1136029		NC_000004.12:88278529:T:C
NM_152542.5(PPM1K):c.174A>G (p.Pro58=)	PPM1K		Maple syrup urine disease, mild variant	Likely benign(Last reviewed: Feb 28, 2020)	criteria provided, single submitter	VCV001160032	4	89199562	4	88278410	1160032	1136028		NC_000004.12:88278409:T:C
NM_152542.5(PPM1K):c.582A>G (p.Leu194=)	PPM1K		Maple syrup urine disease, mild variant	Likely benign(Last reviewed: Jul 23, 2020)	criteria provided, single submitter	VCV001159293	4	89190018	4	88268866	1159293	1136027		NC_000004.12:88268865:T:C
NM_152542.5(PPM1K):c.858T>G (p.His286Gln)	PPM1K	H286Q	Maple syrup urine disease, mild variant	Likely benign(Last reviewed: Dec 26, 2019)	criteria provided, single submitter	VCV001082206	4	89186282	4	88265130	1082206	1071955		NC_000004.12:88265129:A:C
NM_152542.5(PPM1K):c.1075T>A (p.Phe359Ile)	PPM1K	F359I	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Oct 7, 2020)	criteria provided, single submitter	VCV001058047	4	89183791	4	88262639	1058047	1042970		NC_000004.12:88262638:A:T
NM_152542.5(PPM1K):c.47A>C (p.Gln16Pro)	PPM1K	Q16P	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001051463	4	89199689	4	88278537	1051463	1042971		NC_000004.12:88278536:T:G
NM_152542.5(PPM1K):c.77G>A (p.Arg26His)	PPM1K	R26H	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Apr 8, 2020)	criteria provided, single submitter	VCV001046955	4	89199659	4	88278507	1046955	1026030		NC_000004.12:88278506:C:T
NM_152542.5(PPM1K):c.587G>A (p.Arg196Gln)	PPM1K	R196Q	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Jul 25, 2020)	criteria provided, single submitter	VCV001038220	4	89190013	4	88268861	1038220	1026029		NC_000004.12:88268860:C:T
NM_152542.5(PPM1K):c.208C>T (p.Arg70Cys)	PPM1K	R70C	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Apr 20, 2020)	criteria provided, single submitter	VCV001001639	4	89199528	4	88278376	1001639	990310		NC_000004.12:88278375:G:A
NM_152542.5(PPM1K):c.974C>T (p.Ala325Val)	PPM1K	A325V	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV001000474	4	89186166	4	88265014	1000474	990309		NC_000004.12:88265013:G:A
NM_152542.5(PPM1K):c.388G>A (p.Gly130Ser)	PPM1K	G130S	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Feb 20, 2020)	criteria provided, single submitter	VCV000949421	4	89199348	4	88278196	949421	923621		NC_000004.12:88278195:C:T
NM_152542.5(PPM1K):c.526C>T (p.Arg176Cys)	PPM1K	R176C	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000939984	4	89198310	4	88277158	939984	932464		NC_000004.12:88277157:G:A
NM_152542.5(PPM1K):c.475C>G (p.Leu159Val)	PPM1K	L159V	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Mar 13, 2019)	criteria provided, single submitter	VCV000860430	4	89198361	4	88277209	860430	829521		NC_000004.12:88277208:G:C
NM_152542.5(PPM1K):c.971A>G (p.His324Arg)	PPM1K	H324R	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Apr 5, 2019)	criteria provided, single submitter	VCV000857355	4	89186169	4	88265017	857355	829520		NC_000004.12:88265016:T:C
NM_152542.5(PPM1K):c.311G>A (p.Arg104Gln)	PPM1K	R104Q	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: May 18, 2019)	criteria provided, single submitter	VCV000835720	4	89199425	4	88278273	835720	829522		NC_000004.12:88278272:C:T
NM_152542.5(PPM1K):c.629G>A (p.Arg210Gln)	PPM1K	R210Q	Maple syrup urine disease, mild variant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000791728	4	89189971	4	88268819	791728	709506	rs77538297	NC_000004.12:88268818:C:T
NM_152542.5(PPM1K):c.961G>A (p.Glu321Lys)	PPM1K	E321K	Maple syrup urine disease, mild variant	Benign(Last reviewed: Nov 10, 2020)	criteria provided, single submitter	VCV000775998	4	89186179	4	88265027	775998	698678	rs35523553	NC_000004.12:88265026:C:T
NM_152542.5(PPM1K):c.525C>T (p.Ala175=)	PPM1K		Maple syrup urine disease, mild variant|not provided	Likely benign(Last reviewed: Apr 28, 2018)	criteria provided, single submitter	VCV000757668	4	89198311	4	88277159	757668	764640	rs778580842	NC_000004.12:88277158:G:A
NM_152542.5(PPM1K):c.708-5A>G	PPM1K		Maple syrup urine disease, mild variant	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000729996	4	89189491	4	88268339	729996	744179	rs192622849	NC_000004.12:88268338:T:C
NM_152542.5(PPM1K):c.988-7C>G	PPM1K		Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000664284	4	89183885	4	88262733	664284	651224	rs1335866068	NC_000004.12:88262732:G:C
NM_152542.5(PPM1K):c.542-3T>C	PPM1K		Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000655372	4	89190061	4	88268909	655372	651281	rs534271377	NC_000004.12:88268908:A:G
NM_152542.5(PPM1K):c.509C>A (p.Ala170Asp)	PPM1K	A170D	Maple syrup urine disease, mild variant	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000580759	4	89198327	4	88277175	580759	562287	rs770171465	NC_000004.12:88277174:G:T
NM_152542.5(PPM1K):c.978G>A (p.Val326=)	PPM1K		Maple syrup urine disease, mild variant	Benign(Last reviewed: Nov 13, 2020)	criteria provided, single submitter	VCV000473876	4	89186162	4	88265010	473876	453594	rs34981823	NC_000004.12:88265009:C:T
NM_152542.5(PPM1K):c.481A>G (p.Thr161Ala)	PPM1K	T161A	Maple syrup urine disease, mild variant	Benign(Last reviewed: Oct 19, 2020)	criteria provided, single submitter	VCV000473875	4	89198355	4	88277203	473875	454044	rs113436519	NC_000004.12:88277202:T:C
NM_152542.5(PPM1K):c.339C>T (p.Phe113=)	PPM1K		Maple syrup urine disease, mild variant	Benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV000473874	4	89199397	4	88278245	473874	454373	rs116564150	NC_000004.12:88278244:G:A
